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ANALYSIS OF OPTIONS FOR IMPLEMENTING DISCLOSURE OF ORIGIN 
REQUIREMENTS IN INTELLECTUAL PROPERTY APPLICATIONS 
 
The Conference of the Parties, at its seventh meeting, in decision VII/19 E, paragraph 9, invited 
UNCTAD to examine a number of issues related to disclosure of origin requirements in intellectual 
property applications and to prepare a report for submission to the ongoing process of work of the CBD. 
 
The Executive Secretary is pleased to circulate an analytical study entitled "Analysis of Options 
for Implementing Disclosure of Origin Requirements in Intellectual Property Applications", by Joshua 
Sarnoff and Carlos Correa, which was commissioned by the UNCTAD Secretariat in response to the 
invitation by the Conference of the Parties.  The paper was written by the authors in their personal 
capacities as experts in the field, and does not necessarily represent the views of the UNCTAD 
Secretariat.  It is intended to make an in-depth, practical and substantive contribution to policy dialogue 
and consensus-building on the topics considered.   
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A. Background to the CBD invitation to UNCTAD 
 
In 2002, the Conference of the Parties (COP) of the Convention on Biological Diversity 
(CBD) at its Sixth Meeting adopted the Bonn Guidelines to address access to genetic 
resources and fair and equitable benefit-sharing arising from use of those resources. In 
the Bonn Guidelines, the CBD COP invited Parties and governments to encourage 
disclosure of the country of origin of genetic resources and of associated traditional 
knowledge in applications for intellectual property where the subject matter of the 
application concerns or makes use of such knowledge in its development. Since 2002, 
various proposals to facilitate or to mandate such “disclosure of origin” requirements 
within the world intellectual property law system have been submitted by countries to 
intergovernmental organizations, notably the World Trade Organization (WTO) and the 
World Intellectual Property Organization (WIPO). In 2004, at its Seventh Meeting, the 
CBD COP, in Decision VII/19, invited WIPO and the United Nations Conference on 
Trade and Development (UNCTAD) to analyse issues relating to implementation of 
disclosure of origin requirements in the intellectual property law system. 
 
Specifically, the CBD COP identified for analysis five distinct topics relating to 
disclosure of origin requirements. These are: 
 
• Options for model provisions on proposed disclosure requirements; 
• Practical options for intellectual property application procedures with 
regard to the triggers of disclosure requirements; 
• Options for incentive measures for applicants; 
• Identification of the implications for the functioning of disclosure 
requirements in various WIPO-administered treaties; and  
• Intellectual property-related issues raised by proposed international 
certificates of origin/source/legal provenance. 
 
This analysis has been commissioned by the UNCTAD secretariat as a contribution to its 
response to the CBD COP’s invitation. However, the views in this document are solely 
those of the authors and do not necessarily reflect the views of UNCTAD or the authors’ 
institutions. The analysis is intended to make a thorough, practical, and substantive 
contribution to discussions on the topics identified above. It builds upon prior analyses of 
these issues by the authors, by WIPO, by various countries, and in a growing body of 
literature. 
 
The analysis begins with an introduction, which provides additional background on the 
CBD COP invitation, identifies the need for and features of an international system of 
mandatory disclosure of origin requirements, and defines the scope of the analysis and 
the terminology used therein. The discussion of terminology is important, both to assure a 




The introduction is followed by a five additional sections that address the topics 
identified by the CBD COP.  Part II discusses the basic choices for “model provisions,” 
focusing on an international regime of mandatory disclosure requirements, triggers for 
disclosure requirements and the consequences of disclosure failures, as well as the choice 
of treaty regime in which to adopt disclosure requirements. Part III examines in greater 
depth the options relating to substantive and procedural triggers for disclosure 
requirements. Part IV addresses incentives for enforcement of disclosure obligations that 
are internal to the intellectual property law system. Part V discusses practical issues in 
implementing disclosure of origin requirements within existing WIPO-administered 
treaties, focusing on WIPO patent law treaties. These practical considerations apply 
beyond the specific context of patent applications and have relevance for other 
intellectual property treaty regimes, such as the WTO’s Agreement on Trade-Related 
Aspects of Intellectual Property Rights (the TRIPS Agreement), the Union for the 
Protection of New Varieties of Plants (UPOV), and the International Treaty on Plant 
Genetic Resources for Food and Agriculture (ITPGRFA). Finally, Part VI analyses 
intellectual property law issues raised by international certificates of origin when such 
certificates are used to effectuate disclosure of origin requirements.   
 
B. Summary of principal findings 
 
The remainder of this executive summary provides a brief overview of the most 
significant issues and conclusions of the analysis. It briefly reviews the issues addressed 
and the conclusions of the introduction and of parts II to VI, with a view to facilitating an 




There is a need for an international system of mandatory disclosure of origin 
requirements.   
An international system of mandatory disclosure of origin requirements is needed to 
prevent misappropriation of genetic resources and associated traditional knowledge, to 
promote compliance with CBD access and benefit-sharing requirements, and to prevent 
misuse of the intellectual property system. As recognized by the Bonn Guidelines, 
disclosure of origin requirements for intellectual property applications are an important 
element of the CBD access and benefit-sharing regime, reflecting the interconnection of 
the CBD regime with the international intellectual property law system. Although 
national legislation imposing disclosure of origin requirements already exists in some 
countries, in many others where intellectual property may be sought such requirements 
have yet to be adopted. Thus new international treaty provisions are required to assure 
worldwide implementation of disclosure of origin requirements. 
 
Objections raised to mandating adoption of disclosure of origin requirements through 
new international treaty provisions either do not stand up to analysis or do not outweigh 




(a) May be useful in improving substantive examinations and in 
assuring the integrity of determinations under traditional 
intellectual property legal requirements, in providing greater 
certainty as to the validity of granted rights or privileges, and in 
reducing the need for revocation of improperly granted intellectual 
property; 
(b) May assist in identifying situations and facilitating corrective 
actions where intellectual property is improperly granted, or where 
access to genetic resources and associated traditional knowledge 
has been obtained without concluding contracts establishing prior 
informed consent and equitable benefit-sharing;  
(c) Are necessary to prevent misappropriation of commercial benefits 
that are improperly obtained as a consequence of applying for, 
owning or transferring intellectual property;  
(d) May help to make more coherent existing and future national laws 
regarding misappropriation that affect the validity of intellectual 
property or the entitlement to own or retain benefits from 
intellectual property; and  
(e) May reduce uncertainties of and make more transparent an 
international system of national access and benefit-sharing, and 
intellectual property laws. 
 
Suggested outline for an international system of mandatory disclosure of origin 
requirements.   
To be effective in deterring violations of access and benefit-sharing requirements and in 
preventing misappropriation, disclosure of origin requirements must provide authority to 
deny entitlements to apply for, own or enforce intellectual property. Similarly, they must 
provide authority to permit national intellectual property offices to delay processing of 
intellectual property applications or to consider such applications withdrawn when 
required information is not provided in a timely manner. Disclosures of origin should be 
required at the earliest stage of intellectual property applications, and should obligate 
applicants to disclose: 
 
(a) The source of genetic resources and associated traditional 
knowledge; 
(b) The country providing genetic resources and associated 
traditional knowledge; 
(c) Available documentary information regarding compliance with 
access and benefit-sharing requirements; and  
(d) Information known to the applicant (following a specified level 
of effort for inquiry) regarding persons involved in the subject 
matter of the application and the country of origin of genetic 
resources and associated traditional knowledge. 
 
These disclosures should be based on a broad set of substantive triggers that relate the 
subject matter of the application to the genetic resources and associated traditional 
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knowledge. Required disclosures should be reviewed at the international and national 
stages of application proceedings for completeness and for formal compliance with 
specified procedures, but should not ordinarily be reviewed for substantive validity or 
legality (unless such review already is required). In contrast, substantive reviews of 
disclosures should occur principally in a judicial action, or in a pre-grant or post-grant 
administrative challenge proceeding.  In the absence of bad faith, opportunities to rectify 
disclosure failures should be provided, and remedies tailored to the scope and nature of 
the disclosure failures. 
 
Scope of the analysis. 
This analysis focuses on the concerns raised by the CBD with regard to disclosure of 
origin requirements in intellectual property applications. Although the Convention 
broadly concerns genetic resources, biological materials and biological diversity, the 
access and benefit-sharing requirements of Article 15 address only genetic resources. 
Accordingly, this analysis focuses on disclosure of origin requirements for genetic 
resources, and explores a wide variety of substantive and procedural relationships 
between the genetic resources and the subject matter of intellectual property applications. 
Similarly, the CBD’s Article 8(j) directly addresses for purposes of equitable benefit-
sharing only that body of traditional knowledge that is relevant for the conservation and 
sustainable use of biological diversity. Traditional knowledge, innovation and practices, 
however, encompass a much wider array of information. As has the CBD COP, this 
analysis focuses on traditional knowledge that is associated with genetic resources. 
Nevertheless, the principles discussed here may have relevance for biological materials 
other than genetic resources and for other forms of traditional knowledge that relate to the 
subject matter of intellectual property applications. 
 
Terminology. 
Many of the terms associated with disclosure of origin requirements relating to genetic 
resources and traditional knowledge have no standard definitions. Yet the scope of and 
burdens in complying with required disclosures will depend on the definitions of relevant 
terms and how they relate to the various substantive and procedural triggers adopted. In 
order to provide greater clarity, this analysis defines several key terms using definitions 
that are derived from or supplement those adopted by the CBD. 
 
(a) Genetic resources means “genetic material of actual or potential 
value,” i.e. valuable “material of plant, animal, microbial or other 
origin containing functional units of heredity.” 
(b) The country of origin means the country that possesses the 
relevant genetic resources in in-situ conditions, even if a country 
of origin is not the country where the genetic resources 
historically originated.  There may be many countries of origin. 
(c) The country providing genetic resources means the country 
from which genetic resources relevant to an intellectual property 
application have been supplied.  
(d) The source of genetic resources means the person or entity 
directly providing access to genetic resources. A source may 
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either possess or lack authority to provide access under specified 
conditions of use and of equitable benefit-sharing. 
(e) Authority refers to the ability of the source to legally provide 
access on specified conditions of use, and to establish conditions 
to ensure that the source or other relevant persons involved will 
receive an equitable share of benefits arising from the use of 
genetic resources. Authority is used here to define a legal 
condition, rather than to refer to a government entity 
(administrative or judicial) that determines whether access under 
specified conditions is permitted or prohibited. 
(f) Legal provenance means possession of or other access to 
genetic resources for use under specified conditions, pursuant to 
authority.  
(g) Biopiracy means obtaining access to genetic resources without 
authority. 
(h) Misappropriation means using genetic resources in violation of 
access conditions or deriving benefits without equitable benefit- 
sharing. 
(i) Traditional knowledge means knowledge, innovations and 
practices of indigenous or local communities associated with 
genetic resources. 
(j) Intellectual property applications means applications relating 
to intangible subject matter that require some government action 
(such as registration or examination) before rights or privileges 
will vest. 
(k) The applicant for intellectual property means any and all 
persons entitled or required to apply for the relevant intellectual 
property. 
(l) Persons involved means all persons who were involved in the 
development of the subject matter of or the application for 
intellectual property, or whose involvement may have a bearing 
on the entitlement of the applicant to apply for or receive benefits 
of intellectual property. 
(m) Certificate of origin means a document issued by a competent 
entity that identifies the source of genetic resources and 
associated traditional knowledge, attests to the authority of the 
source to provide access under specified conditions of use, and 
attests to ex-ante compliance with applicable benefit-sharing 
requirements.  Certificates of origin thus differ from declarations 
(typically under oath) made by applicants for intellectual 
property, and from other common uses of the term to denote 
certificates that identify the country of origin.  By certifying 
authority to use genetic resources and associated traditional 
knowledge, certificates of origin document the legal provenance 
of genetic resources and associated traditional knowledge under 
specified conditions and in the absence of misappropriation. 
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Certificate of origin thus corresponds to common uses of the 
terms certificate of source and certificate of legal provenance. 
Monitoring may be needed to assure ex-post compliance with 
certificates of origin once they are issued. 
 
Options for model provisions for disclosure of origin requirements  
 
Principles relating to the recognition and enforcement of foreign laws may already 
impose mandatory disclosure of origin requirements. 
Disclosure of origin requirements already exist under the national laws of many 
countries, and contracts for access and benefit-sharing may impose requirements to make 
such disclosures in intellectual property applications wherever filed, even when not 
required by such national laws. Mandatory disclosure requirements thus already exist to 
the extent that national disclosure of origin laws and contracts requiring such disclosures 
are recognized and enforced under legal principles such as comity in the various 
jurisdictions where intellectual property is sought. However, the principles governing 
recognition and enforcement of national disclosure of origin requirements (including 
choice of law and jurisdictional principles) are not well established or understood. New 
international treaty provisions may help to make the recognition and enforcement of such 
national laws and contractual provisions more coherent. 
 
Disclosure of origin requirements should be consistent with international 
intellectual property treaties. 
 Prior analyses have established that most of the proposed forms of national disclosure of 
origin requirements are consistent with WIPO-administered patent law treaties, as well as 
with the TRIPS Agreement and the UPOV Convention.  In particular, existing intellectual 
property law treaties do not preclude disclosure of origin requirements, as they relate to 
substantive entitlements to apply for and to own intellectual property. Permissible 
consequences of failing to comply with disclosure of origin requirements may include 
refusing to grant intellectual property, or invalidation of intellectual property when 
required information was accidentally or intentionally omitted or when false or fraudulent 
documentation was submitted. Therefore, proposals to facilitate such disclosures that 
seek, for example, to amend the Rules of the Patent Cooperation Treaty (PCT) may not 
be needed. 
 
Mandatory disclosure of origin requirements are needed, and may provide greater 
coherence to the international system. 
As noted by many developing countries, although mandatory disclosure of origin 
requirements exist pursuant to the national legislation of some countries, there are good 
reasons to adopt new international treaty provisions requiring mandatory disclosure of 
origin obligations. Without mandatory obligations, national disclosure of origin 
requirements may not be recognized and enforced by other countries in which intellectual 
property is applied for, and information provided pursuant to such requirements may not 
be employed to prevent improper issuance of intellectual property. On the other hand, 
mandatory disclosure of origin requirements will provide numerous benefits for both the 
CBD regime and the intellectual property law system, including greater coherence in 
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recognition and enforcement of existing disclosure of origin obligations.  In addition, 
mandatory requirements may: improve determinations of inventorship or other 
relationship to the subject matter, thereby assisting in the identification of persons 
involved who should participate in equitable benefit-sharing; facilitate abilities to use the 
subject matter of the intellectual property; promote compliance with access and benefit-
sharing legislation; and help to track commercialization of intellectual property so as to 
promote more effective benefit-sharing. 
 
Numerous options for mandatory disclosure of origin requirements and compliance 
consequences should be evaluated. 
Disclosure of origin obligations must be evaluated in terms of the nature and timing of 
the information to be disclosed, and the consequent administrative burdens and costs 
associated with providing and reviewing disclosed information.  Issues to be considered 
include:  
 
(a) The substantive and procedural triggers for information to be 
provided and evaluated, including specifying the relevant 
relationships between genetic resources and associated 
traditional knowledge and the subject matter of intellectual 
property at the international and national stage of application 
procedures, in pre-grant and post-grant administrative challenges 
and in judicial proceedings;  
(b) The form, prescribed formats and timing of the information and 
documentation to be submitted, and whether and when it should 
be supplemented or corrected, including disclosures of 
information only, disclosures accompanied by declarations of 
applicants, disclosures accompanied by documentary information 
regarding access and benefit-sharing, and disclosures 
accompanied by international certificates of origin;  
(c) The degree to which information and documentation is reviewed 
for sufficiency and validity, including completeness, substantive 
adequacy of information, accuracy of declarations and 
documents, and validity of international certificates of origin; 
and  
(d) The degree to which disclosure failures of varying types should 
be sanctioned, including: leaving decisions to the discretion of 
contracting States; relying on sanctions that do not affect the 
validity or ownership of intellectual property; imposing civil 
liability or criminal penalties; using unfair competition or other 
legal regimes in addition to the intellectual property system; 
imposing administrative fines or criminal penalties for omissions 
or false or fraudulent statements; requiring revocation or 
invalidation of intellectual property; requiring full or partial 





The TRIPS Agreement is the most appropriate treaty regime in which to adopt 
mandatory disclosure of origin requirements. 
The choice of treaty regime in which to mandate disclosure of origin requirements 
requires careful attention, so as to ensure that the obligations will apply to all intellectual 
property for which applications are made and that there will be continuing coordination 
between CBD obligations and the intellectual property law system. Particularly in light of 
the broad membership of the WTO and its existing dispute settlement procedures, the 
TRIPS Agreement is the most appropriate treaty regime in which to include mandatory 
disclosure of origin requirements. 
 
Practical options for intellectual property application procedures   
 
Substantive triggers. 
Substantive triggers for disclosures of origin must define the relationships between 
genetic resources and associated traditional knowledge and applications for intellectual 
property that require disclosures in various procedural contexts. Substantive triggers 
should reflect the purposes to be accomplished by disclosure obligations. Disclosures of 
origin may assist in making determinations: within the intellectual property law system; 
regarding entitlements to apply for and own intellectual property and to receive an 
equitable share of the benefits under other laws; and of compliance with CBD access and 
benefit-sharing legislation and contracts. Substantive triggers will need to be broad (i.e. 
addressing many types of inputs into the process of discovery of and application for the 
subject matter, as well as of its use) to assure the proper recognition and enforcement of 
entitlements to apply for and own intellectual property and to ensure that benefit-sharing 
is equitable. Mandatory disclosure obligations should also specify the types of required 
disclosures, such as disclosures of information only, disclosures accompanied by 
declarations of applicants, and disclosures accompanied by documentary information. 
Different disclosure obligations may apply to various substantive and procedural triggers. 
 
Substantive triggers may address: 
 
(a) The relationship of the source of genetic resources and associated 
traditional knowledge to the subject matter of the intellectual 
property application (e.g. by forming part of the subject matter, 
by use during its development, by use as a necessary prerequisite 
or background, or to facilitate development, or by forming part 
of the prior art); 
(b) The relationship of the source to the applicant for intellectual 
property under intellectual property and other laws; 
(c) The relationship of the applicant to persons involved; 
(d) Disclosure of the country of origin; and 
(e) Disclosure of documentary information regarding compliance 





Mandatory disclosure obligations may also need to specify the manner in which 
applicants must provide required information. Options for disclosures may include: 
 
(a) Presenting information on standardized forms using standardized 
terms; 
(b) Addressing specified mandatory contents; 
(c) Describing specified levels of effort and documenting 
investigations performed; 
(d) Reaching a specified set of conclusions and explaining the bases 
thereof; and  
(e) Providing indications of levels of confidence. 
 
Procedural triggers. 
Procedural triggers for disclosures of origin must define the opportunities for required 
disclosures and evaluations, the format in which information is to be submitted and the 
types of evaluations that are to be made. Procedural triggers may be imposed by national 
access and benefit-sharing legislation, by contracts or by new treaty requirements. In 
specifying mandatory procedural triggers, consideration must be given not only to 
evaluations that are made by international and national intellectual property offices, but 
also to other uses to which required disclosures may be put during and after the 
application process. Application disclosure requirements thus may include information 
that may not be evaluated during the application process.  Consideration must also be 
given to whether and when to require or  permit applicants or owners to supplement or  
correct disclosures during or after the application process. 
 
Opportunities for required disclosures and evaluations may include: 
 
(a) The international stage of application processing (in a coordinated 
international system of national intellectual property application 
procedures); 
(b) The national stage of application processing; 
(c) Pre-grant and post-grant administrative challenge proceedings; and 
(d) Judicial proceedings. 
 
Evaluations of disclosed information may include determining: 
 
(a) Completeness; 
(b) Conformity to standardized forms and formats; 
(c) Accuracy of factual information; 
(d) Substantive validity of conclusions reached; 
(e) Conformity to declarations and documentary information; and  




Options for incentives for enforcement of disclosure obligations 
 
Different types of incentive measures exist to induce compliance with mandatory 
disclosure of origin requirements.  These include various types of sanctions and positive 
incentives that do not have a sanctioning effect. The wide range of sanctions to address 
the failure of applicants to make required disclosures of origin may be mandatory or 
facultative; and they may be directly within or external to the intellectual property law 
system. Options for direct or indirect mandatory or facultative sanctions may include: 
 
(a) Curable or incurable, temporary or permanent bars to the 
processing of applications;  
(b) Administrative fines, civil liability or criminal penalties;  
(c)  Termination, or full or partial transfer of entitlements to apply for 
or own intellectual property;  
(d) Curable or incurable, temporary or permanent, full or partial 
unenforceability, revocation, narrowing of the subject matter, or 
invalidation of granted intellectual property;  
(e) Return or transfer of benefits received from intellectual property; 
and 
(f) Enforcement of existing or new obligations that provide for 
equitable benefit-sharing. 
 
Any measures to induce compliance regarding disclosures of origins must provide an 
effective deterrent to non-compliance, and must ensure that the intellectual property 
system is not misused to further inequitable conduct. Also, incentive measures should 
minimize burdens on applicants that might generate perverse results, and should provide 
flexibility to respond to a wide variety of disclosure failures. Sanctions may be applied 
sequentially or in combination, rather than as exclusive alternatives. 
 
Implications for WIPO-administered treaties   
 
Although most of the proposed forms of disclosure of origin requirements are legally 
compatible with existing WIPO-administered treaties, those treaties were not adopted 
with disclosure of origin requirements in mind.  Moreover, even if some forms of 
mandatory disclosure of origin obligations were deemed incompatible with existing 
WIPO-administered treaty provisions, the disclosure of origin obligations (as later-
enacted treaty obligations) would take precedence for parties to both sets of treaties.  
Nevertheless, the rules, forms and procedures adopted pursuant to WIPO-administered 
treaties may need to be changed in order to more effectively implement mandatory 
disclosure of origin obligations. 
Analysis of the PCT regime identifies a number of issues that need to be addressed in 
effectuating disclosure of origin requirements within the international system of 




(a) Revising rules, forms and administrative instructions to address the 
types of information to be supplied, including use of standardized 
formats and wording for the provision of information; 
(b) Adopting procedures (including the use of electronic documents) 
for duplicating, evaluating and transmitting the different types of 
information supplied, taking into account the costs involved and 
the uses to which the information will be put;  
(c) Revising the fees charged to applicants to reflect the type of 
information submitted and the costs incurred in processing and 
evaluating the information at the international and national stages 
of application procedures; and  
(d) Addressing the timing and need for translation of required 
information and documentation. 
 
Intellectual property-related issues for international certificates of origin 
 
International certificates of origin not only may assist in tracing flows of genetic 
resources and associated traditional knowledge, but also attest to the legal provenance to 
provide access to such resources and knowledge under specified conditions for their use. 
Thus, certificates of origin could assist in demonstrating compliance with CBD access 
and benefit-sharing requirements and in complying with mandatory disclosure of origin 
requirements. However, the use of certificates of origin raises the same considerations 
previously discussed regarding substantive and procedural triggers for disclosure, 
evaluations of submitted information and consequences for disclosure failures. In 
addition, the use of certificates of origin raises other issues regarding ex-ante verification 
of information by certifying entities, the consequences of errors of certification, ex-post 
tracking of certified information to assure its continuing validity, and misuse of 
certificates by persons to whom they are issued and by others. Moreover, determining 
what entities have authority to issue certificates may require complex considerations. 
 
Like other types of certification documents, international certificates of origin may be 
issued erroneously, falsified or put to improper uses.  Consideration must be given to 
what standards should apply to issuing certifications, whether to mandate or to facilitate 
use of certificates of origin in satisfying disclosure of origin requirements, how to address 
errors of certification and improper uses of certificates, and what consequences should 
attach to false, deceptive or confusing uses of certificates. Additional consideration must 




In summary, there is a need for new international treaty provisions that would mandate 
disclosure of origin requirements in applications for intellectual property. The most 
appropriate treaty regime for adopting such requirements is the TRIPS Agreement. 
Numerous benefits could be derived from disclosure of origin requirements, although 
care should be taken to minimize the administrative costs and burdens of implementation. 
The treaty provisions will need to specify the substantive and procedural triggers for 
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making required disclosures, the types and timing of evaluations of disclosed 
information, the mandatory or facultative consequences of various types of disclosure 
failures, and whether to mandate or facilitate the use of international certificates of origin 
in making required disclosures. Although disclosure of origin requirements are consistent 
with existing intellectual property treaties, such requirements may be facilitated by 
revising existing rules, forms and procedures for implementing those treaties.   
 
Additional research and evaluation would help to inform policy choices regarding the 
contents of mandatory disclosure of origin requirements to be included in new 
international treaty provisions.  In particular, additional analysis would be beneficial 
regarding: the relationship of existing national laws governing misappropriation with 
entitlements to apply for and own intellectual property; and the recognition and 
enforcement of national access and benefit-sharing laws and contractual provisions that 
impose disclosure of origin requirements, and their relationship with the intellectual 
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I.  Introduction and background 
 
1. This analysis has been commissioned by the secretariat of the United Nations 
Conference on Trade and Development (UNCTAD) in response to an invitation from the 
Conference of the Parties (COP) of the Convention on Biological Diversity (CBD) in 
Decision VII/19, adopted at its Seventh Meeting in 2004.1 The views in this document are 
solely those of the authors and do not necessarily reflect the views of UNCTAD or the 
authors’ institutions. 
 
2. CBD, Bonn Guidelines, WIPO Technical Study and CBD COP Decision 
VII/19 
Article 15.5 of the CBD provides for access to genetic resources subject to the prior 
informed consent of the Party providing those resources.  Articles 15.4 and 15.7 of the 
CBD subjects any granted access to genetic resources to mutually agreed terms, and 
requires Parties to take measures to share in a fair and equitable way with the Party 
providing the genetic resources the results of research and development and the benefits 
deriving from their commercialization and other uses. Article 8(j) of the CBD encourages 
respect for and preservation of traditional knowledge, and the equitable sharing of 
benefits arising from the utilization of traditional knowledge that is relevant for the 
conservation and sustainable use of biological diversity. These requirements of prior 
informed consent and mutually agreed terms with regard to the provision of access to 
genetic resources, and for equitable benefit-sharing of genetic resources and traditional 
knowledge, are generically referred to as the “access and benefit-sharing” requirements. 
 
3.  In 2002, the sixth COP of the CBD adopted voluntary guidelines (the Bonn 
Guidelines) to address access to genetic resources and fair and equitable benefit-sharing 
arising from use of those resources.2 In the Bonn Guidelines, the CBD COP invited 
Parties and governments to encourage applicants for intellectual property to disclose the 
country of origin of genetic resources and the origin of traditional knowledge, 
innovations and practices of indigenous and local communities embodying traditional 
lifestyles (traditional knowledge), when the subject matter of the application concerns or 
makes use of genetic resources or traditional knowledge in its development.3 Such 
disclosure requirements are generically referred to as “disclosure of origin” requirements. 
In adopting the Bonn Guidelines, the CBD COP noted that disclosure of origin 
requirements could contribute to tracking compliance with prior informed consent and 
the mutually agreed terms (including provisions for equitable sharing of the benefits of 
research and commercialization) on which access to those resources was granted.4 
 
                                                 
1 UNEP/CBD/COP/7/21, Article 15, available at: http://www.biodiv.org/doc/meetings/cop/cop-
07/official/cop-07-21-part2-en.pdf 
2  UNEP/CBD/COP/6/20, ¶ 3 and Annex, available at: http://www.biodiv.org/doc/decisions/COP-06-dec-
en.pdf. 
3 UNEP/CBD/COP/6/20, Decision VI-24.C. and ¶¶ 1, 2, available at  
http://www.biodiv.org/doc/decisions/COP-06-dec-en.pdf 
4 Id., ¶ 1. 
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4. In the Bonn Guidelines, the CBD COP also urged consideration of measures 
aimed at preventing the misappropriation of genetic resources obtained without the prior 
informed consent of the Contracting Party providing such resources. Specifically, it 
suggested measures to support compliance with access and benefit-sharing requirements, 
including disclosure of the country of origin of genetic resources and the origin of 
traditional knowledge, measures to prevent use of genetic resources obtained without 
prior informed consent, and measures discouraging unfair trade practices.5 The CBD 
COP further suggested that national governments monitor applications for intellectual 
property relating to the material supplied, recognized that verification of compliance with 
access and benefit-sharing requirements may involve systems of voluntary certification, 
and authorized Parties to adopt appropriate, effective and proportional measures to 
address violations of national requirements for implementing the CBD.6   
 
5. The CBD COP invited the World Intellectual Property Organization (WIPO) to 
submit for the Seventh Meeting an analysis of disclosure of origin requirements in patent 
applications and consistency with WIPO-administered treaties.7 Specifically, it requested 
analysis relating to the disclosure of: 
 
  (a) Genetic resources used in developing claimed inventions; 
  (b)  The country of origin of such genetic resources; 
  (c)  Associated traditional knowledge used in such development; 
  (d)  The source of such associated traditional knowledge; and  
  (e)  Evidence of prior informed consent.8   
 
WIPO responded by submitting a detailed technical study on disclosure of origin issues.9 
The study analysed various disclosure of origin requirements in patent applications10 
under the WIPO-administered Paris Convention for the Protection of Intellectual Property 
(Paris Convention),11 the Patent Law Treaty (PLT)12 and the Patent Cooperation Treaty 
                                                 
5 Id., VI-24 A., Annex, ¶¶ 16(d)(ii), (iii) and (vi). 
6 Id., VI-24.A. Annex, ¶¶ 55, 58, 61. Such measures also would help to accomplish the United Nations’ 
Millennium Development Goals, specifically Goal 7 (to ensure environmental sustainability) and Goal 8 (to 
develop a global partnership for development). See UN Millennium Development Goals, available at: 
http://www.un.org/millenniumgoals/; UN General Assembly document no. A/Res/55/2,  2000, at:  
 http://www.un.org/millennium/declaration/ares552e.pdf; UN General Assembly document no. A/56/326, 
pp. 33-34 (adopting a goal to press for full implementation of the CBD), available at: 
http://www.un.org/documents/ga/docs/56/a56326.pdf. 
7 UNEP/CBD/COP/6/20, Decision VI-24. C, ¶ 4, UNEP/CBD/COP/6/20. 
8 Id. 
9 UNEP/CBD/COP/7/INF/17, also referred to as WO/GA/30/7 Add.1, available at: 
 http://www.biodiv.org/doc/meetings/cop/cop-07/information/cop-07-inf-17-en.pdf. 
10 Id, ¶¶ 161–181. 
11 Concluded March 20, 1883 at Paris, effective 1884, as revised through July 14, 1967 at Stockholm and as 
amended Sept. 28, 1979 at Stockholm, available at: http://www.wipo.int/clea/docs/en/wo/wo020en.htm 




(PCT),13 as well as those of the World Trade Organization (WTO) Agreement on Trade-
Related Aspects of Intellectual Property Rights (TRIPS Agreement).14 
 
6. In Decision VII/19, the CBD COP sought to further existing efforts at developing 
an international regime to effectively implement access and benefit-sharing and 
disclosure of origin requirements. Decision VII/19 directs two CBD Working Groups to 
elaborate and negotiate an international regime on access to genetic resources and 
benefit-sharing, with the aim of adopting international instruments to effectively 
implement the relevant CBD provisions. Of particular relevance here, the CBD COP 
recognized the need for further analysis of issues identified in the WIPO Technical Study 
and elsewhere regarding disclosure of origin requirements and international certificates of 
origin/source/legal provenance, generically referred to as “certificates of origin.” The 
CBD COP thus invited WIPO and UNCTAD to identify and analyse issues raised by 
disclosure of origin requirements and certificates of origin, including five specific 
issues.15 The box below provides the text of the invitation identifying these issues. 
                                                 
13 Concluded June 19, 1970 at Washington, as amended Sept. 28, 1979 and modified Feb. 3, 1984 and Oct. 
3, 2001, effective April 1, 2002, available at: http://www.wipo.int/pct/en/texts/pdf/pct.pdf. 
14 Annex 1C of the Marrakesh Agreement Establishing the World Trade Organization, concluded April 15, 
1994, effective Jan. 1, 1995, available at: http://www.wto.org/english/tratop_e/trips_e/t_agm0_e.htm. 


































7. In January 2005, WIPO published a first draft analysis in response to the CBD 
COP’s invitation in Decision VII/19.16 In May 2005, following receipt of comments on 
the first draft, WIPO published a second draft analysis on these issues (hereafter referred 
to as the 'WIPO Examination').17 The WIPO Examination contains useful discussions of 
the identified issues (building on its earlier Technical Study), and summarizes the various 
country submissions to WIPO for purposes of developing its response to the CBD COP’s 
invitation. Additional analyses and discussions of options to implement disclosure of 
origin requirements and certificates of origin have been developed for and by other 
intergovernmental organizations (e.g. the WTO, the United Nations Environment 
                                                 
16 WIPO/IP/GR/05/01, available at: 
http://www.wipo.int/tk/en/genetic/proposals/first_draft_examination_cbd_invitation.pdf.  
17 WIPO/IP/GR/05/03, available at: 
http://www.wipo.int/edocs/mdocs/tk/en/wipo_ip_gr_05/wipo_ip_gr_05_3.pdf. 
CBD Decision VII/19 – Request and Invitation 
 
7. Requests the Ad hoc Open-ended Working Group on Access and Benefit-
Sharing to identify issues related to the disclosure of origin of genetic resources and 
associated traditional knowledge in applications for intellectual property rights, including 
those raised by a proposed international certificate of origin/source/legal provenance, and 
transmit the results of this examination to the World Intellectual Property Organization and 
other relevant forums; 
8. Invites the World Intellectual Property Organization to examine, and where 
appropriate address, taking into account the need to ensure that this work is supportive of 
and does not run counter to the objectives of the Convention on Biological Diversity, issues 
regarding the interrelation of access to genetic resources and disclosure requirements in 
intellectual property rights applications, including, inter alia: 
(a)   Options for model provisions on proposed disclosure requirements; 
(b)  Practical options for intellectual property rights application procedures with
regard to the triggers of disclosure requirements; 
(c)   Options for incentive measures for applicants; 
(d)   Identification of the implications for the functioning of disclosure requirements
in various World Intellectual Property Organization-administered treaties; 
(e) Intellectual property-related issues raised by proposed international certificate
of origin/source/legal provenance; 
and regularly provide reports to the Convention on Biological Diversity on its work, in 
particular on actions or steps proposed to address the above issues, in order for the 
Convention on Biological Diversity to provide additional information to the World 
Intellectual Property Organization for its consideration in the spirit of mutual 
supportiveness; 
 9. Invites the United Nations Conference on Trade and Development and other 
relevant international organizations to examine the issues in, and related to, the matters 
specified in paragraphs 7 and 8 in a manner supportive of the objectives of the Convention 
on Biological Diversity and prepare a report for submission to the ongoing process of the 
work of the Convention on Biological Diversity on access and benefit-sharing; 
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Programme (UNEP) and UNCTAD).18 Groups of countries, non-governmental 
organizations (NGOs), and academics also have provided detailed suggestions for 
elements of an international disclosure of origin requirements regime. For example, 
various developing countries have proposed that the TRIPS Agreement be amended to 
require applicants for patents to disclose the source and country of origin of genetic 
resources and associated traditional knowledge used in inventions relating to biological 
materials or traditional knowledge, along with documentary information regarding legal 
access and required benefit-sharing.19  This analysis builds upon the prior analyses. 
 
8. In accordance with the CBD invitation, this analysis is organized in five sections.  
Part II discusses options for model provisions on disclosure of origin requirements that 
could be mandated by new international treaty provisions. Part III examines practical 
options relating to the procedural and substantive triggers for disclosure of origin 
requirements. Part IV addresses incentive measures for such requirements, focusing in 
particular on enforcement mechanisms within the intellectual property law system.  Part 
V discusses implications for the functioning of disclosure requirements within WIPO-
administered patent law treaties. Prior work of the authors and WIPO, briefly 
summarized in Part II,20 has demonstrated that most of the relevant forms of disclosure of 
origin requirements (including refusal to grant intellectual property or sanctions that 
include invalidation or unenforceability) are fully consistent with existing WIPO patent 
law treaties, with the TRIPS Agreement, with the Union for the Protection of New 
Varieties of Plants (UPOV),21 and with the International Treaty on Plant Genetic 
Resources for Food and Agriculture (ITPGRFA).22 Accordingly, Part V does not repeat 
the legal analysis, but rather focuses on practical aspects of implementation of disclosure 
of origin requirements within the relevant treaty regimes.  It analyses the PCT and the 
PLT to illustrate issues at the international stage of application processing in a 
coordinated international system of national intellectual property application procedures, 
and at the national stage of application processing.  Finally, Part VI analyses intellectual 
property law issues raised by international certificates of origin.  
 
                                                 
18 See, for example, WTO, Article 27.3b, traditional knowledge, biodiversity (secretariat webpage listing 
relevant submissions through 2004), available at: 
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm; WIPO-UNEP, Gupta A.K. (2004), available 
at:  
http://www.wipo.int/tk/en/publications/769e_unep_tk.pdf; UNU-IAS (2003), available at: 
http://www.ias.unu.edu/news/details.cfm/articleID/458; UNCTAD, TD/B/Com.1/EM.13/3, available at: 
http://www.unctad.org/fr/docs/c1em13d3.fr.pdf.  Also, see papers and reports from UNCTAD workshops 
in February 2004 jointly with the Commonwealth Secretariat, and in April 2002 with the Government of 
India, at:  http://r0.unctad.org/trade_env/test1/meetings/tk2.htm and 
 http://r0.unctad.org/trade_env/test1/meetings/delhi.htm. 
19 For example, see WTO, IP/C/W/356, ¶ 10; WTO, IP/C/W/403, ¶ 1; WTO, IP/C/W/404, pp.  5-6, (all 
available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm). 
20 For example, see Sarnoff, J.D. (2004), pp. 31–37, 51, available at: http://www.piipa.org/library.asp; 
WIPO, WO/GA/30/7, ¶¶ 148, 153, 175, 183. 
21 Concluded Dec. 2, 1961 at Paris, entered into force Aug. 10, 1968, as revised at Geneva Nov. 10, 1972, 
Oct. 23, 1978, and Mar. 19, 1991 (entered into force Apr. 1998), available at: 
http://www.upov.int/en/publications/conventions/index.html. 




9. Before addressing the specific issues identified by the CBD, however, this 
analysis discusses the need for an international system of mandatory disclosure of origin 
requirements and for greater clarity, defines relevant terminology and defines the scope 
of the analysis. 
 
A. Mandatory disclosure of origin requirements 
 
The need for an international system of mandatory disclosure of origin requirements 
   
10. As stated elsewhere by developing countries and in a growing body of literature, 
an international system of mandatory disclosure of origin requirements is needed to 
prevent misappropriation, promote compliance with CBD access and benefit-sharing 
requirements, and prevent misuse of the intellectual property law system.23 As recognized 
by the Bonn Guidelines,24 disclosure of origin requirements for intellectual property 
applications are an important element of the CBD access and benefit-sharing regime, 
reflecting the interrelationship of the CBD regime and the international intellectual 
property law system.25 Intellectual property applicants should not be rewarded with rights 
or privileges that convey commercial benefits, when the subject matter of the applications 
was obtained or derived from genetic resources or traditional knowledge acquired in 
violation of CBD prior informed consent requirements and conditions of access for 
genetic resources. Similarly, intellectual property owners should not retain such 
commercial benefits in violation of CBD benefit-sharing requirements.   
 
11. Disclosure of origin requirements could fulfil important traditional functions 
within the intellectual property system.26 Specifically, such requirements may: improve 
the substantive examination of patents and other subject matter for which rights or 
privileges are sought; enhance determinations of inventorship and other entitlements to 
apply for intellectual property; and facilitate or permit use of the subject matter. The 
United States, however, has taken the position that erroneously granted patents “are the 
rare exception rather than the rule”, and thus that disclosure of origin requirements are 
not needed to assist such traditional determinations in regard to patents.27 The factual 
basis for this assertion is not apparent, and has been called into question by the United 
States Federal Trade Commission and in other analyses of the United States patent 
                                                 
23 See, for example, TRIPS Council Meeting, 14 June 2005, Agenda Items C-E, Statement by India (TRIPS 
Council India Statement), p. 2 (noting “transboundary implications” of commercial exploitation of 
erroneously granted patents contrary to CBD objectives); WTO, IP/C/W/447, p. 2 (suggesting 
establishment of an international obligation under the TRIPS Agreement “and another binding international 
instrument”), available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm; Correa C.M. 
(2003), pp. 2-3, available at: http://www.iprsonline.org/resources/trips.htm; CIEL (2005), ¶¶ 22–26, 
available at: 
 http://www.ciel.org/Publications/WIPO_CBD%20Request_1Apr05.pdf. 
24 UNEP/CBD/COP/6/20, CBD COP Decision VI-24.C, ¶¶ 1, 2,. 
25 See, for example, CBD Art. 16.5 (obligating Parties to cooperate “to ensure that [intellectual property] 
rights are supportive of and do not run counter to” CBD objectives). 
26 See, for example, Correa C.M. (2003), pp. 2–3. 
27 WTO, IP/C/W/449, p. 2, available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
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system.28 As a result, numerous measures to revise the United States Patent Act to 
remedy perceived, widespread issuance of erroneously granted patents are under 
consideration.29 Thus, even if not required to assure the proper application of intellectual 
property laws, disclosure of origin requirements certainly may assist in making the 
relevant determinations and thereby enhancing the integrity of the intellectual property 
law system.30 
 
12. In addition, disclosure of origin requirements may promote compliance with CBD 
access and benefit-sharing legislation (by, inter alia, reducing opportunities and 
incentives for misappropriation), and they may assist in tracking the commercial 
exploitation of genetic resources and traditional knowledge in order to ensure equitable 
benefit-sharing. The United States, however, has taken the position that a contract-based 
access and benefit-sharing regime requiring disclosures of commercial applications of 
genetic resources or traditional knowledge “provides a more effective means” of 
monitoring CBD access and benefit-sharing objectives, particularly as commercial 
benefits may be obtained from the use of genetic resources or traditional knowledge 
without inventing subject matter that qualifies for patent protection.31  However, a 
contractual system would not address improper commercialization through issuance of 
erroneously granted patents or other intellectual property,32 and it is unclear how such a 
system would assure the achievement of CBD objectives in the absence of concluded 
contracts.33 
 
13. Even if intellectual property was properly granted under applicable intellectual 
property laws, such rights or privileges may convey commercial value before being used 
to obtain commercial benefits by excluding commercial competition or maintaining 
commercial monopoly market power. For example, commercial benefits may result from 
higher stock prices or through the sale of intellectual property as an asset.34  Denying or 
invalidating intellectual property obtained in violation of CBD access and benefit-sharing 
principles thus may be necessary to prevent misappropriation of genetic resources or 
                                                 
28 See, for example, TRIPS Council India Statement, p. 2; US Federal Trade Commission (2003), pp. 4–13  
(noting concern over questionable patents and recommending adoption of an opposition system, 
elimination of the strong presumption of patent validity, revision of the obviousness standard, and increases 
in Patent Office funding), available at: http://www.ftc.gov/opa/2003/10/cpreport.htm; National Research 
Council, National Academy of Sciences, Merrill S.A., Levin, R.C. and Myers M.B. (eds.) (2004), pp. 61–
62  (noting the contention  of legal scholars that changes in patentability standards have resulted in issuance 
of patents on obvious inventions and expressing concern about the United States Patent and Trademark 
Office’s application of those standards), available at: http://www.nap.edu/html/patentsystem/. 
29 See, for example, H.R. 2795, Patent Reform Act of 2005, available at: http://thomas.loc.gov/; H.R. 2791, 
United States Patent and Trademark Fee Modernization Act of 2005, available at: http://thomas.loc.gov/. 
30 See, for example, TRIPS Council India Statement, p. 4; WTO, IP/C/W/443, ¶¶ 12, 17, available at: 
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
31 WTO, IP/C/W/449, ¶¶ 18, 22, available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
32 See, for example, TRIPS Council India Statement, pp. 2 and 3 (noting the need to employ costly 
revocation proceedings to limit use of erroneously granted patents). 
33 See, for example, WTO, IP/C/W/446, p. 3, available at: 
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
34 See, for example, id. p. 3; Long, C. (2002), pp. 625–628 (discussing various valuable market information 
functions served by obtaining patents); Kieff, F.S. (2001), pp. 707–710 (explaining how exclusionary rights 
facilitate social ordering and bargaining). 
 
 23
traditional knowledge that results in commercial benefits obtained directly from 
acquiring, owning or transferring intellectual property. 
 
14. Various national laws prevent such misappropriation by limiting the conditions 
that define the validity of intellectual property or entitlements to own or retain benefits 
deriving from intellectual property.35 This is true even when the relevant genetic 
resources or traditional knowledge have been misappropriated from countries that have 
not established national access and benefit-sharing legal regimes under the CBD.36  For 
example, trade secrecy laws in the United States might prohibit applications for patents 
when access to genetic resources or traditional knowledge was obtained in another 
country without appropriate authority, even though the other country may not have 
appropriate national legislation regarding conditions for access and benefit-sharing.37 
 
15. The United States, however, has raised concerns that new disclosure of origin 
requirements “would cause the additional uncertainty that may lead to invalidation” of 
intellectual property.38 On the contrary, rather than cause uncertainty, new international 
treaty provisions addressing disclosure of origin requirements may help to make more 
coherent existing and future national laws regarding misappropriation, including their 
recognition and enforcement in other countries. At least such an instrument may make 
existing uncertainties more transparent and predictable with regard to national access and 
benefit-sharing and to intellectual property laws that are applicable to transboundary 
resource and information flows.39 The relationships between national laws addressing 
misappropriation and intellectual property have not been adequately studied. Additional 
analysis of national laws that addresses the relationship between misappropriation of 
genetic resources or traditional knowledge and their effect on the validity of or 
entitlement to own or retain benefits from intellectual property would significantly assist 
future discussions on disclosure of origin requirements.40 
 
16. The present analysis focuses on the need for and the significant features of new 
international treaty provisions that would mandate requirements for disclosure of origin 
with regard to genetic resources and associated traditional knowledge. As noted in a 
recent multi-country submission to the WTO, contractual arrangements alone cannot 
                                                 
35 See, for example, WTO, IP/C/W/447, pp. 8-9 (citing the Second Supplementary Provision of Andean 
Community Decision 391, which provides that “Member Countries shall not acknowledge rights, including 
intellectual property rights, over genetic resources … obtained or developed through an access activity that 
does not comply with … this Decision,” and providing authority to request nullification and other actions in 
countries that have conferred rights or granted “protective title documents”). 
36 See, for example, id. ¶ 23 (noting the absence of national legislation in the majority of member 
countries). 
37 See, for example, Restatement (3rd) of Unfair Competition, American Law Inst. (1995), ch. 4, §§ 39, 40 
(defining trade secrets and misappropriation under state laws). 
38 WTO, IP/C/W/449, ¶ 25. 
39 See, for example, WTO, IP/C/W/443, ¶ 9 (an “internationally established and enforced [disclosure of 
origin] system” would promote “transparency and predictability [that] cannot be established through a 
fragmented nation-to-nation system”).  
40 Cf. WTO, IP/C/W/446, pp. 2, 3 (requesting clarification of the circumstances that would warrant 
revoking patents or requiring full or partial transfer of rights in inventions, and how benefit-sharing would 
be determined to be equitable).  
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ensure monitoring and enforcement of CBD requirements in third countries. Obligatory 
and enforceable requirements are needed to address the broad range of intellectual 
property applications that relate to genetic resources and associated traditional 
knowledge.41 The appropriate controls may be obtained by requiring disclosures of origin 
in patent and other intellectual property applications to include information on prior 
informed consent and equitable benefit-sharing.42 Although the Bonn Guidelines invited 
governments to encourage applicants to disclose the country of origin based on broad 
substantive triggers relating genetic resources and associated traditional knowledge in 
intellectual property applications,43 and although national legislation imposing disclosure 
of origin requirements already exists in some countries, such requirements have yet to be 
adopted in many countries where intellectual property may be sought. New international 
treaty provisions are therefore required to assure worldwide implementation of disclosure 
of origin requirements.44 
 
Suggested outline of an international system of mandatory disclosure of origin 
requirements  
 
17. The following principles may provide the outline for more detailed consideration 
of the contents of mandatory disclosure obligations. Such obligations could be included 
in new international treaty provisions that would also specify the relationship between 
required disclosures and mandatory and facultative sanctions. To be effective in deterring 
violations of access and benefit-sharing requirements and in preventing misappropriation, 
disclosure of origin requirements may stipulate denial of the entitlement to apply for, own 
or enforce intellectual property, and may permit delays in the processing of applications, 
or consider applications withdrawn if required information is not provided initially or in a 
timely manner after a request is initiated. In order to assure the availability of information 
on which the integrity of the requisite intellectual property law determinations are to be 
made, mandatory disclosure of origin requirements should be imposed at the international 
stage of any application procedures, where relevant, and otherwise at the national stage of 
application procedures. These requirements should obligate applicants to disclose the 
source of genetic resources and associated traditional knowledge, the country providing 
the genetic resources, available documentary information regarding compliance with 
access and benefit-sharing requirements, and (following a specified level of effort at 
inquiry) information known to the applicant regarding persons involved and the country 
                                                 
41 See WTO, IP/C/W/441 Rev.1, available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm 
(identifying numerous applications for patents made in regard to subject matter apparently obtained or 
developed using biological resources of Peruvian origin and/or traditional knowledge of indigenous 
Peruvian peoples without securing the prior informed consent of Peru or of those indigenous peoples).  See 
also Berglund, M. (2005), p. 255 (discussing the need for “a concerted, global approach incorporating 
internationally enforceable minimum standards” to protect traditional knowledge associated with genetic 
resources “which originates in a third country”), available at: http://www.law.ed.ac.uk/ahrb/script-ed/vol2-
2/TK.asp. 
42 WTO, IP/C/W/438, ¶ 7, available at: 
 http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
43 UNEP/CBD/COP/6/20, CBD COP Decision VI-24.C. ¶¶ 1, 2,  
44 Dinwoodie, G.B. (2004), p. 1, (noting that “international initiatives are essential, given the need to adopt 
similar provisions in different jurisdictions or to recognize foreign requirements across jurisdictions), draft 
available at:  http://r0.unctad.org/trade_env/test1/meetings/tk2/UCNTAD%20Paper(0129).pdf. 
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of origin of genetic resources and associated traditional knowledge. Required disclosures 
should be based on a broad set of substantive triggers that relate the subject matter of the 
application to the genetic resources and associated traditional knowledge.   
 
18. Required disclosures of origin should be reviewed at the international and 
national stages of application proceedings for completeness and for formal compliance 
with specified procedures, but should not ordinarily be reviewed for substantive validity 
or legality (unless such review is already required under intellectual property laws or 
other laws relating to the validity of the subject matter of the application and entitlements 
to apply for and own the intellectual property). Rather, substantive reviews of such 
disclosures should occur principally in a judicial action, or in a pre-grant or post-grant 
administrative challenge proceeding in which an initial showing is made that 
demonstrates the lack of compliance with disclosure requirements or with other legal 
requirements that would affect validity of or entitlements to apply for or own intellectual 
property. 
 
19. Opportunities should be provided to rectify failures to disclose required 
information at the international and national stages of application procedures, in the 
absence of indications of bad faith or a showing that any required inquiries were not 
performed.  However, opportunities for redress should be more limited following the 
granting of intellectual property. 
 
20. Remedies for disclosure failures should, where possible and where appropriate, 
transfer full or partial ownership of intellectual property or impose benefit-sharing 
conditions in preference to invalidating the intellectual property at issue. Also, remedies 
should be tailored, where possible and in the absence of bad faith, to the scope and nature 
of the disclosure failure.45  
 
B. Terminology and scope of the analysis 
 
21. In order to evaluate options for disclosure of origin requirements, it is necessary 
to determine what actions and materials are to be addressed. A detailed discussion of 
mandatory obligations for disclosure of origin requirements and of substantive and 
procedural “triggers” for disclosure is provided in parts II and III.  However, to ensure a 
common understanding of the analysis, it is necessary to clarify the terminology used.46 
The analysis adopts terminology from the CBD, supplementing that terminology as 
necessary. Some of the definitions adopted differ from those used in prior analyses or in 
country submissions regarding disclosure of origin and certificate of origin issues. 
 
22. “Genetic resources” are defined in Article 2 of the CBD as “genetic material of 
actual or potential value,” and “genetic material” is defined as “any material of plant, 
                                                 
45 UNEP/CBD/COP/7/INF/17,  ¶155 (describing the “general trend” of existing sanctions provisions under 
national laws as “a tendency for the consequences of failure to comply to correspond to the nature of the 
information that is not supplied”). 




animal, microbial or other origin containing functional units of heredity.” In contrast, 
“biological resources” “includes genetic resources, organisms or parts thereof, 
populations, or any other biotic component of ecosystems with actual or potential use or 
value for humanity.”  Thus genetic resources are a subset of genetic material, which in 
turn is a subset of biological resources, and these are a subset of all biological materials. 
Although disclosure of origin issues could therefore address a broader category of 
biological materials,47 the focus of this analysis is on “genetic resources.” 
 
23. “Country of origin of genetic resources.” Article 2 of the CBD defines the 
“country of origin of genetic resources” as “the country which possesses those genetic 
resources in in-situ conditions.” “In-situ conditions" is defined as “conditions where 
genetic resources exist within ecosystems and natural habitats, and, in the case of 
domesticated or cultivated species, in the surroundings where they have developed their 
distinctive properties.” A country of origin, therefore, is any country where such 
resources are now located in in-situ conditions, whether or not that country is where the 
resources historically originated. Further, there may be more than one country of origin 
for any particular genetic resource. 
 
24. “Country providing genetic resources.” The access and benefit-sharing 
requirements of the CBD do not apply to the “country of origin,” but rather to the 
“country providing genetic resources.” This is defined in Article 2 of the CBD as “the 
country supplying genetic resources collected from in-situ sources, including populations 
of both wild and domesticated species, or taken from ex-situ sources, which may or may 
not have originated in that country.” Article 15.5 requires that any access to genetic 
resources in a Contracting Party providing genetic resources be subject to the prior 
informed consent of that Party, unless it determines otherwise. Similarly, Article 15.7 
requires Contracting Parties to adopt “legislative, administrative or policy” measures 
“with the aim of sharing in a fair and equitable way the results of research and 
development and the benefits arising from the commercial and other utilization of genetic 
resources with the Contracting Party providing such resources.” However, Article 15.3 
states that “the genetic resources being provided by a Contracting Party … are only those 
that are provided by Contracting Parties that are countries of origin of such resources or 
by the Parties that have acquired the genetic resources in accordance with this 
Convention.”   
 
25. Significantly, genetic resources may be supplied from a country providing genetic 
resources that is not a country of origin of those resources. This is particularly likely to 
occur with ex-situ genetic resources that are maintained in various worldwide collections. 
Unless the subject matter of an intellectual property application requires repeated inputs 
of the same genetic resource in its development, however, only one country is likely to be 
the country providing that specific resource. In contrast, the subject matter may require 
the input of many different genetic resources supplied from different countries. 
 
                                                 
47 See, for example, WTO, IP/C/W/443, ¶ 13 (discussing disclosures of origin with regard to “biological 
material and/or associated traditional knowledge”). 
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26. Considerations relating to disclosure of the country of origin and the country 
providing genetic resources.  
Because the mandatory access and benefit-sharing requirements of CBD Article 15 relate 
directly to the “country providing genetic resources,” disclosure of origin requirements 
that are tied to that Article’s  provisions may not necessarily disclose the country of 
origin of the genetic resources in question. Determining the country (or countries) of 
origin may be a complex undertaking for genetic resources obtained from countries that 
are not themselves a country of origin (for instance, when supplied by gene banks, 
botanical gardens, or other sources that conserve biological materials in ex-situ 
conditions). It may be particularly difficult to determine the country of origin of plant 
varieties that have acquired distinctive characteristics in different countries.48  
 
27. In cases where intellectual property is sought for genetic resources that relate to 
the multilateral access and benefit-sharing system of the ITPGRFA,49 disclosure of origin 
requirements may be addressed by providing information that the relevant genetic 
resources have been obtained from the multilateral system under the standard Material 
Transfer Agreement (to be adopted by the Governing Body of the Treaty).50 Further, if 
disclosure of origin requirements are tied to the access and benefit-sharing requirements 
of the CBD, disclosures in intellectual property applications may not necessarily be 
required when genetic resources are provided from countries that are not Parties to the 
CBD, or when the subject matter does not relate to genetic resources. In such cases, 
mandating disclosure of origin requirements in intellectual property applications would 
extend beyond CBD considerations, but would still be relevant in other contexts, such as 
in the WTO. 
 
28. Requiring applicants for intellectual property to disclose the country of origin 
may force them to search for or to generate information that may not readily be available 
or that may be difficult to obtain or produce. To avoid such burdens, requirements could 
be limited to disclosing only the country providing genetic resources, which information 
should be readily known. Alternatively, requirements for disclosing the country of origin 
could be limited to knowledge already in the possession of applicants.  Between these 
two positions, applicants could be required to exert a specified level of effort to search for 
or generate country of origin information. 
 
29. In some cases, existing traditional intellectual property laws may require 
disclosure of the country of origin in applications, even if this means that applicants must 
search for or generate the required information. Such disclosure may be required, for 
                                                 
48 See, for example, Correa, C.M. (2003),  p. 5. 
49 The ITPGRFA prohibits applications for intellectual property on PGRFA in the form in which they are 
received from the multilateral system, but does not clearly prohibit applications when the subject matter is 
derived from or uses such resources in its development.  See ITPGRFA, Art. 12.3(d) (“Recipients shall not 
claim any intellectual property or other rights that limit the facilitated access to the plant genetic resources 
for food and agriculture, or their genetic parts or components, in the form received from the Multilateral 
System”). 
50 ITPGRFA, Art. 12.4. 
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example, to enable the public to use an invention for which a patent is sought.51 In 
addition, national access and benefit-sharing laws of the country providing genetic 
resources or of the country of application (or contracts pursuant to such laws imposing 
the terms and conditions of access and benefit-sharing) may require disclosure of the 
country of origin in any international or national intellectual property application.52 In 
such cases, any new international treaty provisions that would require applicants to 
disclose the country of origin in intellectual property applications would not impose any 
additional burdens on applicants. Rather, such provisions might facilitate disclosures that 
already are required under intellectual property laws, and would lead to the removal of 
obstacles to disclosures under national laws when required by other countries’ laws or 
contractual provisions. This analysis thus focuses on disclosure of origin requirements 
that are not already mandated by intellectual property laws, national access and benefit-
sharing laws and/or contracts signed pursuant to such laws. 
 
30. “Source” of genetic resources.  The CBD does not define the “source” of genetic 
resources, or of associated traditional knowledge (discussed below). Although the 
Preamble to the CBD reaffirms that “States have sovereign rights over their own 
biological resources,” genetic resources may be owned by private persons or entities, 
which may have rights to control access to and use of owned genetic resources. The CBD 
access and benefit-sharing requirements must therefore address not only the Contracting 
Party providing such resources or materials, but also national legislation defining 
ownership and use of rights to control conditions of access and benefit-sharing. As 
recognized by the WIPO Technical Study, “[t]here may be a specific legal framework for 
access to genetic resources, or access may be regulated indirectly through laws 
concerning rights attached to land ownership or leasehold, through the conditions that 
apply to access to and exploitation of State-owned land and resources, or through the 
effect of the law of contract. Government agencies and access providers have used 
contracts (such as material transfer agreements), licenses and permits, to establish and 
enforce the conditions of access to genetic resources and associated [traditional 
knowledge].”53 Further, various levels of government approval may be required in order 
to provide access to or establish conditions for equitable benefit-sharing.54   
 
31. A “source” of genetic resources may be defined as any person or entity (whether 
private or governmental) directly providing access to genetic resources that relates in any 
relevant way to the subject matter of intellectual property applications. Because more 
than one genetic resource may be involved, there may be more than one source of genetic 
resources to be disclosed in any given application for intellectual property. A source may 
or may not possess the authority to provide access (based on the applicable legal 
requirements) under specified conditions of use and equitable benefit-sharing. 
                                                 
51 The WIPO Technical study (UNEP/CBD/COP/7/INF/17), ¶¶ 39-87 provides useful discussions (not 
repeated here) of obligations to disclose the country of origin under intellectual property laws, and 
summarizes some national or regional laws requiring such disclosure as part of legislation implementing 
CBD access and benefit-sharing requirements.  
52 Id.,  Cf. TRIPS Council India Statement, p. 3 (discussing a United States proposal for a “national 
contract-based system with an ‘international outlook’”).  
53 UNEP/CBD/COP/7/INF/17, ¶ 15. 




32. “Authority” to provide access and to establish conditions for an equitable 
share of benefits.  It is often difficult to determine who has the legal authority to provide 
access to genetic resources and to establish conditions for equitable benefit-sharing 
deriving from such access. Whether any person or entity possesses such authority will 
depend upon national laws and norms of the country providing resources (and in some 
cases may trigger international laws relating to peoples of different nations),55 including 
legal relationships regarding indigenous or local communities.56 In order for an 
international system of disclosure of origin requirements to assist in ensuring compliance 
with access and benefit-sharing requirements, however, the issue of authority must be 
addressed. 
 
33. Authority reflects the application of all laws and required determinations by all 
relevant government entities (administrative and judicial) that are competent to authorize 
the source to provide access and to determine the legality of the conditions established for 
access and for equitable benefit-sharing (including laws defining misappropriation).  
Authority also reflects the application of laws relating to public or private ownership and 
use of the resources in question. “Authority” thus may be understood as a legal condition 
of public or private entities, rather than solely as a government entity that is competent to 
determine whether the source has authority. In some cases, government entities may be 
sources that possess authority to provide access to genetic resources. In others, 
government entities may need to approve the provision of access by private persons (or 
other government entities). Authority to provide access to genetic resources may require 
the approval of more than one individual, community, or private or government entity. 
Persons or entities that receive genetic resources from a source with authority and comply 
with specified conditions of access and benefit-sharing possess the legal provenance to 
use those resources according to the authorized conditions.57 
 
34. “Legal provenance” means possession of or other access to genetic resources for 
use under specified conditions, pursuant to legal authority. The term “legal provenance” 
is frequently employed with reference to certificates of legal provenance, which would 
document and attest to the provision of genetic resources from a source vested with the 
appropriate authority.58 As used in that context, legal provenance may reflect application 
                                                 
55 Tobin, B. (1997), p. 4, available at:  http://www.ias.unu.edu/research/details.cfm/ArticleID/520.   
56 See, for example, WIPO, E:\6-12, p. 2 (noting the “general element” of national treatment and mutual 
recognition of indigenous customary laws and national legislation), available at: 
http://www.wipo.int/tk/en/igc/ngo/afn_igc6.pdf; UNCTAD, Twarog, S. and Kapoor, P. (eds.) (2004), pp. 
83 and 217–218 (discussing recommendations of indigenous groups for strengthening their customary laws 
with regard to traditional knowledge and the constitutional status and rights of indigenous peoples of 
Bolivia), available at: http://p166.unctad.org/file.php/12/ditcted10_en.pdf.; Riley, A.R. (2005), pp. 69, 86–
91, 118–123  (discussing conflicts of approach between indigenous and national legal regimes, and limits to 
indigenous groups’ legal jurisdiction, in regard to cultural property issues). 
57 WTO, IP/C/W/447, p. 1, (pointing out that “the concept of legal provenance presupposes the existence of 
prior informed consent (PIC) and of fair and equitable benefit-sharing”).  
58 Cunningham D., Tobin B. and Watanabe K. (2004), p. 3 (“A certificate of legal provenance would 
document evidence that the resources had been obtained from a legally entitled provider. In the face of 
continuing uncertainties regarding legal rights over resources and absent a binding international regime on 
ABS, legal provenance would fall to be decided by the laws of the country where the resources were 
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of and compliance with the law of “the country of origin or of other legal source,” and is 
“ill-defined in many cases.”59 
 
35. “Biopiracy” and “misappropriation.”  There are no authoritative definitions for 
the term “biopiracy”. Biopiracy may be defined as the effect of obtaining access to 
genetic resources without appropriate authority.60  It also may be defined more broadly to 
involve unauthorized commercialization resulting from access, derivation of unjustified 
benefits, or failure to provide for equitable benefit-sharing.61 In contrast, 
misappropriation has legal significance in many jurisdictions, which includes the concept 
of taking the value of the intellectual or other property through use.62 Accordingly, 
misappropriation may be defined as the consequence of biopiracy, of violating authorized 
conditions of access, or of using the genetic resources to derive unjustified or inequitably 
shared benefits.63 Misappropriation may be remedied by many different legal doctrines, 
including, but not limited to, those relating to unfair competition, trade secrecy and unjust 
enrichment.64 
 
36. “Traditional knowledge.”  Article 8(j) of the CBD requires, “as far as possible 
and as appropriate” that a Contracting Party “subject to its national legislation, respect, 
                                                                                                                                                 
sourced, potentially providing an opportunity for circumvention of the rights of countries of origin.”), 
available at:  
http://www.ias.unu.edu/binaries2/Certificates_of_origin_backgr_paper.doc. 
59   UNU-IAS (2003), p. 38. 
60Smith S. (2004), p.1 (treating biopiracy as unauthorized use of biological resources or traditional 
knowledge, unequal shares of benefits, or patenting without respect to substantive patent law criteria), 
available at: http://www.canmexworkshop.com/documents/papers/I.3d.1.pdf; Dutfield, G. (2004), p. 2 
(treating biopiracy as “theft, misappropriation of, or unfair free riding” or “unauthorized and 
uncompensated collection for commercial ends”), available at:  
http://www.canmexworkshop.com/documents/papers/I.3.pdf. 
61 Correa, C.M. (2002), § VI, Conclusions, available at: 
http://www.southcentre.org/publications/traditionalmedicine/traditionalmedicine.pdf. 
62 See, for example, Restatement of Unfair Competition (3rd), American Law Institute (1995), ch. 4, § 38, 
(discussing appropriation of another’s “intangible trade values” under United States law); id. § 44 
(discussing injunctions to prohibit the appropriation of trade secrets for unauthorized uses).  Cf. WTO, 
IP/C/W/434, ¶ 8 (limiting misappropriation to “improper collection and/or use,” without addressing use to 
obtain intellectual property), available at: 
 http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
63 Cf. WTO, IP/C/W/443, ¶ 12 (describing misappropriation as use in developing the subject matter of 
applications and of applying for intellectual property without obtaining prior informed consent or providing 
for equitable benefit-sharing); WIPO/GRTKF/IC/7/5, Annex I, ¶ B.2. (defining as an act of 
misappropriation any “acquisition or appropriation of traditional knowledge by unfair or illicit means”), 
available at: 
 http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_7/wipo_grtkf_ic_7_5-annex1.pdf. 
64 See, for example, Paris Convention Art. 10bis; TRIPS Agreement Arts. 22.2(b), 39.1; Restatement of 
Unfair Competition (3rd), American Law Institute (1995), ch 4, §§ 38, 44 (United States law); Beatson, J. 
and Schrage, E. (eds.) (2003), pp. 524–530, 544–548 (discussing restitutionary claims and disgorgement or 
royalty remedies for tortuous or delictual behaviour and for breach of contract under United Kingdom 
common law and German civil law); Ultra-Precision Mfg. Ltd. v. Ford Motor Co., 411 F.3d 1369, 1377-82 
(Fed. Cir. 2005) (discussing unjust enrichment claims – grounded on implied-in-law contractual provisions, 
breaches of confidential relationship, misappropriation of trade secrets, or conferral of an incremental 




preserve and maintain knowledge, innovations and practices of indigenous and local 
communities embodying traditional lifestyles relevant for the conservation and 
sustainable use of biological diversity and promote their wider application with the 
approval and involvement of the holders of such knowledge, innovations and practices 
and encourage the equitable sharing of the benefits arising from the utilization of such 
knowledge, innovations and practices.” However, Article 2 of the CBD does not define 
“traditional knowledge, innovations and practices.” Traditional knowledge can serve 
several functions, and thus may take many forms.65 The WIPO secretariat has proposed 
to define traditional knowledge, in relevant part, as “the content or substance of 
knowledge resulting from intellectual activity in a traditional context, and includes know-
how, skills, innovations, practices and learning that form part of traditional knowledge 
systems, and knowledge embodying traditional lifestyles of indigenous and local 
communities, or contained in codified knowledge systems passed between generations.”66   
 
37. The language of Article 8(j) suggests that traditional knowledge must be “relevant 
for the conservation and sustainable use of biological diversity” in order to be subject to 
CBD requirements for equitable benefit-sharing.67 Article 2 of the CBD defines 
“biological diversity” (to which Article 8(j) refers) as variability among living organisms 
from all sources including … ecological complexes of which they are part.” Biological 
diversity is therefore broader than and different from genetic resources to which the 
obligations of Article 15 apply. Biological diversity also is broader than the Article 2 
definition of biological resources. The relationship of traditional knowledge to biological 
diversity thus may be broader than the relationship of traditional knowledge to genetic 
resources, genetic material or biological material.   
 
38. Article 8(j), however, does not impose any clear-cut mandate for national 
measures for prior informed consent for access to traditional knowledge. Rather, it 
promotes the wider application of traditional knowledge with the approval and 
involvement of the relevant indigenous/local communities, and encourages equitable 
benefit-sharing. Thus the CBD does not appear to regard the respect or preservation of 
traditional knowledge as an end in itself.68 Nevertheless, the CBD COP has attempted to 
develop guidelines and mechanisms for prior informed consent and for the equitable 
sharing of benefits arising from the use of traditional knowledge,69 and has encouraged 
consideration of “a process and set of requirements governing prior informed consent, 
mutually agreed terms and equitable sharing of benefits with respect to traditional 
                                                 
65 See, for example, WIPO-UNEP, Gupta, A.K. (2004), p. 26 (identifying semiotic, institutional, 
configurational, utilitarian, situational, and religious/spiritual forms of traditional knowledge). 
66 WIPO/GRTKF/IC/8/5, Annex, p. 20, available at: 
 http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_8/wipo_grtkf_ic_8_5.doc.  
67 See, for example, UNEP/CBD/TKBD/1/2, ¶ 30, available at: 
http://www.biodiv.org/doc/meetings/tk/wstkbd-01/official/wstkbd-01-02-en.pdf (noting the connections 
between genetic resources and traditional knowledge warrant implementing Article 8(j) in conjunction with 
Article 15). 
68 Correa, C.M. (2004), p. 2, available at: 
 http://www.southcentre.org/publications/workingpapers/paper18/wp18.pdf. 




knowledge, innovations and practices associated with genetic resources and relevant for 
the conservation and sustainable use of biological diversity.”70 Similarly, all of the 
submissions to the TRIPS Council regarding disclosure of origin obligations in the CBD 
context suggest including traditional knowledge associated with biological materials or 
genetic resources.71 
 
39. Accordingly, “traditional knowledge” may be defined for this analysis as any 
form of knowledge resulting from the intellectual activity of indigenous or local 
communities, part of traditional knowledge systems, or embodying traditional lifestyles 
of indigenous or local communities that is associated with genetic resources and that 
leads to the development of, is incorporated in, is used with, or is otherwise relevant to 
the subject matter of intellectual property applications. The CBD COP invited WIPO to 
examine “the disclosure of origin of relevant traditional knowledge in intellectual 
property applications,” and invited Parties and governments to encourage such 
disclosures “where the subject matter of the application concerns or makes use of such 
knowledge in its development”. It also urged Parties and governments to examine CBD 
provisions “with respect to prior informed consent and mutually agreed terms where 
traditional knowledge is used in its original form or in the development of new products 
and/or new applications”.72 The principles developed in this analysis, however, may be 
relevant to a broader range of traditional knowledge that relates to the subject matter of 
intellectual property applications.73 In particular, the principles may have relevance for 
efforts to develop a sui generis system of protection and equitable benefit-sharing of 
traditional knowledge. 
 
40. Requirements for disclosures of the origin of traditional knowledge associated 
with genetic resources may assist in ensuring prior informed consent and equitable 
benefit-sharing with regard to both the traditional knowledge and the associated genetic 
resources. They may also assist in preventing misappropriation of the traditional 
knowledge associated with genetic resources. For example, the draft provisions for the 
protection of traditional knowledge considered by the WIPO Intergovernmental 
Committee on Intellectual Property, Genetic Resources, Traditional Knowledge and 
Folklore require measures to protect against misappropriation by acquisition, 
appropriation or utilization of traditional knowledge by unfair or illegal means.74   
 
41. As with disclosures relating directly to genetic resources, disclosure of origin 
requirements may address the country of origin of the traditional knowledge, the country 
                                                 
70 UNEP/CBD/COP/7/21, CBD COP Decision VII/16, Annex, Some potential elements to be considered in 
the development of sui generis systems for the protection of traditional knowledge, innovations and 
practices of indigenous and local communities, ¶ 5, 2004, available at: 
http://www.biodiv.org/doc/decisions/COP-07-dec-en.pdf. 
71 Id. p. 12. 
72 UNEP/CBD/COP/6/20, CBD COP Decision VI/10, ¶¶ 31, 46, 47, available at: 
http://www.biodiv.org/doc/decisions/COP-06-dec-en.pdf. 
73 For example, traditional knowledge might lead to inventions that would help to preserve biological 
diversity, but would not use genetic resources in developing the invention, as components of the invention, 
or when using the invention. 
74 WIPO/GRTKF/IC/8/5, ¶¶ 1-2.  
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providing traditional knowledge, the source of traditional knowledge and the authority of 
the source that provides access to traditional knowledge based on specified conditions of 
use and equitable benefit-sharing. In this context, the terms “source,” “country of origin,” 
“country providing” and “authority” have the same meaning as defined above, but have 
as their referent traditional knowledge associated with the relevant genetic resources.  
Thus, disclosure of the country of origin of associated traditional knowledge may require 
applicants to search for or to generate relevant information. Further, establishing whether 
the source possesses authority to provide access under the specified conditions may 
require complex determinations. As recognized by Article 8(j) of the CBD, traditional 
knowledge is located in “indigenous and local communities.” Such communities may 
have customary laws and norms that govern ownership and use rights that differ from and 
are in addition to those established by national legislation.75 Authority to provide access 
to traditional knowledge within such communities may be heterogeneously dispersed 
among community members.76 Also, such communities may extend across national 
boundaries, giving rise to complex issues regarding the legal relations of nations with the 
different members of those communities. Moreover, because knowledge may be readily 
communicated and transmitted, traditional knowledge may be more easily transferred 
than associated genetic resources by the source to a recipient in a different country. 
  
42. “Intellectual property applications.” There are many different forms of 
intellectual property that vest only after some form of application and review procedure.  
For example, intellectual property may vest based on registration that requires 
government review only to record or issue relevant documents, or it may be based on 
detailed examination of the substantive validity and compliance with formalities of the 
contents of applications. Disclosure of origin requirements applicable to intellectual 
property applications thus must address a wide variety of application and review 
procedures.  “Intellectual property applications” may be defined as applications that 
require some degree of government registration or examination before the relevant rights 
or privileges vest. Although the primary focus of this analysis is on patents and plant 
breeders’ rights, intellectual property applications may also be required for utility models, 
petty patents, trademarks, industrial designs and sui generis protections, requiring 
registration or examination.77 In contrast, some forms of intellectual property vest 
without the requirement to file applications, based on status or conduct in relation to the 
subject matter of the rights or privileges. This analysis does not address such intellectual 
property (although many of the principles of the analysis may apply), because the CBD 
invitation was limited to consideration of disclosure of origin requirements only with 
regard to intellectual property applications.    
 
43. “Applicant” for intellectual property.  Intellectual property often is sought by 
applicants who did not themselves develop the subject matter of the application.  For 
                                                 
75 Lettington R.J.L. and Nnadozie K. (2003), ¶ 24, available at: 
 http://www.southcentre.org/publications/occasional/paper12/paper12.pdf. 
76 WIPO-UNEP, Gupta, A.K. (2004), pp. 27, 40 (noting the lack of homogeneity of interests of the 
members of many local communities and that not all prevalent community knowledge is communal or 
traditional in nature). 
77 UNEP/CBD/COP/7/INF/17, ¶ 73. 
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example, applications for patents may be filed (often by or with the assistance of an 
attorney or agent) on behalf of inventors, assignees of inventors in the inventors’ names, 
or assignees in their own names. National patent laws may require applicants to disclose 
the names of and information regarding each person who is considered an inventor of the 
subject matter or has some other basis (such as assignment) for the entitlement to apply.  
The failure to disclose the requisite information may result in substantive invalidity of the 
patent.78 The TRIPS Agreement and other treaties addressing patents, plant breeders’ 
rights and other intellectual property did not harmonize national laws regarding 
ownership of intellectual property or the relation of creative entities to substantive 
entitlements to apply for intellectual property.79 In the Havana case, the WTO Appellate 
Body unequivocally affirmed the ruling of the dispute settlement Panel that the TRIPS 
Agreement does not regulate the issue of ownership of trademarks, leaving entirely to 
national legislation the conditions regarding who is entitled to apply for and own 
intellectual property.80 Accordingly, an “applicant” for intellectual property is defined for 
this analysis as a person or entity entitled or required to apply for or to register an interest 
in intellectual property under the national law of the country where such rights or 
privileges are sought.81  
 
44. “Persons involved” in intellectual property applications. Sources of genetic 
resources and associated traditional knowledge, and persons or entities obtaining access 
directly from those sources, may not necessarily qualify as inventors or applicants under 
national intellectual property laws.82 In such cases, additional disclosures may be needed 
to identify those persons or entities and their relationship with the subject matter of the 
application. For this analysis, “persons involved” in applications are defined as all 
persons who were involved in the development of the subject matter of the application for 
the intellectual property, or whose involvement may have a bearing on the entitlement of 
the applicant to apply for and receive benefits of intellectual property. Persons involved 
in applications thus may have a direct or remote relationship with the applicant or with 
the source of genetic resources and associated traditional knowledge. The definition of 
persons involved is broader than, for example, the definition of “individuals associated 
with the filing or prosecution” of a patent application who are required to supply to the 
United States Patent Office known “information material to patentability.”83 
 
                                                 
78 Id., ¶ 50 (citing European Patent Convention Art. 81), ¶ 51.  
79 Sarnoff, J.D. (2004), p. 35 and nn.173 and 174 (citing WTO, WT/DS176/AB/R, United States – Section 
211 Omnibus Appropriations Act of 1998, Report of the Appellate Body, ¶ 189 (2002), available at: 
http://docsonline.wto.org/DDFDocuments/t/WT/DS/176ABR.doc; UNEP/CBD/COP/7/INF/17,  ¶ 177; and 
UNEP/CBD/WG-ABS/2/INF/2, available at: 
http://www.biodiv.org/doc/meetings/abs/abswg-02/information/abswg-02-inf-02-en.pdf). 
80 WTO, WT/DS176/AB/R, ¶¶ 155–165, 189.  
81 See UNEP/CBD/COP/7/INF/17, ¶¶ 74-79 (discussing registration of different forms of ownership 
interests in the subject matter of intellectual property applications or of the issued rights or privileges). 
82 Id., ¶ 52 (discussing differences under United Kingdom law between inventive and non-inventive 
contributions, for example, directions for research leading to inventions). 
83 See, for example, 37 C.F.R. § 1.56(c)(3) (under United States patent regulations, “[e]very other person 
who is substantively involved in the preparation or prosecution of the application and who is associated 




45. “Certificate of origin.”  The CBD COP’s referral addressed the “proposed 
international certificate of origin/source/legal provenance.” Although the CBD does not 
define certificates of origin, source or legal provenance, these concepts were developed in 
the context of intergovernmental and regional efforts to implement the CBD.84 Some 
prior analyses have discussed “voluntary” or third-party certification schemes, where 
individuals or entities may certify conformity to various types of standards in a single 
step or progressively (step-by-step). Others have suggested that certificates of origin 
could be issued by owners of the genetic resources or traditional knowledge.85 This 
analysis considers international certificates of origin to be documents issued by a 
competent entity that assures the integrity of the contents of the certification.86 A 
certificate of origin also may, but need not necessarily, contain a sworn declaration of a 
source or of a recipient of genetic resources or associated traditional knowledge. Thus 
certificates of origin differ from certifications or declarations that may be required of or 
made by applicants when applying for or owning intellectual property. 
 
46. An international “certificate of origin” may be defined for this analysis as a 
document issued by a competent entity, which identifies the source, attests to the 
authority of the source to provide the relevant resources and knowledge for specified 
conditions of use, and attests to compliance with equitable benefit-sharing requirements 
(pursuant to contractual arrangements or other mechanisms). This definition varies from 
some other formulations of certificates of origin, source and legal provenance.87 In 
particular, “certificate of origin” differs from the common use of the term which denotes 
a certificate that identifies the country of origin, although such information may also be 
included. Because certificates of origin must identify the authority of the source, they 
also document the legal provenance of the genetic resources and associated traditional 
knowledge, in the absence of misappropriation. “Certificate of origin” thus corresponds 
more closely to common usage of the terms certificates of source and certificates of legal 
provenance.88  Monitoring may be needed to assure ex-post compliance with conditions 
of access and equitable benefit-sharing once a certificate of origin is issued. The analysis 
in Part VI focuses on the use of international certificates of origin in relation to disclosure 
of origin requirements. 
                                                 
84 UNEP/CBD/WG-ABS/3/INF/5, Tobin, B., Cunningham, D. and Watanabe, K. (2004), p. 8, available at: 
 http://www.biodiv.org/doc/meeting.aspx?mtg=ABSWG-03&tab=1; Tobin, B. (1997), p. 7 and n.16; UNU-
IAS (2003), p. 38.  
85 See, for example, UNU-IAS (2003), p. 23; de la Cruz, R. (2004),  p. 8, available at: 
 http://www.iucn.org/themes/pbia/themes/trade/final_cruz_EN.pdf. 
86 See, for example, UNU-IAS (2003), p. 38 (discussing “standardised official document[s] issued by the 
country of origin”). Consistency with the WTO Sanitary and Phytosanitary Agreement and the Technical 
Barriers to Trade Agreement is not addressed by this analysis, but may need to be investigated.  See id. p. 
24. Further, we do not mean to prejudge issues regarding the political relationships of indigenous or local 
communities to the countries in which they are located.  Cf. Tobin, B. (1997), p. 3 and n.3 (noting that 
Article 8(j) fails to explicitly recognize indigenous and local community property rights). 
87 For  example, UNEP/CBD/WG-ABS/3/INF/5, Tobin, B., Cunningham, D. and Watanabe, K. (2004), p. 
10, notes that certificates of origin would be granted by the national authority of the country of origin, 
rather than the country providing genetic resources, and that certificates of legal provenance could be 
issued by non-governmental entities in countries other than the country of origin. 
88 UNU-IAS (2003), p. 38; Cunningham, D., Tobin, B. and Watanabe, K. (2004), p. 3.  
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II. Model provisions for disclosure of origin requirements 
 
47. In general terms, three different sets of issues exist for adopting model provisions 
of an international regime to implement disclosure of origin requirements. The first set 
relates to whether to impose disclosure of origin requirements as mandatory treaty 
obligations or just facilitate such disclosures within the existing intellectual property law 
system. The second set relates to the nature of the disclosure obligations and the 
mandatory or facultative consequences to be prescribed for failures of applicants or 
parties to comply with requirements or obligations. The third set relates to the treaty 
regime in which to locate the obligations. Because the nature of the disclosure obligations 
and the consequences of disclosure failures overlap with the second and third set of issues 
posed for analysis by the CBD COP, these issues are more comprehensively addressed in 
Parts III and IV. 
 
A. Mandatory or facilitated disclosure of origin obligations 
 
Foreign recognition and enforcement of existing mandatory disclosure of origin 
obligations  
  
48. As noted in numerous submissions to WIPO and the WTO, various national laws 
already require applicants for intellectual property to disclose the source and country of 
origin of genetic resources and associated traditional knowledge, along with relevant 
documentary information regarding compliance with access and benefit-sharing 
requirements.89 Similarly, contracts providing for compliance with access and benefit-
sharing requirements, and adopted under national laws implementing CBD obligations, 
may also require such disclosures (including copies of the contracts), even when the 
national laws do not.90 In theory, national laws and contracts may mandate such 
                                                 
89 WIPO/GRTKF/IC/Q.3, Part I, Annex, (country submissions in response to WIPO question 3, regarding 
specific requirements to disclose the source and geographic origin of genetic resources or traditional 
knowledge and evidence of compliance with access requirements), available at: 
http://www.wipo.int/tk/en/consultations/questionnaires/ic-q3/responses.pdf; WIPO/IP/GR/05/03, pp. 23–26 
(summarizing various regional and national measures); WTO, IP/C/W/368 (citing the submissions in 
IP/C/W/310 (Australia), IP/C/W/198 (India), IP/C/W/296 (Peru), and IP/C/W/341 (United States)), 
available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. See also Correa, C.M. (2003), 
pp. 3–4 (summarizing provisions of Costa Rica, India, the Andean Group, and Brazil, and discussing the 
European Directive on Biotechnological Inventions, No. 96/9/EC of March 11, 1996, and Belgian Patent 
Act 1984, Art. 49(1)(1), which encourage such disclosures and may prohibit exploitation if contrary to 
ordre public and morality). 
90 WTO, IP/C/W/368, ¶¶ 21, 26 (citing the submissions in WTO, IP/C/W/257 (United States), WTO, 
IP/C/M/29, ¶ 155 (Japan), WTO, IP/C/M/30, ¶ 171 (Korea), WTO, IP/C/M/29, ¶ 174 (Thailand), WTO, 
IP/C/M/30, ¶ 177 (United States)), discusses national legislation requiring contracts for access and benefit-
sharing that would necessitate detailed elaboration of access and use conditions, including provisions for 
judicial jurisdiction, and which might also include requirements to disclose such contracts (as 
documentation of prior informed consent) or additional evidence of compliance with contractual terms (for 
benefit-sharing) in intellectual property applications. Similarly, such contracts may require other 
disclosures of source and the country of origin (including in required descriptions of the subject matter). 
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disclosures of origin in intellectual property applications filed in foreign jurisdictions.91 If 
recognized and enforced in those jurisdictions, under legal principles such as comity, 
these legal and contractual requirements already impose an international system of 
mandatory disclosure of origin obligations.92 
 
49. National or contractual requirements for disclosures of origin in foreign 
intellectual property applications, however, are not uniform in scope, and may potentially 
conflict with intellectual property and other laws in the foreign jurisdictions. Complex 
legal rules regarding conflict of laws and legislative and judicial jurisdictions may 
sometimes preclude such national requirements from being effectuated.93 Not only are 
determinations regarding recognition and enforcement unpredictable, they also increase 
the burdens and costs of enforcing such requirements. As noted in a recent WTO 
submission suggesting an amendment to the TRIPS Agreement to require mandatory 
disclosure of origin requirements, “it would be more cost-effective to establish an 
internationally accepted solution … to prevent biopiracy than to divert national resources 
to expensive judicial processes for the revocation of patents that include illegal genetic 
resources….  Developing countries, in particular, do not have the resources to follow 
each and every patent issued outside their territories on the use of their resources.”94  
Similarly, indigenous and local communities typically lack the resources to effectively 
enforce patents and other rights relating to genetic resources and traditional knowledge.95  
New international treaty provisions imposing mandatory disclosure of origin obligations 
would reduce uncertainties regarding recognition and enforcement of such national 
disclosure requirements in foreign intellectual property applications, and would thereby 
reduce the burdens and costs of preventing and remedying biopiracy and 
misappropriation. Additional analysis of the recognition and enforcement of existing 
national access and benefit-sharing laws and contractual provisions imposing disclosure 
of origin requirements, and their relation to intellectual property laws, would significantly 
assist future discussions of disclosure of origin requirements. 
 
Treaty consistency of existing disclosure obligations  
 
50. Prior analyses have demonstrated that most forms of national disclosure of origin 
requirements for domestic and foreign patent applications (including requirements under 
existing national laws) are consistent with WIPO- and WTO-administered intellectual 
                                                 
91 By comparison, the Indian Biological Diversity Act, 2002, Article 6(1) prohibits applications for 
intellectual property in any form “in or outside India” for inventions based on biological resources 
“obtained from India” without the prior approval of the Indian National Biodiversity Authority. 
92 See, for example, UNU-IAS (2003), pp. 36-37 (discussing recognition issues relating to enforcement of 
foreign judgments); Hilton v. Guyot, 159 U.S. 113, 163-164 (1895) (comity is “the recognition that one 
nation allows within its territory to the legislative, executive, or judicial acts of another, having due regard 
both to international duty and convenience and to the rights of its own citizens or others protected by its 
laws”). 
93 See, for example Sarnoff, J.D. (2004), p. 3 and n.10, p. 19, p. 20 and n.91; UNEP/CBD/COP/7/INF/17, 
¶¶ 117-121, 156-160. 
94 WTO, IP/C/W/356, ¶ 12. 
95 Berglund, M. (2005), p. 245. 
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property law treaties,96 including the TRIPS Agreement, the PCT and the PLT. Such 
consistent requirements may preclude the granting of rights or privileges when 
submission of required documentation has not been made in a timely manner, or they 
may invalidate intellectual property ownership if requisite information or documents 
were accidentally or intentionally omitted, or if false or fraudulent information or 
documents were submitted.97 One potential inconsistency with existing patent law treaties 
would arise if an inadequate disclosure resulted in the denial of an effective filing date for 
an application from the initial date of submission, if the application otherwise met 
specified requirements. However, these treaty requirements may not supersede additional 
requirements for the further processing of applications, and problems may easily be 
avoided simply by according a filing date before additional consequences ensue (such as 
abandonment or refusal to process the application).98 Another potential inconsistency 
could arise if there were inadequate opportunities for prior comment and for judicial 
review of any invalidation of rights or privileges.99 The prior analyses were premised in 
part on the fact that existing international intellectual property treaties have not sought to 
regulate national laws that determine entitlements to apply for or own intellectual 
property. Thus, parties to those treaties remain free to limit substantive entitlements to 
apply for or to own intellectual property, as well as to condition such entitlements on 
disclosure obligations and to sanction disclosure failures.100 The relevant substance of the 
prior analyses is summarized briefly below. 
 
51. The PCT does not prohibit national disclosure of origin requirements at the 
national stage of processing international PCT applications, regardless of whether these 
requirements are considered to be “formal” or “substantive.”101 Nor does the PLT 
prohibit such requirements for national applications filed through the PCT system or 
initially in national patent offices.102 Although PCT Article 27(1) and PLT Article 6(1) 
limit the ability to require compliance with additional requirements relating to the “form 
                                                 
96 See, for example, Sarnoff, J.D. (2004), pp. 31-37, 51; UNEP/CBD/COP/7/INF/17,  ¶¶ 148, 153, 175, 
183. 
97 Sarnoff, J.D. (2004), pp. 37-53. Although UPOV has suggested that disclosure obligations that would 
deny or invalidate plant breeders rights conflict with the UPOV Convention, UPOV did not directly address 
the issue of entitlement to apply for such rights, but rather treated such requirements “as an additional 
condition of protection.” WTO, IP/C/W/347/Add.3, ¶ 20, available at: 
 http://docsonline.wto.org/gen_home.asp?language=1&_=1. 
98  Sarnoff, J.D. (2004), pp. 45, 49 (discussing PCT Art. 11(1) and PLT Art. 5(1)). 
99 Id., pp. 41–42, 45–46, 49–51. 
100Id., pp. 35–37;  see also WTO, WT/DS176/AB/R, ¶¶ 155–65, 189. 
101 Sarnoff, J.D. (2004), pp. 46–49 (discussing PCT Arts. 3(2), (4), 14, 26, and 27(1)).  Cf. 
UNEP/CBD/COP/7/INF/17, ¶¶ 132–135, 6 (discussing differences among treaty requirements applicable to 
substantive and formality requirements); WIPO/IP/GR/05/03, ¶ 73 (discussing substantive and formality 
requirements, and distinguishing both from ownership requirements), ¶¶ 168–172, 176–180 (discussing 
treaty requirements in regard to substantive and formality requirements); WTO, IP/C/W/433, ¶¶ 4–8, 
(discussing formal requirements, substantive requirements, and formal requirements strongly linked to 
substance, concluding that disclosures or origin are formal requirements, and urging amendment of PCT 
rules to authorize requirements for such disclosures), available at:  
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. Neither the PCT nor the PLT clearly 
distinguishes substantive rules from formalities. 




and contents” of applications, these requirements do not apply to disclosure of origin 
requirements as substantive conditions of entitlement.103 Both the PCT and PLT 
expressly state that they do not regulate substantive patentability rules, and they permit 
the imposition of requirements for additional documentation in that regard.104 But even if 
disclosure of origin requirements were to constitute prohibited formalities, the PCT 
would not preclude imposing disclosure obligations at the national stage. Further, there 
were only 10 countries party to the PLT as of April 2005.105 Countries with disclosure of 
origin requirements either would not ratify the PLT, or the PLT might be amended to 
permit such disclosure requirements. Additional discussion of implementation within the 
PCT and PLT treaty regimes is provided in Part V below. 
 
52. The TRIPS Agreement does not prohibit countries from imposing additional 
substantive conditions of entitlement and requirements for applicants to demonstrate their 
entitlement to apply for or own intellectual property. Article 29.1 of the TRIPS 
Agreement specifies mandatory and facultative patent application disclosure 
requirements. But that Article does not preclude countries from imposing additional 
disclosure requirements for national applications, particularly when effectuating 
substantive conditions of entitlement.106 Nor do the TRIPS Agreement, the PCT or the 
PLT prohibit countries from refusing to grant or from invalidating patents or plant 
breeders’ rights when substantive criteria for entitlement have not been met or when 
required disclosures have not been provided.107   
 
53. Assuming for analysis that disclosure of origin requirements were to constitute 
formalities, Article 62.1 of the TRIPS Agreement expressly authorizes members to 
impose “reasonable procedures and formalities” for acquisition and maintenance of 
intellectual property (such as copyright formalities and evidence of use for registered 
marks). Thus disclosure of origin requirements would need to be evaluated for 
reasonableness under Article 62.1. Requirements to disclose the source, the country 
providing genetic resources and associated traditional knowledge, the country of origin, 
persons involved, and documentary information regarding access and benefit-sharing 
may entail varying degrees of burden for applicants. If properly tailored to minimize 
unnecessary burdens, disclosure of origin requirements should be considered 
“reasonable.” In contrast, requirements for intellectual property application offices to 
evaluate such disclosures of origin may entail significant administrative burdens, 
particularly if the national application offices are required to assess compliance with 
access and benefit-sharing requirements imposed by different countries’ laws or by 
                                                 
103 Id., pp. 47-50 (citing, inter alia,  PCT Arts. 27(1), (2), 27(3), 27(5), PLT Art. 6(1), and WIPO, SCP/6/5, 
available at: http://www.wipo.int/scp/en/documents/session_6/pdf/scp6_5.pdf). 
104  UNEP/CBD/COP/7/INF/17, ¶¶ 165, 169–171, 175 (citing TRIPS Art. 29.2, PLT Art. 2(2), and WIPO 
SCP/6/5)). 
105 These are Croatia, Denmark, Estonia, Kyrgyzstan, Nigeria, the Republic of Moldova, Romania, 
Slovakia, Slovenia and Ukraine. 
106 Sarnoff, J.D. (2004), pp. 40-41; WTO,  IP/C/W/383, ¶ 48 (noting that Article 29.1 permits additional 
disclosure requirements that do not relate to substantive patent validity criteria), available at: 
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
107 Sarnoff, J.D. (2004), pp. 37-41, 50-51. 
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contracts.108  However, TRIPS Article 62.1 would not prohibit such requirements, as it 
does not regulate the reasonableness of administrative procedures per se.109 
 
The Swiss proposal to facilitate disclosure obligations   
 
54. Because it views PCT Article 27(1) and PLT Article 6(1) as precluding disclosure 
of origin requirements for PCT at the international and national stage and for PLT at the 
national stage of applications, Switzerland has proposed amendment of the PCT to 
expressly authorize disclosure of origin requirements for national applications. The PCT 
amendments would apply also to the PLT for national and regional applications, as PLT 
Article 6(1) incorporates by reference PCT requirements relating to the form and contents 
of an international application.110 The Swiss proposal would not mandate national 
disclosure of origin requirements. Rather, it would authorize PCT and PLT parties to 
impose disclosure of origin requirements at the national stage of application processing, 
and it would permit (but would not require) applicants to include such disclosures at the 
international stage of PCT applications. If such disclosures were voluntarily included at 
the international stage, the PCT would require receiving offices to publish them.111 The 
Swiss proposal would apply only to declaring the “source” of genetic resources, which is 
defined broadly to include both the source (as defined for this analysis) and the country 
providing genetic resources or traditional knowledge. The proposal would not require 
disclosure of more than the “primary source” (but would permit disclosure of additional 
sources if known), defined as the country providing genetic resources or traditional 
knowledge.112 Furthermore, the proposal would not require disclosure unless the 
invention that is the subject of the patent application was “directly based” on genetic 
resources or traditional knowledge.113 Thus the Swiss proposal would adopt a very 
narrow substantive trigger for requiring disclosures of origin in patent applications. 
 
55. The Swiss proposal, however, would not by itself permit applicants to declare the 
source of genetic resources or traditional knowledge at the international stage, unless the 
declaration was relevant to the national application of at least one designated country. Of 
potentially greater significance, this proposal would prevent designated countries from 
requiring applicants to provide additional documentation regarding the disclosure of 
source in national patent applications, in the absence of reasonable doubt as to the 
veracity of the declaration made in the prescribed form (which would be adopted by 
                                                 
108 Correa, C.M. (2003),  p. 9. 
109 Gervais, D. (2003), p. 330. 
110 UNEP/CBD/COP/7/INF/17, ¶ 168 (citing WIPO/SCP/6/5). 
111 WTO, IP/C/W/433;  WTO, IP/C/W/423, available at: 
 http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm; WTO, IP/C/W/400/Rev.1, available at: 
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm; WIPO/IP/GR/05/03, ¶¶ 52-54 (summarizing 
the Swiss Proposal and citing WIPO documents PCT/R/WG/4/13, PCT/R/WG/5/11 Rev, PCT/R/WG/6/11, 
and PCT/R/W/7/7). 
112 WTO, IP/C/W/433, ¶¶ 11-13 (discussing proposed PCT Rules 4.17(vi) and 51bis.1(g)); WTO, 
IP/C/W/423, ¶¶ 21-23. 
113 WTO, IP/C/W/423, ¶¶ 27-28 (noting that “directly based” in proposed PCT Rule 51bis.1(g) requires the 
invention to “make immediate use of the genetic resource” and for the inventor to have had sufficient 




amendment of the Administrative Instructions).114 Designated offices could request 
applicants to correct defective declarations (where reasonable doubt exists) or missing 
declarations, and could refuse the application or consider it withdrawn after at least two 
months from notice. But the failure to comply with disclosure obligations would not 
provide grounds for revocation of issued patents (under PLT Article 10(1) if applicable), 
unless the failure reflected fraudulent intent.115 The Swiss proposal thus might preclude 
nations from imposing more substantial disclosure of origin requirements on national-
stage PCT applications and on national applications subject to the PLT.  It would prohibit 
requirements to disclose additional sources and the country of origin, as well as 
documentary information regarding compliance with CBD access and benefit-sharing 
requirements.116 If adopted, countries currently requiring such disclosures at the national 
stage would have to change their laws in order to conform to the PCT or the PLT. 
 
Mandatory disclosure of origin obligations  
 
56. Authority currently exists for countries to require disclosures of origin in patent 
applications. Authority also exists for countries to deny intellectual property during the 
application process if a failure to make required disclosures is recognized, and to 
invalidate intellectual property if required disclosures were not made or were improperly 
made. None of the existing intellectual property law treaties, however, mandates that 
parties impose disclosure of origin requirements on intellectual property applicants. Nor 
do these treaties obligate parties to impose any specific consequences for failures to 
comply with national disclosure of origin requirements, or to recognize and enforce other 
countries’ access and benefit-sharing laws and contracts requiring applicants to make 
such disclosures.117 Thus, although disclosure of origin requirements may be imposed at 
the national level, there is no coherent international system in place to assure that such 
requirements are effectuated on a worldwide basis. Concerns have been raised that 
                                                 
114  WTO, IP/C/W/433, Annex (Comment to Proposed PCT Rule 4.17(vi), Proposed PCT Rule 51bis.2(d) 
and Comment); WTO, IP/C/W/423, ¶ 25. 
115 WTO, IP/C/W/423, ¶¶ 25-26 (discussing proposed revisions to PCT Rule 51bis.3(a) and a proposed new 
PCT Rule 51bis.1(g)). 
116  WTO, IP/C/W/400/Rev.1, ¶¶ 12-20 (discussing Switzerland’s views that requirements to disclose 
evidence of compliance with CBD access and benefit-sharing obligations should not be included in 
facultative PCT and PLT disclosure provisions, and that requiring such disclosures would be contrary to 
Art. 62.1 of the TRIPS Agreement). To the extent that such disclosures are needed to comply with 
substantive patent law requirements (such as enablement), additional disclosures may be necessary and 
relevant information may be incorporated into the written specification of the invention in the application.  
The Swiss Proposal does not discuss whether additional disclosure obligations may be compelled of 
applicants for intellectual property through requirements of national access and benefit-sharing laws of 
different countries.  If such disclosures were considered “voluntary,” they would not trigger the restrictions 
of proposed PCT Article 51bis.3(a).  It is also unclear whether receiving offices would transmit any such 
additional documents to designated offices if submitted by applicants.  Complex issues also arise if national 
access and benefit-sharing laws were to require invalidation of the right to seek or own patents in other 
countries if such additional disclosures were not made or were falsely or fraudulently made.  See Sarnoff, 
J.D. (2004), p. 46. 
117 CBD Article 15.2, however, requires Parties not to impose “restrictions that run counter to the 
objectives” of the Conventions.  CBD Article 5 requires Parties to cooperate with other Parties on “matters 
of mutual interest.”  CBD Article 16.5 obligates Parties to cooperate “to ensure that [intellectual property] 
rights are supportive of and do not run counter to” CBD objectives. 
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adoption of proposed mandatory requirements “would lead to significant 
uncertainties,”118 but these concerns are misplaced.  Uncertainties already exist, and they 
cannot be resolved without an agreed solution through new international treaty provisions 
or other agreements directly addressing disclosure of origin requirements. 
 
57. Some developed countries and many developing countries have identified the 
need for a mandatory international system to address disclosure of origin issues.119 As 
noted by several developing countries, most of the proposals to improve patent 
examination relating to genetic resources and traditional knowledge (so as to deter 
biopiracy and to prevent misappropriation) are unlikely to address the full scope of prior 
art. Further, to the extent that they are voluntary measures, those proposals would 
“provide no guarantee” that information on the source and country of origin will be 
considered in order to prevent the improper issuance of patents.120 Enforcement 
mechanisms external to the intellectual property law system or reliance on contractual 
measures are inadequate, because there is no obligation to legislate for such measures or 
to enforce such contracts. Moreover, such contracts are unlikely to be entered into unless 
they are obligatory and enforceable.121 On the other hand, mandatory disclosures in 
intellectual property applications would continue to be useful after the application stage, 
and would reduce the need for costly administrative or judicial challenges to the validity 
of the patent or the entitlement of the applicant or owner. Developing countries in 
particular lack adequate resources to undertake such challenges on a worldwide scale.122  
 
58. Numerous benefits from adopting mandatory disclosure obligations have been 
identified for both the CBD regime and the intellectual property law system. These 
include: improving the substantive examination of applications; providing greater 
certainty regarding the validity of granted rights and privileges; reducing the need for 
revocation of improperly granted intellectual property; improving identification of 
possible cases of misappropriation; facilitating actions to challenge the validity of 
wrongly issued intellectual property; improving determinations of inventorship or other 
relationship to the subject matter, thereby assisting identification of persons  who should 
participate in equitable benefit-sharing; facilitating abilities to use the subject matter of 
the intellectual property; promoting compliance with access and benefit-sharing 
legislation; and tracking commercialization to promote more effective benefit-sharing.123 
                                                 
118 WTO, IP/C/W/449, p. 2. 
119 See, for example, Correa, C.M. (2005), pp. 2–3; South Centre/CIEL (2004), ¶ 23-24, (discussing the 
New Delhi Ministerial Declaration  of the Group of Like Minded Megadiverse Countries); WTO, 
IP/C/W/383, ¶¶ 50-56 (acknowledging the “merits” of addressing disclosure issues through a mandatory 
international system, but opposing additional formal or substantive patentability criteria); WIPO (2005), 
Provisional Compilation, p. 10, Submission of Brazil; id., p. 18, Submission of Ghana; id., p. 59, 
Submission of the African Group; id., p. 61, Submission of the Andean Community. 
120 WTO, IP/C/W/429/Rev.1 and Add.1-Add.3, ¶¶ 3-4;  available at:  
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
121 WTO, IP/C/W/438, ¶ 7; WTO, IP/C/W/443, ¶ 8. 
122 WTO, IP/C/W/429 Rev.1 and Add.1-Add.3, ¶ 5. 
123 See, for example, Correa, C.M. (2003),pp. 2–3; Correa, C.M. (2005), p. 3 
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Of course, disclosure obligations should be seen as only one of many elements of an 
international system to prevent biopiracy and misappropriation.124   
 
59. Objections to disclosure of origin requirements have been raised based on 
concerns that such requirements will not necessarily prevent misappropriation (even if 
misappropriation is understood only by reference to lack of authority to grant access and 
lack of prior informed consent for access).125 Additional objections are based on concerns 
that invalidation of intellectual property will not necessarily assure, and may even 
prevent, equitable benefit-sharing.126 In response, it has been noted that disclosure of 
origin requirements seek not to replace but to supplement other methods for enforcing 
prior informed consent and benefit-sharing regimes.127 These objections appear to be 
based on the controversial view that such measures are unduly burdensome to applicants 
and administrative offices, and unduly costly to other interests (such as the certainty of 
patent validity) when compared to the benefits to be obtained.128 Furthermore, such 
objections do not take account of the need to monitor intellectual property once validity is 
granted under applicable intellectual property law requirements (and the associated costs 
of doing so), so as to deter and remedy misappropriation (e.g. by violating contractual 
conditions under which rights or privileges were to be obtained or equitable benefits  
shared).129  Nor do these objections take account of the need to prevent misuse of the 
intellectual property system itself.130 Objections that disclosure of origin requirements 
would not prevent misappropriation when applications for intellectual property are not 
filed131 are similarly misplaced. However, they do imply the need for effective 
international measures that directly protect against improper access and misappropriation 
of genetic resources and traditional knowledge.132   
 
60. It bears noting that many countries are still in the process of enacting legislation 
to effectuate CBD access and benefit-sharing requirements. Determining compliance with 
CBD prior informed consent and equitable benefit-sharing principles in such situations 
                                                 
124 WTO, IP/C/W/442, ¶ 5, available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm; 
Correa, C.M. (2005), pp. 3–4. 
125 See, for example, WTO, IP/C/W/434, ¶ 7 (“only contractual obligations … can ensure that prior 
informed consent is achieved”); WIPO (2005), Provisional Compilation, p. 45, Submission of United 
States. 
126 See, for example, WTO, IP/C/W/434, ¶¶ 9–11; WIPO (2005), Provisional Compilation, pp. 45–46, 
Submission of United States. 
127 See, for example, WTO, IP/C/W/403, ¶¶ 5-8; WTO, IP/C/W/442, ¶ 5; South Centre/CIEL (2004), ¶ 24. 
128 See for example, WTO, IP/C/W/434, ¶¶ 14-16 and ¶ 25 (arguing that disclosures would be too 
burdensome for the patent system and that effective enforcement should be limited to direct civil and 
criminal enforcement of access and benefit-sharing laws). Cf. WTO, IP/C/W/442, ¶¶ 6-8 (disputing the 
burdens and articulating the need for an international framework for protection); WTO, IP/C/W/443, ¶ 4 
(noting existing uncertainties to facilitated access resulting from the lack of international disclosure of 
origin rules); id., ¶ 10 (noting that properly tailored legal consequences of disclosure failures may deter 
persons acting in bad faith); and id. ¶¶ 19–22 (disputing that administrative burdens would be substantial 
and noting that examiners would not be required to determine validity of prior informed consent or 
adequacy of benefit-sharing). 
129 WTO, IP/C/W/443, ¶ 13. 
130  CIEL (2005), ¶¶ 23–25. 
131  WTO, IP/C/W/443, ¶ 16. 
132  Id., ¶ 6. 
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may be a complex undertaking. Such determinations may need to take account of legal 
principles that have not been incorporated into legislation, and may raise complex issues 
that have not previously been addressed or adequately resolved. For example, authorized 
access may depend on common law or on traditional rules of property, as well as on 
inchoate sovereign interests over their resources and on complex principles of 
international law.133 Equitable benefit-sharing may need to be determined in the absence 
of contractual or other agreements that reflect mutually approved terms.134 Additional 
analysis of CBD access and benefit-sharing obligations and of disclosure of origin 
requirements in such circumstances would be helpful. 
 
61. For the reasons articulated above, this analysis concludes that mandatory 
international obligations to impose disclosure of origin requirements are both necessary 
and appropriate. Such obligations should be adopted within an appropriate intellectual 
property law treaty regime. The treaty provisions should address what disclosures should 
be required, whether to recognize and apply the access and benefit-sharing requirements 
of countries providing the genetic resources and associated traditional knowledge, and 
how international and national intellectual property application offices and national 
judiciaries should evaluate the adequacy of such disclosures.  The treaty also may need to 
address whether to recognize and enforce contracts that require disclosures that differ 
from or add to the mandatory treaty obligations or national laws. 
 
B. Specification of mandatory disclosure obligations and consequences 
 
62. The investigatory burdens and costs to applicants of providing disclosures of 
origin and documentary information regarding access and benefit-sharing, as well as the 
administrative burdens and costs of evaluating such information, should be limited to 
what is necessary to attain the intended objectives of the disclosure obligations.135  
Various options are explored below concerning the scope of the disclosures and the 
administrative burdens they may entail. Unless and until new international treaty 
provisions are adopted, the scope of required disclosures and consequences of disclosure 
failures will vary across countries.136 Similarly, the failure to disclose required 
                                                 
133 See, for example, CBD Preamble (affirming sovereign rights over their resources); WTO, IP/C/W/442 
(suggesting that declarations of authorized access could be provided in the absence of a national access and 
benefit-sharing regime). 
134 See, for example, WTO, IP/C/442, ¶ 11 (suggesting that equitable benefit-sharing may be provided if it 
“fully respects the prevalent laws, regulations and practices of the country of origin”). 
135 Correa, C.M. (2003), p. 9; WTO, IP/C/W/434, ¶ 15; WIPO (2005), Provisional Compilation, p. 25, 
Submission of Japan; WIPO (2005), Provisional Compilation, pp. 47, 50, Submission of the United States. 
136 See, for example, WTO, IP/C/W/447, p. 9 (discussing the Third Supplementary Provision of Andean 
Community Decision 391, which obliges Member Countries to require applicants to disclose the 
registration number and a copy of the contract providing access to genetic resources “as a prerequisite for 
granting the respective right” and requires establishment of an information exchange system between 
national authorities granting access and national intellectual property offices; also discussing Andean 
Community Decision 486, Arts. 26(h) and (i) and 75(g) and (h), (which require disclosure of copies of 
contracts for access to genetic resources and documents certifying the license or authorization to use 
traditional knowledge, and requiring patents to be declared void if the applicant has failed to submit these 
copies); and pp. 11–12 (summarizing significant features of existing requirements of various nations to 
disclose evidence or certificates of origin and to prohibit intellectual property where access was not legal). 
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information may result in different legal consequences, such as punitive sanctions and/or 
invalidation of granted rights or privileges. Objections have been made to mandating 
invalidation of intellectual property for disclosure failures, as the absence of intellectual 
property might in some circumstances jeopardize or prevent commercialization that could 
lead to appropriate benefit-sharing.137 However, some flexibility in the mandatory 
obligations may be warranted to permit the consequences of disclosure failures to be 
tailored to the circumstances. The goals of such tailoring would be, where appropriate, to 
encourage the correction of unintentional disclosure errors and to permit the transfer 
(rather than invalidation) of intellectual property or the return of unjustly obtained 
benefits in cases of fraudulent conduct, unauthorized access or inequitable benefit-
sharing.138   
 
63. Because these issues overlap with the discussions of procedural triggers in Part III 
and of incentive measures in Part IV, the analysis in this section is limited to an overview 
of various administrative and post-administrative options. 
 
Disclosures in application submissions and their evaluation 
 
64.  In order to promote compliance with CBD access and benefit-sharing 
requirements, disclosure of origin obligations must provide useful information, but 
should not impose undue costs and burdens on applicants or administrative offices. 
Significantly, information contained in intellectual property applications may be used 
after the application process, for example in administrative or judicial proceedings to 
invalidate improperly granted intellectual property or to seek remedies for 
misappropriation. Requiring applicants to disclose information on the source of and 
country providing genetic resources and associated traditional knowledge, the authority 
of the source, the country of origin, and compliance with access and benefit-sharing 
requirements not only may help to assure proper entitlements to apply for and own 
intellectual property, but also may assist compliance with CBD access and benefit-
sharing requirements, even when such information is not evaluated in the application 
context.139 When specifying what disclosure of origin requirements to mandate by treaty, 
consideration should be given to what information must be disclosed during the 
application process, what evaluations should be made of the information, how the 
information may otherwise be used, and whether and when information should be 
supplemented or corrected. 
                                                 
137 See, for example, WIPO (2005), Provisional Compilation, pp. 42, 46, Submission of the United States; 
and pp. 56, Submission of the European Communities; WTO, IP/C/W/383, ¶ 55. 
138 See, for example, TRIPS Council India Statement, p. 3 (noting a purpose to prevent monopolies on 
biological material or traditional knowledge when they are not warranted); Correa, C.M. (2003),, pp. 52–
53. 
139 For example, documentary information regarding benefit-sharing may be reviewed not only for 
technical compliance with benefit-sharing legislation of the country providing genetic resources, but also to 
assure that the “shares of benefits that accrued … was equitable and fair in the circumstances.”  WTO, 
IP/C/W/443, ¶ 3. Such documentary information is likely to extend beyond contractual provisions 
providing for access and benefit-sharing; moreover, it may not be fully available for review during the 
application process, and if available may not be reviewed for substantive fairness within the application 
process without imposing significant burdens on that process.  See, for example, WTO, IP/C/W/442, ¶ 9–




65. There are several contexts in which information provided by mandatory 
disclosure of origin requirements may be evaluated.  These include: 
 
• International applications; 
• National applications; 
• Pre-grant administrative opposition or other challenges; 
• Post-grant administrative re-examination, interference, revocation, 
opposition or other challenges; and  
• Judicial proceedings (including enforcement actions and separate legal 
actions addressing validity, ownership or misappropriation). 
 
66. There are also numerous options regarding what information and documentation 
should be disclosed by applicants, and whether and when it should be supplemented or 
corrected at a later period. These include: 
 
• Disclosures of information only (which may be required in prescribed 
forms or content); 
• Disclosures of information accompanied by various declarations by 
applicants (e.g. declarations of adequate investigation, declarations of the 
accuracy of submitted information, and declarations of compliance with 
access and benefit-sharing requirements); 
• Disclosures of information accompanied by documentary information 
regarding access and benefit-sharing (e.g. submission of contracts 
providing conditions for access and benefit-sharing; evidence of 
compliance with contractual requirements); and 
• Disclosures of information accompanied by international certificates of 
origin. 
 
Obviously, these different options may be combined in various ways, and the information 
may be put to different uses in different contexts.  Requiring information to be provided 
at entry to the international stage (if any) or the national stage of the application process 
would assure that such information (if transmitted and retained) would be available for 
consideration at later stages. So long as transmission of the information does not impose 
significant burdens, analysis can focus on whether it would be useful to provide the 
information at earlier stages (e.g. requiring submission at the international stage to assure 
efficient transmission to multiple national stage application offices), even if the 
information is evaluated only at later stages. 
 
67. Further, there are numerous options concerning the scope of evaluations of 
information submitted pursuant to mandatory disclosure obligations.  These include: 
 
• Evaluations for completeness of submitted information, declarations and 
documents; 
• Evaluations for substantive adequacy of disclosed information; 
• Evaluations of relevance and accuracy of declarations; 
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• Evaluations of relevance and accuracy of documentary information 
regarding access and benefit-sharing; and 
• Evaluations of validity of international certificates of origin. 
 
Different evaluations may occur in different procedural contexts.   
 
68. National intellectual property offices seldom scrutinize demonstrations of 
entitlement to apply for or to own intellectual property (e.g. recorded assignment 
documents) for their substantive validity, unless those documents (and thus the right to 
apply for or to own intellectual property) are suspect or are otherwise challenged in a pre-
grant or post-grant administrative proceeding.140 Nevertheless, such documents are 
routinely required to be filed, and reference is required to be made to those documents in 
intellectual property applications.141 
 
Consequences of disclosure failures, fraudulent conduct, lack of authority and 
inequitable benefit-sharing 
 
69. Various options have been proposed for the consequences of providing 
incomplete, incorrect or fraudulent disclosures of origin.  These include: 
 
• Leaving decisions on sanctions to contracting States (including 
recognition and enforcement of other States’ laws, where applicable);142 
• Relying on “effective, proportionate and dissuasive [external] sanctions,” 
without affecting the validity or ownership of intellectual property (so as 
to provide greater certainty regarding validity and ownership);143 
• Imposing civil liability or criminal penalties for violation of contractual 
obligations;144 
                                                 
140 Under United States law, 37 Code of Federal Regulations (C.F.R.) § 1.48(g), the United States Patent 
and Trademark Office (US PTO) may require additional information, as needed, to correct inventorship; 
and 37 C.F.R. § 3.73(b) requires documentation of assignee ownership “to the satisfaction of the Director” 
of the US PTO, including relevant chain of title information. See also 37 C.F.R. §§ 1.171, 1.175, 1.324, 
1.634 (United States law addressing correction of inventorship in reissue applications, issued patents and 
interferences). 
141 See, for example, United States laws 35 U.S.C. § 261, ¶ 4 (requiring recording of assignments, grants or 
conveyances of patents to be valid against subsequent purchasers), 37 C.F.R. § 1.76(b)(1) (requiring for 
voluntary application data sheets inclusion of information demonstrating authority of assignees to apply for 
patents, pursuant to 37 C.F.R. § 1.46, which authorizes issuance of patents to assignees), 37 C.F.R. § 
3.11(a) (providing for recording of assignments and other documents affecting title to applications, patents, 
or registrations), 37 C.F.R. § 3.21 (requiring registered assignments to cross-reference related applications), 
and 37 C.F.R. § 3.56 (treating conditional assignments as absolute unless withdrawn, because the Office 
does not evaluate or determine whether conditions have been met).  
142 See, for example, WIPO (2005), Provisional Compilation, p. 56, Submission of the European 
Communities. 
143 WIPO (2005), Provisional Compilation, p. 56, Submission of the European Communities.  See also 
WTO, IP/C/W/434, ¶ 3 (viewing “with the utmost caution” proposals that “would add uncertainties in 
patent rights”), and ¶ 14 (sanctions that include invalidation “would create a ‘cloud’ of uncertainty over the 
patent right”). 
144 For example, WTO, IP/C/W/434, ¶ 26; WIPO (2005), Provisional Compilation, p. 50, Submission of the 
United States; Correa, C.M. (2005), pp. 8–9 (summarizing the positions of a US PTO presentation). 
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• Using unfair competition rules and other legal regimes to address 
violations of access and benefit-sharing requirements;145 
• Addressing the failure to provide required information or the submission 
of false or fraudulent statements or documents by imposing administrative 
fines or criminal penalties internal or external to the intellectual property 
system (depending on the effect of the information on the applications);146 
• Requiring evaluations of various forms of disclosure and refusing to 
process applications or to grant rights or privileges where required 
information is not submitted (potentially subject to opportunities for 
correction) or where information is falsely or fraudulently submitted;147 
• Requiring revocation or invalidation of intellectual property following 
determinations that various forms of required information were not 
submitted (potentially subject to opportunities for correction) or where 
information was falsely or fraudulently submitted;148 
• Requiring full or partial transfer of rights or privileges in the subject 
matter of intellectual property, so as to promote fair and equitable benefit-
sharing;149 and 
• Requiring the return of any unjustified benefits conferred in violation of 
access and benefit-sharing requirements.150 
 
These options for mandatory disclosure obligations are not mutually exclusive, and there 
may be reasons for resorting to multiple options so as to assure adequate deterrence, 
enforcement and compensation. 
 
Conflict of laws and jurisdictional rules 
 
70. Mandatory disclosure of origin obligations will assist in effectuating a number of 
existing legal regimes, such as laws implementing CBD access and benefit-sharing 
requirements and specifying the consequences of failure to comply with those 
requirements; laws addressing entitlements to apply for intellectual property; and laws 
relating to misappropriation and to the return of unjustified benefits.  In the absence of 
mandatory disclosure of origin obligations specified by new international treaty 
provisions, these and other laws will continue to apply and to impose the various 
consequences listed above. New international treaty provisions addressing mandatory 
sanctions thus may assist in clarifying the applicable legal framework, and in establishing 
more uniform conditions for recognition and enforcement of the various sets of 
potentially applicable legal requirements.151 Alternatively, an international agreement 
could assure that national disclosure of origin requirements take precedence over national 
                                                 
145 For example, WTO, IP/C/W/434, ¶ 11. 
146 For example, WTO, IP/C/W/442, ¶¶ 13, 14. 
147 For example, id. ¶¶ 13. 
148 For example, id. ¶ 14. 
149 For example, id. 
150 For example, CIEL (2005),  ¶ 24. 
151 Dinwoodie, G.B. (2003), pp. 202, 206 (discussing ways that substantive treaty law may affect or 
constitute choice of law rules and may affect harmonization); UNEP/CBD/COP/7/INF/17, ¶ 157 
(discussing choice of law and recognition of judgment issues). 
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intellectual property laws that otherwise might preclude recognition and enforcement of 
disclosure of origin requirements.152  Mandatory disclosure of origin obligations thus may 
help to make the international system of national laws requiring disclosures of origin 
more coherent. 
 
71. Consideration should also be given to including mandatory provisions regarding 
jurisdiction, recognition and enforcement of judgments (such as mutual recognition, 
application of mandatory rules, and jurisdiction that cannot be declined)153 or less strict 
obligations to adjudicate disputes (such as forum non-conveniens principles that would 
permit national agencies and courts to decline jurisdiction)154 relating to compliance with 
national access and benefit-sharing laws and with mandatory, treaty-based or additional 
disclosure obligations. Similarly, consideration should be given to whether and under 
what conditions compliance issues should be referred to an appropriate intergovernmental 
organization or to the courts or agencies of other countries (e.g. for definitive 
interpretations of CBD access and benefit-sharing requirements or of CBD implementing 
legislation of the country providing genetic resources and associated traditional 
knowledge).155 
                                                 
152 WIPO/GRTKF/IC/8/6, ¶¶ 27-29 (discussing jus cogens and other means to ensure national effect of 
international obligations), available at:  
 http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_8/wipo_grtkf_ic_8_6.doc. 
153 Drahos, P. (2004), pp. 27–28 (discussing mutual recognition principles), available at:  
http://r0.unctad.org/trade_env/test1/meetings/tk2/drahos.draft.doc; Convention on the law applicable to 
contractual obligations, concluded June 19, 1980 at Rome, Art. 7(1) (Rome I Convention) (authorizing 
application of mandatory rules of law of other countries “with which the situation has a close connection” 
for contractual disputes), available at: http://www.rome-convention.org/instruments/i_conv_cons_en.htm; 
Dinwoodie, G.B. (2003), p. 202 (discussing universal jurisdiction); European Union, Council Regulation 
(EC) No 44/2001 of 22 December 2000 on jurisdiction and the recognition and enforcement of judgments 
in civil and commercial matters, O.J. L 12/1 (Jan. 16, 2001) (adopting complex rules for when courts have 
jurisdiction and must recognize and enforce judgments rendered in other jurisdictions), available at: 
http://europa.eu.int/eur-lex/pri/en/oj/dat/2001/l_012/l_01220010116en00010023.pdf. 
154 See, for example, United States Department of State (2001) (noting that the forum non conveniens 
doctrine in United States law permits courts to decline jurisdiction where the forum is inconvenient and 
adequate alternative forums exist), available at: http://www.state.gov/www/global/legal_affairs/us_annex-
c.html; Altman v. Republic of Austria, 317 F.3d 954, 972 (9th Cir. 2002) (noting that the forum non 
conveniens doctrine authorizes district courts in the United States to decline to exercise jurisdiction based 
on the convenience of the parties and the interests of justice, subject only to abuse of discretion review), 
affirmed on other grounds, 541 U.S. 677 (2004). 
155 See, for example, Handelskwekerij G.J. Bier B.V. v. Mines de Potasse d'Alsace S.A., Case 21/76, [1976] 
E.C.R. 1735, 1745 (referring from a national appellate court to the European Court of Justice a question of 
interpretation under the European Convention on Jurisdiction and Enforcement of Judgments in Civil and 
Commercial Matters, Art. 2, done at Brussels, Sept. 27, 1968, 33 O.J. Eur. Comm. (C189/1) 1 (July 28, 
1990)); Dinwoodie, G.B. (2004), pp. 14–15 (discussing concerns over judicial competence that might 
“counsel in favor of input from courts in countries with developed bodies of traditional knowledge law,” 
noting concerns of developed countries over deference to foreign institutions in the contexts of negotiation 
of the Hague Convention on Jurisdiction, Recognition and Enforcement of Foreign Judgments in Civil and 
Commercial Matters, Working Document No. 110E (Revised) (27 April 2004), and suggesting use of 
international institutions to determine compliance issues).  Cf. United States law 28 U.S.C. §§ 1781, 1782 
(discussing authority to receive letters rogatory and to compel assistance to foreign and international 
tribunals); European Convention on Transfer of Proceedings in Criminal Matters, opened for signature May 





72. Finally, mandatory disclosure of origin treaty provisions will likely need to be 
translated into domestic legislation and administrative rules, because such obligations 
may need to be phrased in general terms and because some national legal systems do not 
permit adoption of self-implementing treaty provisions. An obvious principle underlying 
the drafting of such treaty provisions is that the language of mandatory disclosure of 
origin obligations should be made as clear as possible so as to avoid disputes regarding 
their meaning and to facilitate their translation into national laws and rules. Further, 
attention should be given in the text to how failures by parties to fully implement those 
requirements should be addressed. Provisions for dispute resolution among parties 
already exist for the TRIPS Agreement,156 which appears to be the most appropriate 
treaty regime in which to locate provisions on mandatory disclosure of origin obligations. 
 
C. Choice of treaty regime to implement mandatory disclosure obligations 
 
73. Numerous countries have suggested amending the TRIPS Agreement’s patent 
provisions (specifically TRIPS Article 29) to include mandatory disclosure of origin 
obligations.157 Applying such disclosure obligations only in the context of patents, 
however, would not affect other intellectual property applications whose subject matter 
implicates CBD access and benefit-sharing requirements.158 Of particular relevance, such 
a limitation would not apply mandatory disclosure obligations to the subject matter of 
plant breeders’ rights, if such rights were not provided by patents but rather by plant 
breeders’ certificates under the UPOV Convention (as is permitted by Article 27.3(b) of 
the TRIPS Agreement).  The UPOV Convention’s  1978 and 1991 texts addressing plant 
breeders’ rights might need to be amended to assure mandatory disclosure of origin 
obligations in applications for those rights.  However, there are many fewer parties to the 
UPOV Convention than to the TRIPS Agreement. Thus, if such obligations were 
provided only in the UPOV Convention, they would not apply directly to countries that 
are not signatories to that Convention.   
 
74. Without regard to the political economy of the choice of treaty regime in which to 
locate mandatory disclosure of origin obligations,159 the most appropriate seems to be the 
TRIPS Agreement (without limiting those obligations to patent applications). The main 
reasons for this are: the large membership of the WTO; the recognized expertise of the 
WTO in intellectual property issues; the comprehensive approach of the TRIPS 
Agreement to the intellectual property system; the obligation of the WTO to address the 
relationship of the TRIPS Agreement to the CBD, pursuant to paragraph 19 of the Doha 
                                                 
156 See generally, WTO, Marrakesh Agreement Establishing the World Trade Organization, Annex II, 
Understanding on rules and procedures governing the settlement of disputes, concluded April 15, 1994, 
effective Jan. 1, 1995, available at: 
 http://www.wto.org/english/tratop_e/dispu_e/dsu_e.htm. 
157 WTO, IP/C/W/356, § 10 (proposing to amend the TRIPS patent provisions); WTO, IP/C/W/403, § 1 
(same); WTO, IP/C/W/404, p. 6 (proposing to amend Art. 29). 
158 Again, application of disclosure of origin requirements to utility models, petty patents, trademarks, 
industrial designs and other sui generis protections is not addressed here, but is implicated by the analysis.  
159 Helfer, L.R. (2004), Yu, P.K. (2004), p323 
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Declaration;160 the provision in the TRIPS Agreement for a review procedure;161 and the 
existence of the WTO’s binding mechanism for dispute settlement to address violations 
of requirements.162 Because the WTO does not implement many intellectual property law 
treaties, however, appropriate measures would need to be included in the TRIPS 
Agreement to ensure the application of new mandatory disclosure of origin treaty 
provisions to other intellectual property treaty regimes.163 Those regimes might then need 
to be amended to effectively incorporate the relevant obligations to be effectuated.164 
Provision might also be made to assure a continuing role for the CBD to provide 
assistance and coordination in developing and implementing disclosure of origin 
requirements. 
 
75. On the other hand,, including new mandatory disclosure of origin treaty 
provisions in the CBD would more readily allow linkage and continuing coordination of 
disclosure of origin obligations with CBD access and benefit-sharing requirements. The 
CBD secretariat also has substantial technical expertise regarding genetic resources and 
associated traditional knowledge associated with the subject matter of intellectual 
property applications, as well as substantial legal expertise regarding the CBD and 
national access and benefit-sharing requirements. Nevertheless, the CBD would be a less 
appropriate location than the TRIPS Agreement for such new treaty provisions. Locating 
such provisions within the CBD regime would not incorporate disclosure requirements 
directly into the intellectual property law system, and thus would complicate efforts to 
assure that disclosure obligations are adopted within intellectual property treaty regimes. 
Further, disclosure of origin obligations mandated within the CBD would not directly 
apply to the intellectual property systems of countries that are not Parties to the CBD,165 
but which may be Parties to the TRIPS Agreement.  The CBD COP could make a 
contribution to possible negotiations on the contents of disclosure obligations to be 
adopted within the TRIPS Agreement, either within the context of the ongoing review of 
the TRIPS Agreement and WTO Doha Round negotiations or of CBD COP efforts to 
develop international treaty provisions for further addressing access and benefit-sharing 
requirements. 
 
                                                 
160 WTO, WT/MIN(01)/DEC/1, p. ¶ 19, 2001, available at: 
 http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_e.pdf. 
161 TRIPS Agreement, Art. 71.1. 
162 WTO, IP/C/W/447, p. 13 (the TRIPS review process and binding mandates “makes this the ideal forum 
for incorporating requirements concerning disclosure of origin and legal provenance in the text of the 
TRIPS Agreement”). 
163 See, for example, TRIPS Agreement, Arts. 2, 27.3(b) (requiring compliance with specific provisions of 
the Paris Convention, and limiting the effects of the Agreement on existing obligations under other 
Conventions; requiring protection for plants under patent requirements regulated by the TRIPS Agreement 
or under the UPOV Convention or a sui generis protection system).  
164 Under the Vienna Convention, later-enacted treaties control in the event of conflict.  Vienna Convention 
on the Law of Treaties, May 23, 1969, Arts. 31(2) and (3), 1155 U.N.T.S. 331 (Vienna Convention). Thus, 
it may not be necessary to amend those treaties to permit effectuation, but coordination and any necessary 
amendment would be preferable. 
165 Notably, although the United States is a signatory to the CBD, it has not ratified the Convention. See 




76. Given the comprehensive nature of the TRIPS Agreement and other relevant 
features of the WTO regime, WIPO would not appear to be the most appropriate choice 
of forum for developing new international treaty provisions to effectuate disclosure of 
origin requirements. The TRIPS Agreement is part of a set of WTO agreements that 
address not only intellectual property but other concerns as well; it may therefore more 
readily integrate CBD access and benefit-sharing considerations within the intellectual 
property law system. In contrast, WIPO has a narrower focus on the intellectual property 
law system. Although WIPO possesses a wealth of expertise regarding intellectual 
property concerns and the mechanics of intellectual property applications and their 
processing, it lacks relevant expertise relating to biological diversity and to issues of 
access and benefit-sharing.166 Further, although the Paris Convention addresses a broad 
range of intellectual property issues,167 it does not generally establish comprehensive 
minimum standards as does the TRIPS Agreement and neither does it relate its 
requirements to other intellectual property treaty regimes. New treaty provisions adopted 
within a WIPO-administered treaty context, moreover, would be subject to voluntary 
ratification, and would not be able to take advantage of the dispute settlement mechanism 
that the WTO provides.   
                                                 
166 CIEL (2005), ¶¶ 5–8. 
167 Paris Convention Arts. 4–11. 
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III. Options for application procedure triggers 
 
77. Disclosure of origin obligations may require submission of various types of 
information that may be subjected to different kinds of evaluations during and after the 
process of applying for intellectual property. The analysis below first identifies how 
genetic resources and associated traditional knowledge may substantively relate to the 
subject matter of applications for intellectual property, the types of evaluations that may 
be performed, and the types of information that may be submitted. This is followed by a 
discussion of the different procedural triggers for submitting and evaluating disclosure of 
origin information and a brief description of various consequences that might result from 
disclosure failures. 
 
A. Substantive triggers 
 
78. One of the most basic issues for disclosure of origin obligations is when the 
subject matter of the application for intellectual property is sufficiently related to genetic 
resources and associated traditional knowledge as to require the disclosure of relevant 
information.168 Prior analyses have noted that evaluations pursuant to traditional patent 
law doctrines – such as understanding the scope of the claimed subject matter, 
determining whether it constitutes prohibited subject matter, evaluating the adequacy of 
written descriptions and enablement, examining prior art, and assessing inventorship and 
entitlement to apply for or own patents – already may require applicants to disclose the 
source and country of origin of genetic resources and traditional knowledge and to list 
some persons involved in developing the subject matter.169 Deposits of source materials 
or other biological materials may also be required.170 Material transfer agreement 
contracts also may specify the relationship between source materials and “derivatives,” 
and such relationships may, in some cases, impose ownership or disclosure obligations 
that extend beyond traditional patent law doctrines such as inventorship.171 Thus the 
relationships of genetic resources and associated traditional knowledge to the subject 
matter of applications under traditional patent law doctrines cannot be reduced to simple 
formulations.172 
 
79. Numerous proposals have been made to require disclosures of origin in regard to 
genetic resources under various conditions, when such information is not already 
specifically required under national patent laws.  For example: 
 
                                                 
168 WTO, IP/C/W/429 Rev. 1, ¶ 7. 
169 See, for example, WTO, IP/C/W/429 Rev. 1, ¶¶ 4–6, 8; UNEP/CBD/COP/7/INF/17, ¶¶ 32–52, 57–64. 
170 See, for example UNEP/CBD/COP/7/INF/17, ¶¶ 32(a), 102–105; Budapest Treaty on the International 
Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure (1977), concluded Apr. 
28, 1977, effective Aug. 19, 1980, amended Sept. 26, 1980, effective May 24, 1984, available at: 
http://www.wipo.int/treaties/en/registration/budapest/pdf/trtdocs_wo002.pdf; and WIPO (2005), 
Provisional Compilation, Submission of Japan, pp. 23–24 (noting that disclosures cannot substitute for 
deposits). 
171 UNEP/CBD/COP/7/INF/17, ¶¶ 107–109. 
172 Id., ¶¶ 92–109, 112–114. 
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• The Bonn Guidelines suggest the need for such disclosures when “the 
subject matter of the application concerns or makes use of genetic 
resources [or traditional knowledge] in its development”;173 
• The Swiss proposal would require disclosures only when the subject 
matter of the patent application is “directly based” on genetic resources or 
traditional knowledge, by making immediate use of the genetic resources 
and by having sufficient contact with the traditional knowledge to identify 
relevant properties;174 and 
• Various national or regional laws, such as those of the Andean 
Community, require extensive disclosures (including contracts for access 
and documentary information on legal provenance for access to traditional 
knowledge) based on much broader relationships to the subject matter of 
the applications (e.g. for products or processes that are developed or 
obtained from genetic resources or traditional knowledge).175  
 
Consideration must therefore be given to the purposes to be accomplished by disclosure 
requirements and the benefits or burdens such disclosures would provide or impose. 
 
1. Substantive triggers and the purposes of disclosure requirements 
 
80. The appropriate linkage for disclosure of origin requirements of genetic resources 
and associated traditional knowledge to the subject matter of an intellectual property 
application will depend on the reasons for making the disclosures and on the types of 
information to be disclosed and evaluated.176 Broader reasons for making disclosures 
entail correspondingly broader substantive relations between the subject matter and the 
applicant on one hand and the kinds of information that may become relevant for 
disclosure on the other. The following paragraphs present a non-comprehensive list of 
determinations that would constitute reasons for requiring disclosures of origin, which 
gives an indication of the breadth of information that may be relevant. In general, the 
applicant should already know at the time the application is filed what genetic resources 
and associated traditional knowledge are involved, and the sources and countries 
providing such resources and knowledge.177  However, the applicant may not necessarily 
                                                 
173 UNEP/CBD/COP/6/20, CBD COP Decision VI/24, Annex, C, ¶¶ 1, 2. 
174 WTO, IP/C/W/423, ¶¶ 27-28.  
175 Andean Community, Decision 486, Common intellectual property regime, concluded Sept. 14, 2000 at: 
Lima, Arts. 26(h) and (i), available at: http://www.comunidadandina.org/ingles/treaties/dec/D486e.htm.  
See also Andean Community, Decision 391, Common regime on access to genetic resources, concluded 
July 2, 1996 at Caracas, Complementary provisions (second provision which prohibits recognition of 
intellectual property obtained in violation of access requirements, and authorizing member countries to 
request nullification of granted rights or privileges), available at: 
http://www.comunidadandina.org/ingles/treaties/dec/d391e.htm. 
176 Various countries have implicitly identified these purposes as the underlying premises to be explored for 
disclosure of origin obligations, asking how such requirements would help in various contexts, for example, 
improving examination, ensuring a “harmonious relationship” between the CBD and the TRIPS 
Agreement, and achieving the objectives of the CBD; WTO, IP/C/W/420 and Add.1, II. Checklist of Issues, 
¶¶ 1–3 available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm. 
177 Two notable exceptions are when the subject matter was developed without the applicant realizing that 
such resources, materials or knowledge were used in or otherwise related to the development, or when the 
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know all persons involved, the countries of origin, what authority the source possessed to 
transfer the resources, materials or knowledge under the applicable conditions, and 
whether use of the resources, materials or knowledge leading to or incorporated in the 
subject matter of the application conforms to applicable legal requirements. Such 
determinations sometimes may require legal judgments that the applicant cannot itself 
perform, such as judicial determinations of unfair competition or unjust enrichment. In 
such cases, disclosures of information nevertheless may facilitate the identification of the 
persons involved, the country of origin and the authority of the source, which may also 
facilitate required legal determinations. 
 
Determinations relating directly to intellectual property laws   
 
81. Because national intellectual property laws differ, existing requirements for 
disclosure of origin in intellectual property applications also differ. For patent 
applications, genetic resources and associated traditional knowledge typically are 
required to be disclosed to the extent they constitute known prior art relevant to 
examination, or when they are needed to enable those skilled in the art to practice the 
claimed subject matter. In some jurisdictions, national patent laws also require applicants 
to disclose their status as inventors,178 and to disclose the source of genetic resources and 
associated traditional knowledge if the source is a joint inventor or holds a sufficient 
interest to be treated as an applicant or owner. Further, national patent laws may impose 
requirements for applicants and owners to share the commercial benefits of the invention 
with other persons involved.179 The applicant also may disclose the country of origin 
when identifying the sources and countries providing genetic resources and associated 
traditional knowledge, the inventors, co-applicants and co-owners, and other persons 
involved. On the other hand, the applicant may not know or be required to disclose 
whether the source had authority to transfer genetic resources and associated traditional 
knowledge, whether benefits have been equitably shared, or the identity of the original 
source and country providing resources or knowledge where improvements are made to 
derivatives of the original resources. However, disclosures may be required even though 
the subject matter is not “directly based” on such inputs, as the scope of information 
relevant to substantive validity and entitlement determinations may extend beyond what 
the applicant did with the inputs.180   
 
82. Because intellectual property laws do not exhaust the laws governing ownership 
interests or rights to equitable benefit-sharing (including the law of contracts181), the 
                                                                                                                                                 
applicant has not fully described those aspects of the resources, materials or knowledge of which use was 
made. 
178 In many jurisdictions, applicants must file in the name of the inventor. Under the Paris Convention, the 
inventor is entitled (but not required) to be identified. Paris Convention, Art. 4ter. 
179 For example, Japanese Patent Law Art. 35 requires the provision of reasonable remuneration to 
inventors who transfer their rights or otherwise enable their employers to obtain patents on their inventions. 
180 For example, UNEP/CBD/COP/7/INF/17, ¶¶ 98–100 (describing various uses of inputs in relation to the 
subject matter of applications).  
181Id., ¶¶ 74–79 (discussing licences and material transfer agreements containing shared ownership 
requirements for derived subject matter, and varying consequences of failures to record ownership interests 
relating to transfers and enforceability of intellectual property). 
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category of determinations relating to intellectual property laws is not self-contained. 
National intellectual property laws may require applicants to provide declarations and 
supporting documentation regarding their entitlements to apply for and own intellectual 
property; they may also require supporting documentation regarding declared information 
(at least to the extent that the national office “may reasonably doubt the veracity” of the 
applicant’s declaration).182 Accordingly, disclosures of origin required by intellectual 
property laws may include, by reference, disclosures required by laws governing 
entitlements and equity. 
 
Determination of entitlements and equity under other laws  
 
83. Numerous laws, including those defining misappropriation and unjustified 
enrichment, define who may qualify as an applicant for or owner of intellectual property 
and who may possess beneficial interests in intellectual property that would require 
equitable benefit-sharing. Various submissions have noted the need for disclosures of 
origin to: assist in deterring, identifying and remedying misappropriation; prevent misuse 
of the intellectual property law system for advancing and providing benefits in cases of 
inequitable conduct; and ensure equitable sharing of the commercial benefits of genetic 
resources and associated traditional knowledge.183 Accordingly, laws addressing 
entitlements and equity may require disclosure of the authority of the source to provide 
access to genetic resources and associated traditional knowledge for the uses leading to 
the subject matter of the intellectual property application, documentary information 
regarding equitable benefit-sharing, or identification of the original source and country of 
origin in the case of derivatives. Moreover, failure to disclose such information may 
affect the validity or enforceability of the intellectual property. For example, failure to 
disclose unauthorized acquisition of genetic resources and associated traditional 
knowledge might qualify as inequitable conduct or “unclean hands”, which would 
prevent enforcement of patents.184 Such legal and equitable concerns may apply even in 
the absence of bad faith (e.g. where a source unknowingly lacked authority to provide 
access to those inputs).185 
 
                                                 
182 Id., ¶ 177 (quoting PCT Rule 51bis.2(a) and (b)). 
183 For example, WTO, IP/C/W/443, ¶ 3; CIEL (2005), ¶ 25 and n.54, ¶ 26 and n.55. 
184 For example, Precision Instrument Mfg. Co. v. Automotive Maintenance Mach. Co., 324 U.S. 806, 809–
810, 815, 819–820 (1945) (case under United States law upholding the dismissal of an action to enforce 
patents that were obtained based on fraudulent statements in an interference regarding the date of invention 
– and probably also involving incorrect inventorship); Seismograph Service Corp. v. Offshore Raydist, 135 
F. Supp. 342, 347-48, 353-56 (E.D. La. 1955) (case under United States law invalidating on prior art 
grounds a patent that was based on misappropriated information and possible false inventorship, and 
suggesting that an equitable remedy of a royalty free licence would have been appropriate had the patent 
been valid), affirmed in pertinent part, 263 F.2d 5, 22 (5th Cir. 1959). 
185 Many ex-situ repositories and depositories exist for genetic resources and biological materials.  
Although ITPGRFA Art. 12.3(d) prohibits intellectual property or other rights or privileges that would 
restrict access to materials obtained through the multilateral system in the form received, the ITPGRFA 




Determination of compliance with CBD legislation and contracts   
 
84. Legislation implementing CBD access and benefit-sharing obligations, and 
contracts adopted pursuant to such legislation or to effectuate access and benefit-sharing 
requirements, also may require disclosures of origin. Disclosing the source or country 
providing genetic resources and associated traditional knowledge and the country of 
origin may assist countries and indigenous or traditional communities to identify 
unauthorized access or use and inequitable benefit-sharing. Such disclosures may be 
particularly helpful in the absence of CBD-implementing legislation in the country 
providing genetic resources and associated traditional knowledge, or in the absence of 
contracts establishing conditions for access and equitable benefit-sharing.186 Conversely, 
CBD-implementing legislation  or contracts concluded in the country providing genetic 
resources and associated traditional knowledge, or the country of application, could 
require disclosures of any relevant information. Such disclosure requirements raise 
recognition and enforcement issues.187 
 
Other motivations for requiring disclosures   
 
97. Various other motivations have been identified for requiring disclosures of origin, 
which would suggest different substantive triggers and the submission of different types 
of information. For example, disclosure of the source, the country providing genetic 
resources and associated traditional knowledge, and the country of origin may provide a 
more predictable environment for governments, investors, traditional communities and 
researchers to enter into transfers of such resources or knowledge.188 Further, prior 
informed consent for access and equitable benefit-sharing principles are not limited to 
genetic resources and associated traditional knowledge regulated by the CBD.  
Accordingly, mandatory disclosure of origin requirements could extend beyond the CBD 
context. 
 
2. Types of information to be disclosed 
 
98. In many cases, the level of effort involved in developing and submitting various 
types of information may not be significant if the applicant already possesses such 
information. Relevant information may need to be known in order to ground the 
applicant’s belief in its entitlement to apply for and to own the relevant intellectual 
property. Intellectual property laws may require the presentation of known information, 
although it may not be required in a format that would distinctly identify it as a disclosure 
of origin.189   
 
                                                 
186 For example, WTO, IP/C/W/368, ¶ 24 (citing IP/C/M/32, ¶ 128 and IP/C/M/28, ¶ 158). 
187 For example, Colombia has proposed that the text of a Swiss proposal to amend the PCT refer to 
national law applied by any Member State, rather than to the designated office, to assure that the disclosure 
obligation is mandatory in all PCT Members even when the country of origin is not designated by the 
applicant. See WIPO (2005), Provisional Compilation, Submission of Colombia, p. 15. 
188 For example, WTO, IP/C/W/368, ¶ 24 (citing WTO, IP/C/W/228). 
189 WTO, IP/C/W/429 Rev. 1, ¶¶ 9-10 (noting the need to “cull out” relevant information from that “usually 
collected and recorded in the process of invention”). 
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99. For each of the substantive relationships that might trigger disclosures, there are 
at least three non-exclusive categories of information that could be submitted: 
 
• The required information only; 
• The required information along with a declaration by the applicant, which 
may address adequacy of any required investigation, accuracy of any 
disclosed information, or compliance with applicable access and benefit-
sharing requirements; and  
• The required information along with supporting documents. 
 
In addition, required information may be submitted along with an international certificate 
of origin issued by a competent entity attesting to compliance with authorization and 
benefit-sharing requirements.190 Issues relating to certificates of origin are discussed in 
Part VI below.   
 
100. For each of the categories of information to be disclosed, disclosure of origin 
requirements may require disclosure of specified contents and the use of specified 
formats.  These include: 
 
• Presenting information on standardized forms using standardized terms; 
• Addressing specified mandatory contents; 
• Describing specified levels of effort and documenting investigations 
performed; 
• Listing a specified set of conclusions reached and explaining the bases 
therefore; and 
• Providing indications of levels of confidence. 
 
Disclosure of information only and level of effort   
 
101.    Mandatory disclosure obligations may require applicants to disclose relevant 
information already known to the applicant,191 similar to existing patent laws that require 
disclosure of known, relevant information.192 For some types of disclosures of origin, 
however, it may be necessary to specify the level of effort to be imposed on the applicant 
to identify and disclose the relevant information. For example, the applicant should 
normally know the source and country providing genetic resources and associated 
traditional knowledge, and ought to know the authority of the source to provide access on 
the specified conditions of use (or at least should have good reason to believe in that 
authority, when legal judgments are required that the applicant is not qualified to make). 
However, the applicant may not necessarily know the country of origin, persons involved 
and the original country of origin for improvements to derived genetic resources.  
Mandatory disclosure obligations thus may need to specify the extent of investigation 
                                                 
190 Correa, C.M. (2003),  p. 9. 
191 Id., p. 6. 
192 For example, United States laws, 37 C.F.R. § 1.56(a) and (c), require disclosure of all information 
material relevant to patentability known by a variety of persons involved in applying for patents. 
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required of applicants to obtain such information based on the uses to which that 
information may be put during or after application. 
 
Declarations of applicants 
 
102.   Sworn oaths or declarations by applicants for intellectual property may be a useful 
addition to the disclosure of information only, particularly in cases where the applicants 
know that they have obtained and used the relevant genetic resources and associated 
traditional knowledge from a source with authority and have provided or arranged for 
equitable benefit-sharing. They could also be useful for applicants who know whether 
and to what extent they have made investigations to identify information and to 
determine that the information is correct and complete. However, such declarations may 
be difficult to provide in the absence of clear rules identifying the level of effort required 
or of transparent standards for determining prior informed consent for access and 
equitable benefit-sharing. And they may not be possible when they require legal 
judgments that the applicant is not qualified to make. Moreover, declarations may impose 
substantial burdens on applicants to verify the accuracy of the information on which the 
declarations are based. Nevertheless, declarations could prove useful as a preventive 
measure to assure conformity to applicable requirements and as a deterrent to 
unauthorized conduct, particularly where fraudulent declarations may result in significant 




103.  Documentary information may also be a useful addition to the disclosure of 
information only or to such disclosure supplemented by declarations. Various countries 
have suggested including in mandatory disclosure of origin requirements evidence of 
compliance with access and benefit-sharing requirements (including submission of 
contracts for access and benefit-sharing).193 However, it may be impossible to provide 
complete documentation regarding compliance with equitable benefit-sharing obligations, 
as such obligations may extend to future commercial benefits, the generation of which the 
application for intellectual property is intended to enable. Furthermore, documentary 
information regarding entitlements to apply for, own or receive benefits from intellectual 
property, and regarding compliance with laws implementing CBD access and benefit-
sharing requirements, may involve complex legal determinations that intellectual 
property application offices are not well suited to make. As a result, the application 
offices would not readily be able to evaluate such documentary information, although 
evaluation may already have been required to determine the substantive validity of or 
entitlements to apply for or own intellectual property.194 
 
                                                 
193 For example, WTO, IP/C/W/356, ¶ 10; WTO, IP/C/W/403, ¶ 1; WTO, IP/C/W/404, pp. 5–6. 
194 WTO, IP/C/W/433, ¶¶ 21–22 (noting that proposals to include such evidence have not argued for 
substantive evaluation of the documents by national patent offices, when there is no challenge to the 
validity of a patent in a pre-grant or post-grant opposition or revocation proceeding); Correa, C.M. (2003),  
p. 9 (noting the lack of technical preparation for national intellectual property offices to assess such 
requirements of foreign laws). 
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Trade secrecy of disclosed information  
 
104. Trade secrecy concerns may be triggered by disclosures where the information is 
not itself part of the subject matter of the intellectual property application, and is not 
required to be disclosed under the relevant intellectual property laws. These concerns  
could be addressed by subjecting such information to protection from public disclosure 
upon an adequate showing of trade secret status.195 
 
3. Relationships establishing substantive triggers 
 
105.  Disclosed information may relate to many different types of substantive 
evaluations that are relevant to determinations during and after the process of applying 
for intellectual property.  Substantive triggers may include those: 
 
• Relating the source to the subject matter of the application; 
• Relating the source to the applicant. 
• Relating the applicant to persons involved; 
• Disclosing the country of origin; and  
• Disclosing documentary information regarding compliance with access 
(including prior informed consent) and benefit-sharing requirements. 
 
Consideration must be given to whether and to what extent to require information relating 
to these different substantive triggers. 
 
Relationship of the source with the subject matter 
 
106.  The source of genetic resources and associated traditional knowledge may relate 
to the subject matter of intellectual property applications in a variety of ways. These may 
include: 
 
• Forming part of the subject matter for which intellectual property is sought 
(including as a required disclosure to enable others to use or replicate the 
subject matter); 
• Use during the process of developing the subject matter; 
• Use as a necessary prerequisite for developing the subject matter; 
• Use to facilitate development of the subject matter;  
• Use as necessary background material or information for development of 
the subject matter; and 
• Forming part of the prior art relevant for examination of the application.196 
 
                                                 
195 For example, United States law, 40 C.F.R. Part 350, requires assertion and documentation of claims to 
trade secrecy status of information submitted in regard to emergency planning information disclosure 
requirements. 
196 WTO, IP/C/W/429 Rev.1, ¶ 8; WTO, IP/C/W/404, p. 6; UNEP/CBD/COP/7/INF/17, ¶¶ 92-101; 
WIPO/IP/GR/05/03, ¶ 83. 
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In addition, the importance of the genetic resources and associated traditional knowledge 
to the subject matter may vary, ranging from essential (e.g. as a component of the subject 
matter or integral to its development) to marginal (e.g. as providing prior art disclosures 
of how others had failed to develop the subject matter, without suggesting the subject 
matter).  
 
107. Determining whether and what disclosures to require in all of these situations 
should depend not only on whether such information is required under traditional 
intellectual property law principles, but also on the additional purposes to be 
accomplished and on the importance of the input to the subject matter.  A broad approach 
to triggering disclosure of such information should be adopted, because it may be 
difficult to determine by generic category and in advance what types of relationships to 
the subject matter will exist, and how those relationships may affect entitlements to apply 
for or own the intellectual property sought. The applicant should normally possess 
information regarding the source of genetic resources and associated traditional 
knowledge,197 so that little effort would be required to submit such information or 
declarations of the source or documents identifying the source. Yet the potential use of 
such information may be substantial.  
 
108. Where information regarding the source is known, information on the country 
providing the genetic resources and associated traditional knowledge should also be 
known. A broad approach to triggering disclosure of such information should be adopted. 
Disclosure of the country providing genetic resources and associated traditional 
knowledge is critical to ensuring that applicable access and equitable benefit-sharing 
requirements have been complied with under the laws of countries implementing the 
CBD.  In contrast, more complicated evaluations are needed regarding the benefits and 
burdens of disclosing additional information relating to the country of origin, persons 
involved, and authority to use the genetic resources and associated traditional knowledge. 
 
109. So-called negative declarations may help ensure that the applicant has performed 
an adequate investigation before concluding that genetic resources and traditional 
knowledge were not involved in the development of the subject matter of the application, 
and thus that no additional disclosures of origin are required. By the same token, positive 
declarations may help to ensure the integrity of submitted information and documents 
regarding the source, the country providing genetic resources and associated traditional 
knowledge, the country of origin, persons involved, and the legal authority for access and 
benefit-sharing. Documentary information regarding the source or country providing 
genetic resources and associated traditional knowledge may be unnecessary if 
declarations are required, although such documentation could help to prevent or detect 
fraudulent declarations. 
                                                 
197 Brazil has proposed the disclosure of information on the source and (subject to reasonable efforts) the 
country of origin “even where the use was only incidental … if the disclosure were relevant” for 
substantive patentability, to understand or use the invention, or for inventorship or entitlement 
determinations. WIPO (2005), Provisional Compilation, p. 11, Submission of Brazil. Even if substantial 
effort is required, such information may need to be obtained and disclosed in order for the application 




Relationship of the source with the applicant  
 
110.  Both intellectual property laws and other laws define the relationship of the 
source with the applicant. Applicants in some jurisdictions are routinely required to 
disclose their relationship with the subject matter (e.g. as an inventor,  an assignee, or  
some other person having a beneficial interest). Applicants normally should know these 
relationships in order to ground their belief in their entitlement to apply for or own the 
intellectual property.  In contrast, it may be more difficult to know of persons involved 
who may possess a beneficial interest in the subject matter of the application, and in some 
cases entitlement issues may require legal judgments that the applicant is not authorized 
to make.  In such cases, it may nevertheless be useful for the applicant to identify the 
issues that give rise to uncertainties.  
 
111. Accordingly, a broad approach to triggering disclosures of relevant information 
also should be adopted in regard to the relationship of the source with the applicant.198 
Much of the information should be readily available to the applicant, and thus should not 
require substantial effort to disclose. This is true even though such disclosures may not 
normally be reviewed by national intellectual property offices (except when they are 
clearly lacking in relevant content or when they are subjected to a third-party challenge).   
 
112.  Declarations of applicants also may be appropriate in regard to the relationship of 
the source with the applicant. For example, inventors of patentable subject matter (and 
assignees in the event the inventor is deceased or unwilling) are routinely required to sign 
oaths or declarations of inventorship of the subject matter for which patents are 
claimed.199 Such declarations could be appropriately limited in the event of legal 
uncertainty (e.g. by statements such as “to the extent of the applicant’s knowledge” or 
“subject to a contrary legal determination”). Submission of documentary information 
regarding the relationship of the source with the applicant may be more appropriate in 
this context, as intellectual property laws may already require such information to be 
submitted ; it may also be required in order to comply with CBD access and benefit-
sharing legislation.   
 
Relationship of the applicant with persons involved  
 
113.  It may be difficult to determine which other persons may be involved in the 
application, as well as the relationship of those persons with the applicant. Information 
regarding persons involved may not readily be available to the applicant. For example, 
the source or the country providing genetic resources and associated traditional 
knowledge may owe equitable benefit-sharing obligations to indigenous or local 
                                                 
198 In the rare case where the source is unknown, disclosure of the genetic resources and associated 
traditional knowledge could be made along with a statement that the source is unknown. Cf. WIPO (2005), 
Provisional Compilation, p. 14, Submission of Colombia (discussing declarations that the origin is 
unknown). 
199 For example, United States laws, 35 U.S.C. §§ 115, 117, 118, require an oath or declaration, authorizing 
filing in the event of death, and authorizing filing by assignees of unwilling inventors along with 
documents proving the relevant facts. 
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communities living in different countries. Confirming the existence and scope of such 
obligations would likely require legal judgments that applicants may not be qualified to 
make, even if they possessed the relevant information.  Investigating such issues could 
involve significant expenditures of time and resources, without leading to definitive 
conclusions. 
 
114. Accordingly, careful evaluation should be made as to whether the potential 
existence of persons involved should trigger mandatory disclosure of origin obligations. 
To the extent the applicant is aware of such information, disclosure may more readily be 
required. Such disclosure will help ensure that the persons involved know of the applicant 
and the application. Thus consideration also should be given to mandating a specified 
level of effort to identify persons involved, so as to better assure appropriate access and 
benefit-sharing. The investigatory burden should not be so great as to discourage the use 
of genetic resources and associated traditional knowledge, which would defeat the 
purpose of facilitated access and benefit-sharing.200 
 
115. Requirements for disclosure or investigation of persons involved should not 
“create uncertainties” with regard to the application process, or generate unnecessary 
additional litigation.201 Such uncertainties may already exist if there are persons involved 
who possess interests in the application or in equitable benefit-sharing that the applicant 
has not recognized. It is the fact that persons are involved, and not the disclosure of their 
relationship per se, that may call into question the validity of the intellectual property or 
the entitlement of the applicant. Disclosure of information relating to persons involved 
may thus help to identify and  resolve such existing uncertainties.  Because abusive use of 
challenge procedures or litigation can be dealt with adequately, the fear of such abuses is 
not sufficient reason to reject disclosures of origin relating to persons involved. 
 
116. Consideration should also be given to requiring declarations from applicants 
identifying known persons involved and specifying a level of effort to investigate 
whether persons are involved; they could also provide negative declarations that no other 
persons are involved. Performing exhaustive searches may be unduly burdensome. 
Although applicants may not be able to specify the relationship of persons involved that 
require legal judgments that applicants may not be qualified to make, applicants may 
identify those issues, and thus may assist identification and resolution of existing 
uncertainties. Documentary information might be required to demonstrate the relationship 
of persons involved with the applicant, particularly when required to demonstrate 
compliance with CBD access and benefit-sharing requirements. 
 
                                                 
200 For example, WIPO (2005), Provisional Compilation, p. 25, Submission of Japan. 
201 For example, WIPO (2005), Provisional Compilation, pp. 42, 47 and 50, Submission of the United 
States. The contractual approach suggested by the United States (including disclosures to “appropriate 
authorities” regarding applications of genetic resources or traditional knowledge, pp. 48–49) does not 
remove any such uncertainties. Rather, contracts only add to the types of relevant information that must be 
evaluated in regard to whether applicants are entitled to seek intellectual property and whether they specify 
additional terms for access and equitable benefit-sharing. Further, contracts may require that the contracts 
and other information be disclosed in intellectual property applications.  
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Disclosure of the country of origin   
 
117. Disclosure of the country of origin may also involve complex determinations, and 
may require extensive investigations to obtain information that applicants may not 
routinely possess.  For example, it may be difficult to identify the country of origin of 
plant varieties, particularly as plant varieties may acquire distinctive characteristics in 
different countries.202  Similarly, it may be difficult to identify traditional knowledge that 
constitutes prior art,203 and thus to identify the country of origin when such knowledge 
formed part of the background to the invention.  Because of concerns over sovereign 
rights and for other reasons, some countries have suggested that a duty to investigate the 
country of origin is warranted.204 
 
118. Accordingly, careful evaluation should be made as to whether a disclosure of the 
country of origin should be required. Such information should likely be disclosed when  
it is already known by applicants, and consideration should be given to imposing 
investigatory obligations to identify countries of origin. This will help with notifying 
countries of origin of the use of the resources and of the application for intellectual 
property when they are not the country providing the genetic resources and associated 
traditional knowledge. 
 
119. Careful evaluation should also be made as to whether to require applicants to 
provide declarations of the country of origin and that required investigations were made, 
or negative declarations that no unidentified country of origin is involved. Documentary 
information relating to the country of origin or to the level of effort of the declaration also 
might be required, and could assist in assuring the validity of the information and the 
integrity of the declarations. 
 
Disclosure of documentary information on access and benefit-sharing   
 
120. Applicants should normally possess information regarding and documents 
(including contracts) demonstrating their compliance with prior informed consent for 
access and equitable benefit-sharing obligations imposed by the CBD and by national 
legislation implementing the CBD. If they do not have such information and documents, 
they may be in violation of the relevant laws. Accordingly, a broad approach to triggering 
disclosure of such information and documents should be required, at least for information 
                                                 
202  Correa, C.M. (2003),  p. 5.  In the case of plant genetic resources for food and agriculture obtained from 
the Multilateral System set forth by the ITPGRFA, the benefits are multilaterally shared. ITPGRFA, Art. 
13. Hence, it might suffice for disclosure obligations to provide an indication that the relevant plant genetic 
resources have been obtained from the multilateral system under the standard Material Transfer Agreement, 
so long as the purpose and conditions of access are limited solely to the utilization and conservation of the 
resources for research, breeding and training for food and agriculture, not including chemical, 
pharmaceutical and/or other non-food/feed industrial uses. ITPGRFA, Art. 12.3(a). 
203 WIPO, Compilation, Submission of Belize, p. 8. 
204 WIPO, Compilation, Submission of Colombia, p. 15 (noting that declaration that the origin of a genetic 
resource is unknown “would not suffice for fully satisfying the disclosure requirement”). 
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already in the applicant’s possession.205  In some cases, applicants may lack documentary 
information, for example when countries have not adopted legislation to implement CBD 
requirements. However, applicants risk biopiracy and misappropriation when they are not 
qualified to make legal judgments that the source has authority to provide the genetic 
resources and associated traditional knowledge for uses leading to intellectual property 
applications or that benefit-sharing arrangements will be equitable.  Requirements to 
disclose information and documents relating to access and benefit-sharing would 
therefore help to identify such cases and the issues they raise. Such disclosures would 
strengthen incentives that already exist for applicants to investigate the authority of the 
source to provide access on specified conditions and ensure the equity of benefit-sharing 
arrangements. 
 
121. Moreover, documentary information on access and benefit-sharing will normally 
relate directly to entitlements to apply for and own intellectual property or to impose 
obligations to restrict use or to share commercial benefits. Such information and 
documents may not routinely be reviewed by national intellectual property offices, except 
when they appear to be insufficient or when they are subjected to a third-party challenge. 
 
122. Declarations by applicants may also be appropriate with regard to compliance 
with access and benefit-sharing requirements. Applicants should know the legal status of 
their use of genetic resources and associated traditional knowledge, and of the retention 
of benefits deriving from that use. Thus any investigatory burdens associated with 
making such declarations should be justified. Such declarations also may assist in 
ensuring the integrity of the disclosed information and documents, as well as compliance 
with CBD-implementing legislation, as false or fraudulent declarations typically may 
invoke substantial liability or civil or criminal penalties. However, where access and 
benefit-sharing requirements are not clear, it may be difficult for applicants to provide 
declarations. Thus requirements for declarations might need to identify legal 
determinations that the applicant in good faith has sought but has been unable to resolve. 
 
B. Procedural triggers 
 
123. Requirements for disclosures of origin may be triggered at various times, so as to 
be of use at different procedural stages during and after application for intellectual 
property. Procedural triggers must define the opportunities for required disclosures and 
evaluations, the format in which information is to be submitted, and the types of 
evaluations that are to be made. They may be imposed by national access and benefit-
sharing legislation, by contracts and by new treaty requirements. Various non-exclusive 
procedural triggers exist for requiring disclosures of origin. Salient times during and after 
application for intellectual property to require such disclosures include:  
 
• The international stage of application processing (in a coordinated 
international system of national intellectual property application 
procedures); 
                                                 
205 WIPO, Compilation, Submission of Brazil, p. 12 (suggesting declarations of source and country of 
origin accompanied by relevant evidence of access and benefit-sharing). 
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• The national stage of application processing; 
• Pre-grant and post-grant administrative challenge proceedings; and 
• Judicial proceedings. 
 
For each of the triggers, it is important to consider: the form, prescribed formats and 
timing for submission of any required disclosures; whether and to what extent the 
disclosed information may be evaluated at the time of the disclosure or at a later stage; 
and whether and when to require or  permit applicants or owners to supplement or  
correct disclosures during or after the application process. 
 
124. When form, prescribed formats, timing and supplementation are evaluated at any 
of the relevant times, it also becomes necessary to consider the consequences for failure 
to conform to procedural requirements. A brief discussion of the consequences of 
disclosure failures is provided here in respect of procedural triggers, and a more extensive 
analysis is provided in Part IV. 
 
1. CBD-related sources of disclosure requirements 
 
Disclosure requirements of CBD- implementing legislation   
 
125. As noted in the WIPO Technical Study, disclosure of origin requirements in 
intellectual property applications may “have [their] roots in the laws and regulations of 
the source country that relevantly govern access and benefit-sharing.”206 These laws and 
regulations thus may become an integral part of the intellectual property law system to 
the extent they require disclosures to (and evaluations by) national application offices or 
other entities within the intellectual property system. For example, national access and 
benefit-sharing legislation could require disclosures regarding genetic resources and 
associated traditional knowledge to be made not only to the competent access and 
benefit-sharing authorities of the country providing genetic resources and associated 
traditional knowledge,207 but also to all jurisdictions (if recognized and enforced in other 
countries) where applications for intellectual property are filed that relate in relevant 
substantive ways to such resources and knowledge.   
 
126. National access and benefit-sharing laws could impose the same types of 
procedural triggers for disclosures of origin as could be imposed pursuant to mandatory 
obligations under new international treaty provisions.  These include disclosures made at 
the time of filing or during the processing of international or national applications, during 
pre-grant or post-grant challenge proceedings, or during various forms of judicial 
proceedings. Thus, procedural triggers imposed pursuant to national access and benefit-
sharing laws are not discussed separately below, but rather are subsumed within the 
general discussion of procedural triggers. 
 
                                                 
206 UNEP/CBD/COP/7/INF/17, ¶116. 
207 For example, WTO, IP/C/W/400 Rev.1, ¶ 11 (discussing potential reference of disclosures of origin in 
PCT applications to a list of “competent government agencies”). 
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Access and benefit-sharing contract-imposed disclosure requirements   
 
127. Provisions of contracts entered into pursuant to national access and benefit-
sharing laws also may require disclosures of origin to competent access and benefit-
sharing authorities and in intellectual property applications throughout the world.208 The 
existence of such contractual disclosure obligations raises “complex question[s] of 
private international law.”209 Because such contracts could impose the same procedural 
triggers for disclosures of origin relating to intellectual property applications as national 
access and benefit-sharing laws, or as mandatory treaty requirements, they are not 
discussed separately below. 
 
2. Procedural triggers for disclosures 
 
Disclosure requirements at the international stage  
 
128. Various countries have suggested that disclosures of origin should be made at 
some point during the international phase of patent applications filed under the PCT. 210  
The PCT establishes a coordinated international system of national application filing 
procedures. Under that treaty, applicants for patents may file a single, initial application 
in one country that designates multiple countries in which patents may ultimately be 
sought.  Applicants thereby obtain the benefit of the international filing date when they 
ultimately prosecute patent applications in regional or national patent offices around the 
world.211 These suggestions (which can be broadened to address the international stage of 
any coordinated international system of national intellectual property application 
procedures) have the advantage of ensuring that disclosures of origin would be 
transferred to all national offices of countries to which applications are made for 
intellectual property through the international system.  However, these suggestions do not 
provide detailed discussions of options for required disclosures at the international stage, 
for evaluations that might be performed at that stage, or for the consequences of 
disclosure failures.212 
                                                 
208  UNEP/CBD/COP/7/INF/17, ¶ 107 (noting that contracts may result from standard material transfer 
agreements stipulated by law or regulations implementing CBD requirements). A discussion of various 
issues to be addressed in contracts is provided in WIPO/GRTKF/IC/7/9, available at: 
http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_7/wipo_grtkf_ic_7_9.pdf.  For example, contractual 
terms to be negotiated by parties include who will decide whether to apply for what types of intellectual 
property(Id., Annex, ¶ 33). 
209 UNEP/CBD/COP/7/INF/17, ¶118 and ¶¶ 108, 129. 
210 WIPO/IP/GR/05/01, ¶ 52 (discussing the Swiss proposal of WTO, IP/C/W/433, WTO, IP/C/W/423, and 
WTO, IP/C/W/400/Rev.1, which would authorize, but not require, disclosure at the time of filing an 
international application “or later during the international phase”); WIPO/IP/GR/05/01, p. 58, Box, 
Summary of triggers for disclosure requirements; Procedural options (noting procedural triggers include 
initial filing, specific deadlines after filing, formal or substantive examinations, prior to grant or sealing of 
patents, during opposition or revocation proceedings, or when patents are asserted or enforced); WTO, 
IP/C/W/442, ¶ 9 (discussing provision of evidence of benefit-sharing “at the time of applying for the grant 
of a patent”). 
211 For example, PCT Art. 3 (international application); PCT Art. 11 (filing date); PCT Art. 20 
(communication of international application to designated offices). 
212 In the case of the Swiss proposal to amend the PCT, if disclosures of origin are required by the national 




129. Disclosures of origin at the international stage could include the same categories 
of information (i.e. disclosures of information only, disclosures with declarations by the 
applicant and disclosures with documentary information) pursuant to the same 
substantive triggers discussed above.  Although the legal consequences of treating these 
required information disclosures as “formal” or “substantive” may vary under existing 
international intellectual property law treaties, this distinction is not particularly helpful 
in terms of specifying alternatives for inclusion as mandatory treaty obligations.213 More 
relevant questions relate to the timing, contents and format of the disclosures, the level of 
effort required, the nature of any required evaluations at the international stage, and 
whether any failures to conform to disclosure requirements will trigger opportunities for 
correction or supplementation and will result in mandatory or facultative sanctions. 
 
130. Disclosures may be required initially upon filing of applications or at other stages 
of international intellectual property application procedures. Because many disclosures of 
origin will directly relate to entitlements to apply for and own intellectual property, they 
should be required at filing.  However, opportunities should be provided (in the absence 
of bad faith or fraudulent intent) to rectify disclosure failures and to supplement initial 
disclosures. 
 
131. Different options exist for whether and how evaluations of disclosed information 
are to be performed at the international stage. Evaluating disclosures of origin at the 
international stage may be efficient if it results in termination of application processing, 
which would avoid duplicating evaluations in multiple national application offices.  On 
the other hand, international stage evaluations may be inefficient if evaluations are 
inevitably duplicated at the national stage. 
 
132. Consideration also needs to be given to the competence of international 
intellectual property application offices to make various types of evaluations. For 
example, disclosures of origin might be evaluated at the international stage for 
substantive compliance by applicants with national access and benefit-sharing legislation 
of the country providing genetic resources and associated traditional knowledge.  
However, international application offices may be poorly qualified to perform such 
evaluations, which may require the intervention of authorities of the countries providing 
the genetic resources and associated traditional knowledge. The outcome of such 
determinations should not vary with the receiving office in which the international 
application is filed or with the national intellectual property application offices that are 
designated. Although international application offices may be better suited to evaluate 
disclosures of origin that relate to entitlements to apply for the subject matter, entitlement 
determinations may vary depending on the laws of designated countries in which the 
                                                                                                                                                 
to supply any missing disclosure at the beginning of the national phase, within a specified time limit of not 
less than two months from the invitation(WTO, IP/C/W/423, ¶ 25). Further, PCT Rule 26ter provides for 
correction or addition to declarations before publication, and for the receiving Office or the International 
Bureau to invite applicants to correct declarations under PCT Rule 4.17 if “not worded as required” or (for 
inventorship) if “not signed as required.” (WTO, IP/C/W/433, p. 10,reprinting Rule 26ter and noting the 
ability of applicants to provide or correct declarations at the international stage). 
213 See, for example,  UNEP/CBD/COP/7/INF/17, ¶¶ 132-35. 
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intellectual property is sought. Evaluations of patentability conducted at the international 
stage for PCT applications214 typically apply harmonized and restrictive substantive 
evaluation criteria that may differ from national patent laws, and thus are preliminary in 
nature.  
 
133. International stage evaluations could review disclosures of origin for: 
 
• Completeness; 
• Conformity to standardized forms; 
• Accuracy of the factual information presented; 
• Substantive validity of conclusions reached; 
• Conformity of the disclosed information with any declarations by 
applicants and documents presented; and 
• Substantive legality of access and benefit-sharing. 
 
Rules may need to be developed to address burdens of proof and standards for rebuttal in 
any such evaluations.215 
 
134. The degree of administrative burden of international stage evaluations increases 
substantially if evaluations are required of the factual accuracy of information, the 
substantive validity of conclusions reached, or the legality of access and benefit-sharing.  
However, some such evaluations may already be required within the intellectual property 
law system, where disclosed information may call into question entitlements to apply for 
intellectual property or the substantive validity of the application.216 Whether or not 
evaluations are performed at the international stage, the information submitted at that 
stage might need to be transmitted to multiple national application offices. Disclosures at 
the international stage thus impose costs on applicants and additional administrative 
burdens on the international application offices.  
 
135. There is also the need to consider whether to specify mandatory or facultative 
sanctions in regard to disclosure failures or to leave such decisions to the discretion of 
countries in which international applications are filed. Various consequences could attend 
the failure to provide complete, conforming, accurate or valid disclosures, initially or 
following any opportunities provided for rectifying inadequacies. The most basic 
consequence could be to delay processing unless or until the appropriate information is 
provided.217 Additional consequences might be imposed when disclosures are found to be 
                                                 
214 For example, PCT Art. 18 (international preliminary search report); PCT Art. 33 (international 
preliminary examination report); PCT Rule 43bis (written opinion of the international search authority). 
UNEP/CBD/COP/7/INF/17, ¶ 137 (discussing prima facie showings in regard to burdens of proof); 
WIPO/IP/GR/05/01, ¶ 87 (discussing burdens of proof in evaluating adequacy of disclosures). 
216 For example, PCT, Arts. 33 and 34 (discussing substantive evaluations and procedures for international 
preliminary examination). 
217 For example, WTO, IP/C/W/442, ¶ 12 (suggesting that applications “would not be processed any 
further” without disclosure of required information, and could be accompanied by imposing time limits for 
making the required disclosures, following which the application “could be deemed withdrawn”); WIPO, 
Compilation, p.56, Submission of the European Communities (suggesting that the required disclosures be 
made using a standard application form, and that failure or refusal to disclose should trigger the opportunity 
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inadequate, including abandonment of applications (thereby terminating rights of 
priority), transfer of rights to prosecute applications, abandonment of entitlements to 
apply for or to own the intellectual property, and administrative fines, civil liability or 
criminal penalties. These consequences may vary depending on consideration of factors 
such as the good faith and diligence of the applicants, administrative burdens of 
performing repeated evaluations of corrected or supplemented information, costs of 
additional evaluations and delays in processing, and whether such costs may be offset by 
applicant fees and other factors.218 
 
136. Various sanctions may also be applied to already issued intellectual property if 
disclosures are found to be inadequate after the international stage. Whether such 
sanctions are imposed may depend on similar factors to those described above. The 
consequences of disclosure failures in this context may include:  
 
• Substantive invalidation of the intellectual property; 
• Termination or transfer of ownership of the intellectual property; 
• Imposition of administrative fines, civil liability or criminal penalties 
(including for violations of relevant access and benefit-sharing legal and 
contractual requirements) within or external to the intellectual property 
law system; and 
• Requiring the return of any unjustified benefits conferred as a result of 
disclosure failures or in violation of access and benefit-sharing 
requirements. 
 
137. Part IV provides further discussion of these consequences.  However, it is useful 
to note here that international application offices may not necessarily possess 
administrative subpoena powers or other compulsory processes to require applicants to 
provide information or to testify, so as to determine good faith or fraudulent intention.219 
Similarly, such offices may not be authorized by national laws or constitutional 
provisions to impose punitive fines, civil liability or criminal penalties. 
 
138. Because of the administrative burdens of performing evaluations other than for 
completeness or consistency, and notwithstanding the potential to avoid duplicative 
determinations at the national stage in multiple jurisdictions, it seems unwarranted to 
require review of disclosures of origin at the international stage for factual accuracy or 
for substantive validity. Intellectual property examiners at the international stage are 
unlikely to possess training in applying access and benefit-sharing requirements or 
contractual provisions under the laws of foreign jurisdictions. Nevertheless, the 
international office should be authorized to require applicants to supplement with 
                                                                                                                                                 
“to remedy the omission within a certain time fixed under” applicable law, and that the application “shall 
not be further processed” in the event of continuing failures). 
218 For example, WIPO/IP/GR/05/01, ¶¶ 87-88 (discussing good faith and fraudulent intent with regard to 
disclosure failures).  Cf. United States law, 35 U.S.C. § 41 (addressing extension of time and petition fees); 
United States law 35 U.S.C. § 133 (limiting response time to six months, except on a showing that delay 
was unavoidable); United States law, 35 U.S.C. § 151 (limiting issue-fee payments to three months). 
219 Cf. United States law, 35 U.S.C. § 24 (authorizing district courts to issue subpoenas to compel testimony 
relating to contested patent cases in the US PTO). 
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additional information and documents any initial disclosures that appear to be inadequate, 
inaccurate or invalid, or when disclosed information appears insufficient to support 
conclusions reached or to demonstrate entitlements and substantive validity. 
 
Disclosure requirements at the national stage 
 
139. As at the international stage, at least three different categories of information 
relating to different substantive triggers may be disclosed at the national stage of the 
application process (i.e. disclosures of information only, disclosures with declarations by 
the applicant, and disclosures with documentary information). Similarly, these 
disclosures could be presented using specified formats (e.g. standardized forms, 
mandatory contents, described levels of effort, specified conclusions and indicated levels 
of confidence) and may be corrected or supplemented over time. Where disclosures are 
required at the international stage, supplementary disclosures may occur upon entry into 
the national stage or thereafter.   
 
140. Evaluations at the national stage may be more extensive, may duplicate, or may 
rely to some extent upon evaluations performed at the international stage. Similar types 
of evaluations of disclosed information may be performed (e.g. for completeness, 
conformity to prescribed formats, factual accuracy, substantive validity of conclusions, 
conformity to declarations and substantive legality). As at the international stage, because 
of the administrative burdens and lack of training to make determinations regarding 
national access and benefit-sharing requirements or contractual requirements under the 
laws of foreign jurisdictions, it seems unwarranted to require review of disclosures of 
origin for factual accuracy or for substantive validity during initial application 
processing.  However, national application offices are more likely to use such disclosed 
information to make determinations regarding substantive entitlements and substantive 
validity of applications under relevant intellectual property law standards. 
 
141. At this stage, as at the international stage, various mandatory or facultative 
sanctions could result from failures to provide complete, conforming, accurate or valid 
disclosures. In addition to delaying processing of applications, following notice and an 
opportunity to correct or supplement disclosure failures in the absence of bad faith or 
fraudulent intent,220 additional consequences may include abandonment of applications or 
abandonment of entitlements to apply for or to own the intellectual property. Following 
issuance of intellectual property, consequences may include substantive invalidation, 
termination or transfer of ownership, imposition of fines, liability or penalties, and 
requiring the return of any unjustified benefits. 
 
Pre-grant and post-grant administrative challenges 
 
142. Pre-grant and post-grant administrative challenges normally address either the 
entitlement to apply for or own the intellectual property or the substantive validity of the 
                                                 
220 For example, WIPO, Compilation, Submission of Colombia, p. 15 (suggesting that the “competent 
national office” should notify the applicant and avoid continuing to “other phases of the application 
procedure” until the requisite disclosure is made). 
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issued intellectual property. Unlike during the initial application process, pre-grant and 
post-grant administrative re-examination, interference, revocation or opposition 
proceedings may involve more substantial administrative procedures and may provide for 
the participation of interested third parties.221 Such proceedings therefore may be more 
appropriate for conducting more extensive evaluations of the factual accuracy  and 
validity of conclusions regarding disclosures of origin. Depending upon when such 
proceedings are available, they may be considered efficient and low-cost alternatives to 
judicial resolution of intellectual property application or ownership disputes.222 The 
availability and procedures for such challenges, however, vary across jurisdictions. 
 
143. Mandatory or facultative evaluations of disclosures of origin in pre-grant or post-
grant challenge proceedings are unlikely to be limited to reviews for completeness and 
for conformity to prescribed formats, because of the inherent potential for such 
challenges to link disclosures of origin to substantive entitlements or to the validity of 
applications or granted intellectual property.  In such challenges, therefore, national 
offices may be required to evaluate information regarding the authority of the source to 
provide access to genetic resources and associated traditional knowledge, and of the 
applicant to provide for equitable benefit-sharing under actual conditions of use. Where 
pre-grant and post-grant challenges do not relate to disclosures of origin, however, it may 
not be warranted for national offices to evaluate the disclosed information for factual 
accuracy or validity of conclusions. 
 
144. Given that pre-grant and post-grant administrative challenges to intellectual 
property are typically conducted when prior information and evaluations have been called 
into question, different types of or additional disclosures of origin may be required, and 
different substantive triggers  adopted. Similarly, correction or supplementation of earlier 
disclosures and submission of documentary information relating to those disclosures is 
more likely to be requested or required. Evaluation of such additional disclosures within 
the context of the administrative proceeding may be efficient, limiting the need for 
subsequent or duplicate judicial actions to determine relevant issues. 
 
145. The same types of mandatory or facultative sanctions could result from disclosure 
failures discovered at the pre-grant or post-grant administrative challenge stage. 
However, because such challenges involve more extensive procedures and may be 
adversarial, additional burden of proof rules and presumptions may need to be specified. 
Unlike during ex parte administrative proceedings, international or national application 
offices may need to adjudicate competing evidentiary presentations of opposing 
                                                 
221 For example, United States law, 35 U.S.C. §§ 311-18 (specifying inter partes re-examination 
procedures); United States law, 35 U.S.C. § 135 (specifying interference procedures); European Patent 
Convention (EPC), Arts. 99–105 (specifying opposition procedures).  Cf. United States law, 35 U.S.C. §§ 
301-07 (specifying ex parte re-examinations, subject to the same procedures as initial examination after a 
determination that sufficient cause exists and after the filing of an initial statement and reply). 
222 See, for example, EPC Art. 99(1) (limiting oppositions to filing within nine months after publication of 
notice of grant); United States Patent and Trademark Office, 21st Century Strategic Plan, Action Paper 40: 
Post-Grant Review of Patent Claims,2003 (noting that post-grant review under United States law provides 
accused infringers and patent holders with an alternative forum to district court litigation of patent validity 
issues”), available at: http://www.uspto.gov/web/offices/com/strat21/action/sr2.htm. 
 
 73
parties.223 Further, pre-grant and post-grant challenge procedures create the potential for 
formal and informal discovery mechanisms, which may assist in addressing information 
gaps in regard to the various disclosure issues to be evaluated. In such proceedings, 
national application offices may or may not possess administrative subpoena powers. 
 
Judicial proceedings  
 
146. Disclosures of origin may be required and evaluations of disclosed information 
may occur in judicial proceedings, giving rise to challenges to the validity of a patent 
(e.g. in infringement or declaratory judgment actions). Disclosures may also be required 
and evaluations made in other judicial actions that relate to the subject matter, the 
applicant, the persons involved, the country of origin, and conformity with access and 
benefit-sharing requirements. Thus the range of issues to be addressed in such judicial 
proceedings  may be broader than in the context of application procedures or pre-grant 
and post-grant administrative challenges.  
 
147. Judicial systems also differ with respect to their reliance on adversarial or 
inquisitorial procedures to reach determinations.224 These differences may affect not only 
how much information and documentation is requested, but also who may participate and 
what type of information discovery may be obtained. Participants in judicial proceedings 
may include applicants for or owners of intellectual property, accused infringers, persons 
involved who may claim various entitlements and other interested third parties. Different 
rules regarding burden of proof and presumptions in regard to disclosures of origin may 
be appropriate for judicial proceedings. In contrast to international or national stage 
examination or administrative challenges, moreover, judicial systems typically possess 
subpoena powers and other compulsory process authority to require testimony and the 
production of documents that may be needed to make determinations and  assess good 
faith and fraudulent intention.225 
  
148. Judicial proceedings thus are better suited to reviewing the full range of issues 
raised by disclosures of origin. In particular, judges may more readily require disclosure 
of (and parties to judicial proceedings may more readily seek to discover) information 
relevant to compliance with earlier stage disclosure requirements, contractual provisions, 
access legislation, and equitable principles for determining ownership entitlements and 
benefit-sharing. Moreover, judges are better equipped to review and evaluate access and 
benefit-sharing legislation of foreign countries and contractual provisions. 
 
149. As with international and national application stages and administrative 
challenges, mandatory disclosures in judicial proceedings could take various forms and 
                                                 
223 Cf. UNEP/CBD/COP/7/INF/17, ¶ 137 (noting the potential for different burden of proof rules in 
litigation). 
224 For example, Law Reform Commission of Western Australia, The adversarial system of civil litigation, 
in: Review of the Criminal and Civil Justice System: Final Report, ch. 6, ¶ 6.2,2000 (noting distinctions 
between inquisitorial and adversarial approaches), available at: 
 http://www.lrc.justice.wa.gov.au/RevCCJS-p92/finalreport/finalreporthtml/ch6adverscivil.html. 
225 For example, Federal Rules of Civil Procedure, 45(a)(1)(C) (authorizing United States district courts to 
issue subpoenas to compel testimony or the production of documents). 
 
 74
could relate to different substantive triggers. In the judicial context, there may be less 
need to require prescribed forms or formats for presenting information or to disclose the 
level of confidence in various conclusions. On the other hand, there may be a greater 
need to evaluate the level of effort previously expended in investigations and to 
document the basis for conclusions reached so as to assess good faith, as earlier 
disclosures and conclusions are more likely to be called into question. Also, judicial 
proceedings are more likely to include persons involved who were not previously 
identified, and thus to address considerations of misappropriation and unjustified 
enrichment.  
  
150. The same types of mandatory or facultative sanctions could result from disclosure 
failures at the judicial proceeding stage, including for determinations that earlier 
disclosures were inadequate, false or fraudulent, or based on inadequate investigatory 
efforts.  However, deferring all evaluations of disclosures of origin until this stage may 
not adequately protect the interests of countries of origin or of the persons involved. 
Developing countries in particular may lack adequate resources to effectively monitor 
and enforce violations of access and benefit-sharing requirements in multiple 
jurisdictions following the granting of intellectual property.226 Earlier administrative 
evaluations of disclosures of origin could reduce the need for later judicial proceedings, 
or could permit countries of origin or persons involved to bring appropriate judicial 
actions at an earlier time in order to transfer ownership,  invalidate intellectual property, 
or  establish entitlements at earlier stages of application procedures and at a lower cost. 
 
151. Because of the wide variety of potential judicial proceedings that could trigger 
disclosure of origin requirements, careful evaluation is needed to determine what 
disclosure of origin obligations should be triggered at the judicial proceedings stage, and 
what mandatory or facultative evaluations should be required of such disclosures. For 
example, it may not be sufficient in judicial actions that dispute validity or ownership 
(even in inquisitorial judicial systems) to rely on the parties to identify and litigate issues 
regarding equitable sharing of benefits with countries of origin and persons involved. It 
may therefore be appropriate to adopt mandatory provisions authorizing persons involved 
to intervene and to participate as full parties in such proceedings.227 This would permit 
persons involved to raise additional issues and to seek to obtain an equitable share of any 
benefits that are conferred through such an infringement action.228  Similarly, it may be 
necessary to mandate new legal claims (rights of action),229 and jurisdiction over such 
claims, to allow persons involved or countries of origin to obtain appropriate relief.
                                                 
226 For example, WTO, IP/C/W/356, ¶ 12. 
227 Cf. Federal Rules of Civil Procedure, 24(a) and (b) (describing requirements under United States law for 
mandatory and facultative intervention). 
228 For example, the person involved might seek to impose a constructive trust over any damages award by 
proving a right to an equitable share of the benefits of commercialization of genetic resources and 
associated traditional knowledge that was acquired from the person involved. 
229 Cf. Cort v. Ash, 422 U.S. 66, 78 (1975) (identifying four requirements for implying private rights of 
action under United States laws); Middlesex County Sewerage Authority v. National Sea Clammers 
Association, 453 U.S. 1, 20 (1981) (describing under United States laws conditions for limiting recourse to 
a statutory private right of action based on a remedial scheme provided in a different statute). 
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IV. Incentives for enforcement of disclosure obligations. 
 
A. Types of measures 
 
152. Measures relating to compliance with mandatory disclosure of origin obligations 
may take different forms, including direct mandatory sanctions, indirect mandatory 
sanctions, facultative sanctions and positive incentives.230 
 
153. Direct mandatory sanctions have mandatory consequences that directly affect the 
intellectual property law system as a result of disclosure of origin requirements. These 
consequences may include:  
 
• Curable or incurable, temporary or permanent bars to processing of 
applications; 
• Administrative fines, civil liability and criminal liability imposed within 
the intellectual property law system; 
• Termination or full or partial transfer of entitlements to apply for or own 
intellectual property;  
• Curable or incurable, temporary or permanent, full or partial 
unenforceability, revocation, narrowing of the subject matter, or 
invalidation of granted intellectual property; 
• Return or transfer231 of benefits received from intellectual property 
ownership; and 
• Enforcement of existing or new obligations to provide for equitable 
benefit-sharing.   
   
Direct mandatory sanctions provide strong “negative” incentives to comply with (and 
thus deterrents to avoidance of) disclosure requirements. Such sanctions may apply as a 
consequence of existing intellectual property and other laws, but could be mandated 
directly by treaty when specifying disclosure of origin requirements. 
 
154. Indirect mandatory sanctions have mandatory consequences external to the 
intellectual property law system, but which supplement the consequences of that system’s 
requirements. Examples of indirect mandatory sanctions are: administrative fines, civil 
liability, or criminal sanctions that are imposed separately from the intellectual property 
law system and in addition to any effects that failures to comply with disclosure of origin 
requirements may have on inventorship, entitlements to apply for or own intellectual 
property, or substantive validity of intellectual property.  
                                                 
230 Cf. Gollin, M.A. (2005), ¶ 1(discussing and adopting different definitions for “direct,” “indirect” and 
“voluntary/permissive” requirements), available at: 
 http://www.iprsonline.org/ictsd/docs/DOO3_Gollin.pdf. 
231 In addition to disgorgement remedies based on unjustified enrichment, some jurisdictions provide for 
duties to account on co-owners of intellectual property (see, for example, H.R. Rep. No. 1476, 94th Cong., 
2nd Sess. 121 (1976), recognizing the judicially developed duty to account in United States copyright law).  





155. Facultative sanctions authorize but do not mandate consequences within or 
external to the intellectual property law system which supplement or duplicate existing 
consequences that may apply as the result of intellectual property and other legal 
requirements.  Facultative sanctions may include the same types of measures as direct or 
indirect mandatory sanctions. 
 
156. Positive incentives are measures to encourage disclosures that do not have 
mandatory or facultative sanctioning effects. Examples of such incentives include 
reduced filing fees for providing specified disclosures of origin in applications for 
intellectual property, as well as reputational or moral benefits of responsible conduct and 
equitable benefit-sharing.232 
 
157. The choice of mandatory or facultative sanctions with regard to disclosures of 
origin may be the most controversial issue to be resolved in developing an international 
agreement. Some countries vigorously oppose any mandatory or facultative sanctions that 
would affect entitlements to apply for or own intellectual property or that would 
invalidate granted rights or privileges,233 even though disclosure failures and false or 
fraudulent submissions already may have such consequences under existing intellectual 
property laws and other laws.234 Other countries seek to apply as direct sanctions only 
existing sanctions under intellectual property laws (e.g. authorizing revocation or 
invalidation of patents only in the case of fraudulent intention, as provided by PLT 
Article 10(1)).235 Yet other countries seek to impose a wide variety of mandatory or 
facultative sanctions, “the nature of which will depend on whether one is dealing with a 
formal or substantive component of the disclosure and on whether it is at the level of pre- 
or post-grant.”236 
 
                                                 
232 For example, WIPO/IP/GR/05/01, ¶ 159 (discussing Submission of Japan regarding “sense of 
responsibility and conduct of fair and equitable benefit sharing”), and box following ¶ 164, Summary of 
incentives (discussing additional positive incentives); WIPO, Compilation, p. 43, Submission of the United 
States (discussing patents as incentives for disclosure of new, useful and unobvious information); WIPO-
UNEP, Gupta , A.K. (2004), pp. 39–40 (discussing incentives to conserve biological diversity and prevent 
knowledge erosion). Although the WIPO Examination discusses “[b]ehavior that may be encouraged by 
incentives,” reflecting objectives of the CBD (and other values such as compliance with applicable laws) 
and “‘[p]erverse’ or undesirable incentives,” these so-called incentives are better classified as desirable 
effects or undesirable behaviour that may result from adoption of various options).  WIPO/IP/GR/05/01, 
box following ¶ 164. 
233 For example, WIPO, Compilation, p. 56, Submission of the European Communities; WTO, IP/C/W/434, 
¶ 2. 
234 For example, WIPO/IP/GR/05/01, ¶¶ 79, 89; Correa, C.M. (2003), p. 10 (noting the inequitable conduct 
doctrine under United States patent law). 
235 For example, WTO, IP/C/W/400 Rev. 1, ¶ 29; WTO, IP/C/W/423, p. 3; Addor, F. (2005), pp. 4, 5 
(discussing the Swiss Proposal, which would limit sanctions to those under PLT Art. 10(1) and would 
require submission and evaluation of documentary information regarding access and benefit-sharing only to 
and by “government agencies competent to receive information”), available at: 
http://www.iprsonline.org/ictsd/docs/DOO6_Addor.pdf. 
236 WTO, IP/C/W/443, ¶ 10. See also WTO, IP/C/W/429/Rev. 1 and Add.1–Add.3, ¶¶ 11-14; 
WIPO/IP/GR/05/01, ¶155 (summarizing Submission of Brazil); WIPO, Compilation, p. 16, Submission of 
Colombia (also noting reduction of application processing time).  
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B. Considerations for sanction provisions 
 
158. Sanctions for disclosure failures may be based on different substantive and 
procedural triggers relating the subject matter of or the applicant for intellectual property 
to the source, the country providing genetic resources and associated traditional 
knowledge, the country of origin, and access and benefit-sharing legislative requirements.  
Careful evaluation of the options is needed, given the many potential sanctions and 
substantial disputes over whether particular sanctions are appropriate as mandatory or 
facultative requirements. Consideration should therefore be given to the following issues: 
 
• Sanctions must provide an effective deterrent to non-compliance with 
CBD access and benefit-sharing requirements, ensuring that the 
intellectual property is not granted inappropriately and that the intellectual 
property system is not misused to further inequitable conduct;237 
• The burdens imposed in ensuring conformity to disclosure requirements 
and the potential fear of sanctions should not deter facilitated access to 
genetic resources and associated traditional knowledge where access and 
equitable benefit-sharing are likely to occur;238 and 
• Flexibility should be provided to tailor the sanctions to the conduct 
involved (either by leaving their application to the discretion of 
Contracting States239 or by specifying requirements or principles for 
applying flexibility), so as to ensure that the sanctions are appropriate and 
do not result in adverse consequences.240 
 
159. When considering what sanctions  to adopt in regard to disclosures of origin, it is 
important to note that sanctions may be applied sequentially or in combination, rather 
than as exclusive alternatives. Decisions to impose sanctions thus may need to take into 
account not only  the type of sanctions that are appropriate in relation to the conduct, but 
also whether previously imposed sanctions may logically or practically preclude or 
render particular additional sanctions inappropriate. This is especially true of sanctions 
that already exist under national intellectual property laws, which might preclude 
application of more lenient sanctions. To the extent that particular sanctions might 
conflict with existing patent law treaties, mandatory sanctions might supersede those 
treaty requirements.241 Moreover, mandatory sanctions may make more coherent the 
existing international system, requiring recognition and enforcement of national laws that 
would impose various sanctions on disclosure of origin failures. 
                                                 
237 For example, WTO, IP/C/W/429/Rev.1 and Add.1–Add.3, ¶¶ 3-6; WTO, IP/C/W/442, ¶¶ 5-8; WIPO, 
Examination, ¶ 164 (summarizing Submission of CIEL). 
238 WTO, IP/C/W/434, ¶¶ 15, 25-27; WTO, IP/C/W/429/Rev.1 and Add.1–Add.3, ¶¶ 9-10; WTO, 
IP/C/W/443, ¶¶ 10–12, 18–23. 
239 For example, WIPO, Compilation, p. 56, Submission of the European Communities. 
240 For example, id. (discussing “effective, proportionate and dissuasive sanctions outside the field of patent 
law”). 
241 See Vienna Convention, Arts. 31(2) and (3). For example, mandatory sanction obligations might require 
withdrawal and resubmission of applications or invalidation of the right to apply for the subject matter, 
even though the applicant had otherwise provided sufficient disclosures to obtain a filing date under PLT 





V. Functioning of disclosure requirements under WIPO treaties 
 
 
160. Most of the proposed forms of disclosure of origin requirements are legally 
compatible with existing WIPO treaties dealing with patent law (as well as with the 
TRIPS Agreement and  the UPOV Convention).242 Even if some forms of mandatory 
disclosure obligations were incompatible with an existing WIPO-administered treaty 
provision, such obligations (as later-enacted treaty provisions) would supersede the 
WIPO-administered treaty provisions for parties to both sets of treaty requirements.  
Alternatively, the WIPO-administered treaties could be amended to be consistent with 
these obligations. This analysis does not repeat the earlier legal analyses, but rather 
considers procedures within the WIPO-administered intellectual property law treaty 
system for processing applications, focusing on patent law requirements.  In doing so, it 
identifies various issues that may need to be addressed in any new international treaty 
provisions imposing mandatory disclosure of origin requirements.   
 
161. Although existing international treaties would legally permit the imposition of 
required disclosure of origin requirements at the national stage, they may not facilitate the 
receipt and transmission of any required or voluntarily disclosed information from 
international “receiving” intellectual property application offices to national “designated” 
offices. Receiving and designated offices may not be prepared to carry out mandatory 
disclosure obligations effectively or efficiently without the development of additional 
administrative rules, procedures and forms to address reproduction, publication and 
transmission of declarations and of supporting evidentiary documentation. Also, both 
international and national application offices may need authority to impose appropriate 
fees to cover the costs and administrative expenses relating to the processing of such 
information. Additional complexities arise with regard to electronic filing and processing 
of disclosures. Furthermore, rules, procedures and forms would need to consider the 
language of documents, linguistic abilities of officials and translation concerns. Finally, 
consideration should be given to the development of necessary administrative expertise, 
particularly if substantive evaluations of disclosed information are to be performed 
during the application process. 
 
A. Rules, forms and processing of information at the international stage 
 
162. The basic premise of the PCT system is the creation of a consistent set of 
international procedures for the administration of patent applications, which permits the 
filing of a single application in a receiving office, thereby having a simultaneous effect 
for filing priority purposes in multiple designated countries.243 Although receiving offices 
are authorized to require applicants to provide supplementary information for disclosures 
                                                 
242 See generally, Sarnoff, J.D. (2004). Additional discussions of specific provisions of the Paris 
Convention, the PLT, and the PCT, focusing on their formal or substantive character, are provided in 
WIPO/IP/GR/05/01, ¶¶ 172–190.   
243 For example,  UNEP/CBD/COP/7/INF/17, ¶¶ 172–173. 
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that appear to be invalid or inadequate,244 they do not routinely evaluate the substantive 
adequacy of the disclosed information.245 Following preliminary reviews in the receiving 
office, applications may be subjected to various preliminary substantive reviews (e.g. for 
preliminary searches and preliminary examinations246) in the receiving office or other 
appropriate application offices. Although the PCT system now requires preliminary 
reports on patentability,247 the reports (and voluntarily requested preliminary 
examinations) are not binding on designated national application offices. The principal 
function thus served by the international system is the receipt, processing and transfer of 
the application information and preliminary analyses to the designated national offices. 
 
Rules and forms   
 
163. At the international stage, disclosures must be provided through a standardized 
application request form in accordance with the PCT Administrative Instructions 
mandating the use of “standardized wording” for completing the form.248 PCT Rules 
direct the international receiving office to delete information contained in the request 
form that is not authorized under the Rules or which the Administrative Instructions do 
not expressly permit to be voluntarily disclosed.249 Additional PCT Rules address specific 
forms of information relating to genetic resources, such as references to deposits of 
biological materials or to the listing of nucleotide or amino acid sequences.250   
 
164. The PCT Rules authorize designated national offices to require additional 
disclosures at the national stage of application processing that relate to: (i) inventorship; 
(ii) entitlements to apply; (iii) entitlements to claim priority to earlier applications; (iv) 
oaths or declarations of inventors; (v) documents relating to “non-prejudicial” (public) 
disclosures under national laws; (vi) confirming signatures of additional applicants; and 
(vii) missing information regarding applicants.251 As recognized by the Swiss Proposal, 
the PCT Rules limit the authority of national offices to require additional formal (but not 
substantive) disclosures to those made at the international stage relating to inventorship 
                                                 
244 Under PCT Rule 26ter 2, the receiving office or the International Bureau “may” invite applicants to 
correct declarations under Rule 4.17 if the office or Bureau “finds” they are not worded or signed as 
required by the Administrative Instructions, but the Rules do not mandate review for such defects. 
245 Cf. WIPO/IP/GR/05/01, ¶¶ 170–171 (discussing formal review of disclosure adequacy at the 
international stage for purposes of obtaining a filing date, and later substantive review for patentability). 
246 PCT Arts. 17, 18, 34 and 35. 
247 PCT Rules 44bis and 70 (as in force from April 1, 2005) (establishing an enhanced international search 
and preliminary examination system, requiring mandatory “international preliminary reports on 
patentability,” whether or not an applicant requests a preliminary examination), available at: 
http://www.wipo.int/pct/en/texts/pdf/pct_regs.pdf. 
248 See WIPO, PCT/RO/101, Notes to the Request Form, p. 3 (April 2005) (referencing WIPO, PCT/AI/2, 
PCT Administrative Instructions §§ 211-15 (as in force Feb. 12, 2004), available at: 
http://www.wipo.int/pct/en/texts/pdf/ai.pdf); id. (noting that where the “standardized wordings are not 
applicable,” declarations  should not be made on the PCT authorized form, but rather should be supplied 
only at the national stage). 
249 PCT Rule 4.18(a) and (b). 
250 PCT Rule 13bis.1, 13bis.2, and 13ter; WIPO, Technical study on disclosure requirements related to 
genetic resources and traditional knowledge, 2003, ¶ 178. 
251 PCT Rules 4.17, 51bis.1(a). 
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and entitlement to apply, unless there is reasonable doubt as to the veracity of the earlier 
disclosures at the international stage.252    
  
165. The types of information that may be supplied at the international stage pursuant 
to disclosure of origin requirements are likely to vary significantly from the types of 
information that were contemplated when creating the PCT Rules, Administrative 
Instructions and Request Form. Thus any new international treaty provisions mandating 
disclosure of origin requirements may need to address amendments to the rules 
implementing various intellectual property treaties, and the creation of appropriate forms 
and instructions to assure that required information is included in, transmitted with and 
published as part of applications for intellectual property. Mandating the types of 
information and documents to be published at the international stage (in full, partial or 
summary form) will help ensure that countries of origin and persons involved receive 
adequate notice of relevant applications at the earliest time. 
 
Processing of information and fees 
 
166.  Specific PCT Rules also address the preparation and recording of the contents of 
applications and accompanying disclosures, and transmission of such information to 
different international application offices (such as the International Bureau and the 
International Search Authority) for various purposes.253 These purposes may include 
publication and provision of references to additional disclosures that are provided in the 
application, the International Search Report and preliminary amendments to the claims.254 
Additional Rules address further transmission of information (including opinions and 
examination reports)255 to applicants and to various international and national application 
offices (including designated offices for national stage processing).256   
 
167. As with the PCT rules that address information content and forms, those 
addressing information processing procedures were established with specific types of 
information in mind. Mandatory disclosure of origin obligations may require submission 
at the international stage of different kinds of information than are required by existing 
application procedures. Such information will need to be transmitted to various 
application offices and may be published. Therefore, careful consideration should be 
given to the types of information management procedures that will best facilitate 
transmission of disclosed information for recording, evaluation and public notice 
purposes, without generating undue administrative burdens and costs. 
 
                                                 
252 PCT Rule 51bis.2(a).  As discussed elsewhere, PCT Art. 27(3) (from which Rule 51bis.2 purports to 
derive its authority) should not be understood to prohibit additional disclosure requirements relating to 
substantive entitlements to apply for patents at the national stage.  See Sarnoff, J.D. (2004), p. 48. Rule 
changes may be needed, however, to ensure that such information can be required to be processed at the 
international stage and transmitted to the national stage. 
253 PCT Rules 22 and 23. 
254 PCT Rules 43, 46 and 48.2. 
255 PCT Rules 43bis, 44, 44bis, 62 and 70. 
256 PCT Rules 47, 71, 73 and 93bis.1. 
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168. The PCT Rules permit electronic filing, processing and transmission of 
applications and associated documents,257which may substantially reduce the costs of 
processing information. However, various countries may not be prepared to manage 
electronic submissions or transmissions,258 and many applicants may not be able to create 
or  transmit electronic documents. Additional concerns could arise with regard to: 
creating, preserving and ensuring the legibility and integrity of electronic records or 
documents;259 ensuring that the information provided uses common formats, and that 
electronic information management systems are interoperable and secure;260 and 
certifying the authenticity of electronic records or documents.261 
 
169. Regarding fees, current PCT Rules262 were established with specific types of 
information in mind.  Accordingly, fees may need to be adjusted to take into account the 
different types of disclosure of origin information that will need to be processed.  
Consideration should be given to ensuring that such fees are not prohibitive for 
applicants.  
 
Language concerns  
 
170. Specific PCT Rules govern the requirements for submission of applications in 
various languages,263 and specify when translations of information contained in 
applications or produced during evaluation of applications may be required.264 Issues 
relating to the language of submitted information and the need for translations may occur 
with greater frequency for disclosures of origin than for other types of disclosures in 
intellectual property applications. Access to genetic resources and associated traditional 
knowledge may be provided from countries that either may not be the countries where the 
patentable subject matter is developed, or may not be the countries in which international 
or national applications are originally filed and subsequently prosecuted. Sources giving 
access to genetic resources and traditional knowledge may provide information and 
documents in languages (including indigenous languages and local dialects) different 
from the official language of the country providing such resources and knowledge. 
Information and documents and CBD access and benefit-sharing legislation from such 
countries thus may be in languages different from the official language of the 
international receiving office or designated offices.   
 
171. Careful consideration therefore should be given to the languages in which 
intellectual property applicants must submit required disclosures of origin and 
documentary information regarding compliance with access and benefit-sharing, and to 
the need for and timing of translations of such information and documents. Applicable 
                                                 
257 PCT Rule 89bis.1(a), 89ter; WIPO, PCT/AI/2, §§ 701–713. 
258 PCT Rules 89bis.1(d) and 89bis.3. 
259 For example, WIPO, PCT/AI/2, §§ 706 and 708. 
260 For example, WIPO, PCT/AI/2, §§ 703, 710, Appendix F. 
261 For example, WIPO, PCT/AI/2, §§ 710(a)(iv), 711(b). 
262 For example, PCT Rules 14–16, 19.4(b), 21(c), 26bis.2(c), 31.1(b), 40.1, 40.2, 48.4, 49.1, 57, 58, 58bis, 
68.2, 68.3, and 91(f). 
263 PCT Rule 12.1. 
264 For example, PCT Rules 12.3, 12.4, 45, 48.3, 55.1, 55.2, 62bis.1, 72, 74 and 76. 
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requirements should reflect the types of mandatory or facultative evaluations of such 




B. Rules, forms and processing of information at the national stage 
 
172. As with international stage applications, mandatory disclosure obligations will 
need to address the rules, forms, procedures and fees at the national stage of processing 
applications for intellectual property, in light of the types of evaluations to be performed. 
However, such national stage procedures and evaluations may vary dramatically among 
different countries, given the wide range of practices and legal requirements that exist for 
different types of intellectual property applications. At the national stage additional 
documentation or the use of forms different from those employed at the international 
stage may be required,265 and translation of information and documents is even more 
likely to be required than at the international stage.266 Also, at this stage, different fee 
structures will apply depending on the types of information required to be submitted and 
the types of evaluations to be performed.267 
 
173. Unlike at the international stage, national application offices may be required to 
evaluate the factual accuracy, validity and authenticity of various disclosures, 
declarations and documents (at least where the information facially appears to relate to 
substantive validity of the application or facially calls into question the entitlement to 
apply for intellectual property). Thus, different considerations may be involved with 
regard to retaining, processing and transmitting disclosures of origin and accompanying 
documentation at the national stage. 
 
Rules, forms, processing and fees   
 
174. Neither the PCT nor the PLT prohibit disclosure of origin requirements at the 
national stage of processing PCT applications or for national applications in PLT 
jurisdictions. Depending on the degree to which mandatory disclosure of origin 
obligations harmonize national application disclosure requirements, different types of 
information may be required to be submitted at the national application stage using 
different forms and formats and pursuant to different procedures. Consideration therefore 
should be given to the degree to which disclosure requirements can and should be made 
consistent, so as to minimize information processing burdens on applicants. Particularly 
where regional application processing may exist,268 or where national application offices 
                                                 
265 For example, PCT Rule 51bis; PLT Arts. 6(2)(a) and 6(6).  See also PLT Art. 2(2) (limiting the Treaty 
from restricting any party from “prescribing such requirements of the applicable substantive law relating to 
patents as it desires”). 
266 For example, PLT Art. 6(3). 
267 For example, PLT Art. 6(4). 
268 For example, Protocol on Patents and Industrial Designs Within the Framework of the African Regional 
Industrial Property Organization (ARIPO), concluded at Harare (Zimbabwe) Dec. 10, 1982, as amended 




rely on prior evaluations and decisions by other countries’ application offices,269 
consistent procedures may greatly facilitate the submission and evaluation of required 
disclosures of origin and documentary information regarding access and benefit-sharing. 
 
175. Standardized requirements and forms may be particularly useful to minimize 
processing burdens and costs for applicants who file in multiple jurisdictions.  As noted 
by others in the context of certificates of origin, common procedures and standardized 
electronic (paperless) systems and databases that can be adapted for local purposes are to 
be preferred, because of the reduction of the need to perform different types of 
evaluations under differing legal regimes and because of the high costs of maintaining 




176. Translation issues may be particularly complex with regard to national stage 
evaluations of disclosures of origin. Disclosures of origin at the international stage are 
unlikely to be made in multiple languages, but may need to be translated so as to be 
understood and evaluated at the national stage in all of the various countries for which 
intellectual property is sought. Similarly, documents relating to access and benefit-
sharing requirements may, of necessity, be drafted in multiple languages. Whether 
translations are required will depend on the types of evaluations to be made of 
information disclosures, declarations and documents. Where translations are required, 
significant costs may be entailed and the potential for translation errors may arise. Thus 
careful consideration should be given to how disclosure of origin requirements might 
facilitate national stage evaluations in various languages. 
 
                                                 
269 For example, Government of Hong Kong (SAR, China) (2005) (noting that Hong Kong SAR registers 
patents granted by the State Intellectual Property Office of the Peoples Republic of China, the European 
Patent Office for patents designating the United Kingdom and the United Kingdom Patent Office), 
available at: http://www.ipd.gov.hk/eng/intellectual_property/patents/how_to_apply.htm#p3.  
270 For example, UNEP/CBD/WG-ABS/3/INF/5, pp. 62, 64–65 and 66.  Of course, a substantial investment 
of resources may be required to develop and adopt those systems. 
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VI. Intellectual property issues raised by international certificates of 
origin 
 
177. International certificates of origin were conceived of in the context of registering 
genetic resources and traditional knowledge and tracking their transboundary flows.271  
As understood here, international certificates of origin are documents issued by entities 
competent to certify that the source of genetic resources and associated traditional 
knowledge has the authority to provide access on specified conditions, and also to certify 
the existence of ex ante benefit-sharing requirements that are compliant with the CBD 
and with relevant laws and equitable principles of the country providing such resources 
or knowledge.272 International certificates of origin thus provide documentation of the 
legal provenance for the recipient to use the genetic resources and associated traditional 
knowledge under the identified conditions of access and benefit-sharing. As a result, 
international certificates of origin may provide highly relevant information regarding the 
types of disclosures of origin that may be required of intellectual property applicants. 
 
178. Numerous issues are raised by mandatory or facultative disclosures of origin in 
intellectual property applications using international certificates of origin. These 
certificates may assist applicants to make required disclosures of origin regarding 
compliance with access and benefit-sharing requirements of the country providing 
genetic resources and associated traditional knowledge. The value of the certificates of 
origin in this context will depend on the types of information contained in them and how 
they would be verified and tracked to ensure the integrity of their continuing application 
to the genetic resources and associated traditional knowledge that are relevant to the 
application for intellectual property.273 As with other disclosures of origin, use of 
certificates of origin could impose significant burdens of analysis, investigation and 
evaluation on applicants, certification entities and intellectual property offices, 
particularly if it is necessary to track ex-post compliance with benefit-sharing 
requirements identified in those certificates.. These considerations, however, do not differ 
significantly from the discussions provided above regarding substantive and procedural 
triggers, and thus are not repeated below. Instead, the analysis focuses on how certificates 
of origin may relate to existing intellectual property law requirements, and identifies 
                                                 
271 For example, UNEP/CBD/WG-ABS/3/INF/5, p. 52 (discussing certificates to “trace the flow of genetic 
resources”), and p. 54 (discussing certificates to monitor the “transboundary movement of genetic resources 
and potentially traditional knowledge”); WIPO, Compilation, p. 41, Submission of Turkey (noting the 
registration of genetic resources in Turkey and supporting an international certification system to register 
all genetic resources). 
272 See, for example, UNEP/CBD/WG-ABS/3/2, ¶¶ 62, 67, 89 and n.33, 91 and n.43 (discussing a draft 
Central American regional agreement that would require competent entities to issue certificates of origin 
establishing the legality of access to genetic resources and traditional knowledge, and that would also 
require intellectual property authorities to demand presentation of the certificate before registering products 
or processes that “may involve the use” of genetic resources and traditional knowledge; also discussing 
Philippine and Costa Rican certification requirements), available at: 
http://www.biodiv.org/doc/meetings/abs/abswg-03/official/abswg-03-02-en.pdf.  Cf. WIPO/IP/GR/05/01, ¶ 
204 (noting questions of legal and practical capability of administrative and legal authorities in one 
jurisdiction to determine conformity with laws and regulations in other jurisdictions). 
273 For example, UNEP/CBD/WG-ABS/3/INF/5, p. 17–18 (citing UNU-IAS (2003)).   
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additional intellectual property law issues (in the context of trademark and unfair 
competition law) that are raised by such certificates. 
 
A. Subject matter of the certification and the certification standard 
 
179. Certificates of origin not only may help to track flows of genetic resources and 
associated traditional knowledge, they also provide a certification of authority to provide 
access to the relevant genetic resources and associated traditional knowledge on specified 
conditions of use and ex ante benefit-sharing. Thus, these certificates may require 
applicants and certification entities to evaluate the genetic resources and associated 
traditional knowledge used at very early stages of developing the subject matter of 
intellectual property applications, or that are used as necessary background information 
for such development. To ensure the integrity and relevance of certificates of origin, 
certification entities also must verify that the uses to which genetic resources and 
associated traditional knowledge have been put conform to the authorized conditions.274 
The certification standard must therefore address the level of confidence required for 
various determinations before certificates of origin can be issued.  
 
180. Certifying authorized access and equitable benefit-sharing may require extremely 
complex evaluations. For example, certification may require determinations of how the 
source acquired the resources under the national laws of multiple jurisdictions, and 
potentially may require determinations of international legal claims of sovereignty over 
genetic resources made by different countries. Certificates of origin also may certify 
additional information relevant to determinations of authorized access and  equitable 
benefit-sharing, thereby facilitating additional disclosures of origin in intellectual 
property applications. For example, certification entities may perform, or may require 
certificate applicants to conduct, investigations to identify countries of origin and persons 
involved.275 Careful consideration should therefore be given to the types of information 
to be certified, the levels of investigatory effort and of confidence required by the 
certification standard with respect to such information, and the burdens and costs of 
providing certifications. As with disclosures of origin, the nature of the certifications 
relating  to intellectual property applications should depend on the types of evaluations to 
be performed and the eventual uses for the certificates of origin. 
 
181. Consideration should also be given to the consequences of certification errors by 
competent entities, and to misuse of certificates by persons to whom they were issued.  
For example, where an applicant for intellectual property obtained a certificate of origin 
based on false representations to the certifying body, that applicant might (depending on 
the laws and equitable principles involved) lose the right to apply for or own the 
intellectual property, might be found to have engaged in inequitable conduct that would 
                                                 
274 For example, UNEP/CBD/WG-ABS/3/INF/5, p. 55 (discussing use of certificates to demonstrate both 
the origin and the right to use resources for specific purposes). 
275 For example, UNEP/CBD/WG-ABS/3/5 (2004), ¶ 96 (noting difficulties of identifying the country of in 




render the intellectual property invalid or unenforceable, or might be required to transfer 
ownership or any commercial benefits that have been or will be obtained. 
 
B. Ex-ante verification and ex-post tracking of certifications 
 
182. Some observers have noted the complexities involved in verifying that certificates 
of origin correspond to the genetic resources being certified, initially and later, 
particularly with respect to derivative genetic materials.276 These concerns have particular 
relevance for certificates of origin relied upon to document compliance with access and 
benefit-sharing requirements when applying for intellectual property.  Certificates of 
origin thus may need to provide traceability of the genetic resources and associated 
traditional knowledge in question from the source providing such inputs, through and 
including development of the subject matter of the intellectual property application and 
any granted rights and privileges.277 Without such traceability, it may be difficult to 
determine whether disclosures of certificates of origin are required, and to verify that the 
certifications correspond to the subject matter of the application in the relevant ways 
disclosed.  
 
183. To ensure the integrity of authorized access and equitable benefit-sharing under 
specified conditions of use, it may be necessary to trace genetic resources and associated 
traditional knowledge not only from the source to the subject matter of and applicant for 
the relevant intellectual property, but also to additional uses to which such resources and 
knowledge may be put (and for which intellectual property applications may not 
necessarily be sought). For example, genetic resources may lead to the development of 
subject matter by the applicant, which in turn may lead to the development of additional 
subject matter by other persons or entities who are not subject to contractual provisions 
for equitable benefit-sharing. Alternatively, the applicant may use genetic resources not 
only to develop the subject matter of the application for intellectual property, but also 
additional subject matter for which intellectual property applications have not been filed 
(e.g. trade secrets), and which provides unjustified and inequitable commercial benefits. 
 
184. Consideration also should be given to how international certificates of origin 
relate to the actual ex-post provision of equitable benefit-sharing based on certification of 
ex-ante arrangements for such benefit-sharing. This is particularly relevant in the context 
of intellectual property applications, as the premise of such applications is the granting of 
                                                 
276 For example, WIPO/IP/GR/05/01, ¶ 203 (quoting from UNEP/CBD/WG-ABS/3/5, p. 18); 
UNEP/CBD/WG-ABS/3/5, ¶ 94 (discussing “check points” for verifying certificates); UNEP/CBD/WG-
ABS/3/7, Annex I, p. 29 (discussing, in the context of additional elements and options for an international 
regime on access and benefit-sharing, internationally recognized certificates of legal provenance of genetic 
resources which employ standardized codes that accompany biological materials and are “passed to all 
extracts, derivatives, or information”), available at: http://www.biodiv.org/doc/meetings/abs/abswg-
03/official/abswg-03-07-en.pdf; Dedeurwaerdere, T., et al. (2004), p. 2, 4 (discussing change in materials 
covered by certificates due to “processing, breeding and refinement” and whether certification would 
address the “gene, sample, species, or batch”), available at:  
http://www.iddri.org/iddri/telecharge/biodiv/workshop-abs.pdf. 
277 Richerzhagen, C. (2004), Part 1 (discussing the “3 T’s: traceability, transparency and tractability” for 
certificates of origin), available at: http://www.ias.unu.edu/research/details.cfm/articleID/601. 
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exclusive rights or privileges that may subsequently result in commercial benefits. 
Tracing certificates of origin to subsequent conduct, however, may entail substantial 
levels of effort, administrative burdens and costs. 
 
C. Authority to certify  
 
185. As noted by others, prior informed consent and mutually agreed terms for access 
and benefit-sharing may involve, among other things, “research permits, collecting 
permits, export, and import permits. In most countries, different offices, even different 
Ministries, have the responsibilities for some or all of these permissions. Research on 
lands managed by local and indigenous communities, or on their biodiversity knowledge 
can require additional agreements (not formal permits, per se).”278 Accordingly, obtaining 
certificates of origin may require interacting with different levels of government and with 
multiple agencies or ministries within each level of government.  
 
186. Certificates of origin may need to differentiate between the types of certifications 
provided (and the entities authorized to provide them), based on when genetic resources 
and associated traditional knowledge were acquired.  For example, it has been proposed 
to distinguish between access obtained before the CBD (and its recognition of sovereign 
rights over genetic resources) and access obtained before and after adoption of CBD 
access and benefit-sharing legislation in the country providing genetic resources.279 This 
is particularly relevant in regard to ex-situ collections and materials provided under the 
multilateral facilitated access system of the ITPGRFA.280 Additional consideration is 
needed of how certificates or origin would assist disclosures of origin and demonstrations 
of compliance with access and benefit-sharing requirements in such situations. 
 
187. Particularly, given the complexities of determining certification authority and of 
making appropriate certifications, careful consideration should be given to whether to 
impose mandatory or facultative requirements to obtain and to disclose certificates of 
origin in order to meet disclosure of origin obligations. Such evaluations will depend in 
part on the robustness and comprehensiveness of the certificate of origin system and on 
the degree to which certificates of origin generate the types of information required to be 
submitted by mandatory disclosure of origin obligations and how useful they are for 
evaluations within or relevant to the intellectual property law system. 
 
                                                 
278 UNEP/CBD/WG-ABS/3/INF/5, p. 27. 
279 Dedeurwaerdere T., et al. (2004), p. 3. 
280 Although facilitated access is subject to strict conditions under material transfer agreements that apply to 
subsequent transfers, and either provide for benefit-sharing to an international fund or encourage such 
benefit-sharing where products are made available for further breeding, access is supposed to be provided 
expeditiously “without the need to track individual accessions.” ITPGRFA, Arts.12.3(b), 12.4, 13.2b(i) and 
d(ii). Further, although recipients are not supposed to claim intellectual property or other rights or 
privileges in accessed materials “in the form received,” ITPGRFA, Art. 12.3(d), significant disputes exist 
regarding application of this provision to isolated and purified genetic sequences. See, for example, Helfer, 
L.R. (2002), at § 4.3.2.4, available at: http://www.fao.org/Legal/Prs-OL/lpo31.pdf. Thus benefits may flow 
to the international fund without regard to the country of origin, may not be required to be shared under the 




D. Confusion, false certifications, errors and related concerns 
 
188. International certificates of origin, like other certification documents issued by 
competent government entities, may be put to numerous commercial uses, in addition to 
enabling access to genetic resources and associated traditional knowledge and 
demonstrating prior informed consent and equitable benefit-sharing so as to obtain 
intellectual property. For example, certification marks and labelling relating to 
certificates of origin may be useful in promoting commercial recognition of the subject 
matter of intellectual property and in obtaining benefits for countries and indigenous or 
local communities that exercise rights over genetic resources and associated traditional 
knowledge. Such uses raise difficult questions regarding the authenticity standards  to be 
applied.281   
 
189. Furthermore, certificates of origin may be put to false, deceptive and confusing 
uses.282 As with consumer confusion regarding the “origin, sponsorship or approval” of 
goods or services in trademark law,283 relevant persons (including officials in intellectual 
property offices) may be confused as to the referents of certificates of origin and the 
authority of the certificate holder to use the certified genetic resources and associated 
traditional knowledge. Confusion may also result if certificates of origin fail to identify 
the country of origin and other persons involved, in instances where such identification 
may be required to demonstrate the legitimacy of access or equitable benefit-sharing. 
Similarly, confusion may result when multiple countries issue certificates of origin that 
are in conflict regarding claims of authority to use genetic resources or  regarding the 
equity of the benefit-sharing arrangements. 
 
190. Concerns as to the integrity of certificates of origin arise precisely because 
certifications are valuable to commercial relations and may provide unjustified 
commercial benefits when they are falsified, contain errors, or are used in a confusing 
manner. Applicants for certificates of origin may falsify information submitted to 
certification entities in order to obtain improper certifications for use in intellectual 
property applications. Applicants for intellectual property also may falsify certificates of 
origin themselves.284 Falsification or other improper uses of certificates of origin may 
result in improper issuance of intellectual property and other public and private harms, 
whether or not access to genetic resources and traditional knowledge was authorized and 
                                                 
281 See, for example, Drahos, P. (2004), pp. 32–34 (discussing failures to accommodate needs of all 
indigenous groups and to fund administration of the Indigenous Label of Authenticity and Collaboration 
Mark adopted by the National Indigenous Arts Advocacy Association of Australia in 1999), available at 
http://www.unctad.org/trade_env/test1/meetings/tk2/drahos.draft.doc 
282 Cf. Escudero, S. (2001), p. 9 (discussing the Madrid Agreement for the Repression of False or Deceptive 
Indications of Source on Goods of 1891, Art. 1(1) (as revised), requiring seizure of goods bearing a false or 
deceptive indication of geographical origin), available at: 
http://www.southcentre.org/publications/workingpapers/paper10/wp10.pdf; United States law 15 U.S.C. § 
1125(a)(1)(B) (prohibiting false designations of origin or misleading designations of fact that misrepresent 
in commercial advertising the geographic origin of goods, services or commercial activities) 
283 United States law 15 U.S.C. § 1125(a)(1)(A); and 15 U.S.C. § 1114(a) (addressing infringement of 
registered marks). 
284 See, for example, Dedeurwaerdere, T., et al. (2004), p. 2 (discussing authorized signatures/seals, special 
paper or stamps, electronic systems and security issues). 
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equitable benefit-sharing provided.  Even when all parties are acting in good faith, 
certificates of origin may contain errors.   
 
191. Consideration should be given to ensuring the integrity of certificates of origin, to 
correcting errors in certification, and to deterring, identifying and punishing false 
statements and falsified certificates.  Existing laws may impose mandatory or facultative 
sanctions within and external to the intellectual property system for errors in certificates 
of origin that are relied on for disclosures in intellectual property applications. For 
example, a certificate of origin that fails to name the correct source may result in the 
failure to name a joint inventor of the subject matter of the intellectual property 
application. Later discovery of the error might entail any of the following remedies under 
existing intellectual property laws: correction of inventorship; transfer of ownership; 
invalidation or unenforceability of the intellectual property; or the return or transfer of 
benefits. Additional consequences within or external to the intellectual property law 
system might be imposed, including administrative fines, civil liability, criminal penalties 
and additional benefit-sharing obligations. Flexibility may be needed to determine the 
sanctions to be employed for various types of certification errors.  
 
192. Finally, consideration should be given to whether and how ownership of 
certificates of origin can be transferred. For example, in the United States, trademarks 
cannot be assigned separately from the goodwill that the trademarks signify.285  
Certificates of origin may need to apply to and be transferred with the relevant genetic 
resources and associated traditional knowledge.286 It may not make sense to permit the 
transfer of ownership in certificates of origin separately from the relevant genetic 
resources and associated traditional knowledge. 
 
 
                                                 
285 See, for example McCarthy Thomas J. (2005), § 18.2 (citing United States cases). 
286 See, for example, UNEP/CBD/WG-ABS/3/7, p. 29 (discussing passing certification codes to extracts, 
derivatives and knowledge); UNEP/CBD/WG-ABS/3/INF/5, p.46, fig. 4 (providing flow diagram of 





193. In summary, there is a need for new international treaty provisions that would 
mandate disclosures of origin requirements in applications for intellectual property.  The 
most appropriate treaty regime to adopt such requirements is the TRIPS Agreement. 
Numerous benefits would derive from disclosure of origin requirements, although care 
should be taken to minimize the administrative costs and burdens of implementation. The 
treaty provisions will need to specify the substantive and procedural triggers for making 
required disclosures, the types and timing of evaluations to be performed with disclosed 
information, the mandatory or facultative consequences of various types of disclosure 
failures, and whether to mandate or facilitate the use of international certificates of origin 
in making required disclosures. Although disclosure of origin requirements are consistent 
with existing intellectual property treaties, such requirements may be facilitated by 
revising existing rules, forms and procedures implementing those treaties.  
 
194. Additional research and evaluation relating to the following issues would help to 
inform policy choices regarding the contents of mandatory disclosure of origin 
requirements:  
 
• Existing national laws addressing the relationship between 
misappropriation of genetic resources or traditional knowledge, and their 
effect on the validity of or entitlement to own or retain benefits from 
intellectual property; and 
• Applicable legal principles for the recognition and enforcement of existing 
national access and benefit-sharing laws and contractual provisions that 
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